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Abstract 
Histone modifications are thought to act as a layer of epigenetic information, because 
of their strong association with gene expression, and their potential role in 
transcriptional memory. However, although specific histone modifications correlate 
with transcriptional status, whether they play a causative role or act in the long term 
inheritance of gene expression patterns is unclear. 
In order to explore this, the histone deacetylase inhibitor valproic acid (VPA) was 
used to induce hyperacetylation of histones in embryonic stem cells. Surprisingly, 
although global levels of acetyl marks were highly increased by VPA treatment (up to 
16-fold), only 10% of genes showed transcriptional changes. Interestingly, these 
global changes in histone modification were not reflected in the changes at individual 
genes where increases in acetylation were rarely greater than 2-fold. Furthermore, 
changes in acetylation levels did not correlate with transcriptional effects. Wash-out 
experiments showed that transient VPA treatment could not induce long term effects 
on transcription, even during ES cell differentiation when histone modifications play a 
crucial role. Finally, the role of polycomb silencing in the response to VPA treatment 
was assessed using an ES cell line in which the polycomb components Eed and 
Ring1b had been knocked out. Target genes showed small up-regulation in knockout 
cells but VPA did not further induce transcription.  
It was concluded that histone acetylation plays an important role in transcription but 
additional signals are required for transcriptional induction and cellular memory. My 
results suggest the existence of protective mechanisms against hyperacetylation and 
highlight the complexity of epigenetic regulation, potentially involving many layers of 
control.   
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"1. Introduction 
1.1 Chromatin sensing of the environment 
The development of a complex organism requires a single genome to generate a 
multitude of cell phenotypes. The term “epigenetic” appeared in 1942 along with the 
idea that genetics and developmental biology should be related. Conrad Waddington, 
by using the prefix epi- (“above” in Greek), suggested the existence of mechanisms 
besides the gene sequence that participate to the acquisition and maintenance of a 
specific cell identity (Holliday, 2006). In addition to differentiation processes, a cell 
will be exposed to multiple events including mitotic and apoptotic signals, DNA repair, 
metabolite availability, drug exposure or the general chemical environment. All those 
events require the more or less rapid activation or silencing of specific genes, and for 
these changes to be maintained for the short or long term (i.e. more than one cell 
cycle). Thus, the cell has to sense its environment in order to adapt transcription 
levels of important genes and maintain proper function (Bird and Tweedie, 1995). In 
the nucleus, the DNA is associated with histone proteins, RNAs and non-histone 
proteins, in an organised structure named “the chromatin fibre”. Chromatin 
components are subject to chemical modifications, which are then interpreted by the 
transcriptional machinery for appropriate gene expression. Importantly, the activities 
of enzymes that add and remove those chemical “marks” have been shown to 
directly or indirectly depend on the environment. It has been proposed that the 
chromatin fibre, via modifying enzymes, acts as an environmental sensor and a 
signalling unit for the alteration of gene expression (Figure 1.1). Thus, it is of general 
interest to understand how environmental agents can impact on the activity of the 
genome in a short or long-term manner (Turner, 2009).   
#Figure 1.1 Role for the chromatin fibre as an environmental sensor in short 
and long-term establishment of gene expression 
Gene expression activity is regulated by a chromatin network composed of 
histones, DNA and non-histone proteins including transcription factors. Those 
components influence transcription through their modification by groups of highly 
specialised enzymes. The activity of modifying enzymes can be altered by 
environmental factors like inhibiting/activating molecules or metabolite availability. 
Thereby, gene expression is potentially affected by external signals. If chromatin 
modifications are causative of transcription and are inherited through cell cycle, 
an environmentally-induced epigenetic change could impact on transcription for 
several rounds of cell division. 
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$1.2 Chromatin fibre and modifications 
1.2.1 Chromatin organisation and dynamics 
The defining characteristic of eukaryotic cells is the presence of a nucleus. It is in this 
organelle that the bulk of genetic information is maintained. The DNA molecule can 
reach two meters in length and the nucleus is only a few microns in diameter. For this 
reason, the DNA fibre undergoes different levels of compaction (from the naked DNA 
to the metaphase chromosome) with the help of associated proteins. The complex 
resulting from the association between the DNA and the highly conserved histone 
proteins was named the chromatin fibre and was described as an array of 
nucleosomes. The first function of a nucleosome is therefore to package the DNA in 
order to resolve steric effects but also to regulate DNA accessibility, an important 
factor for gene expression. A nucleosome consists of a nucleosome core, the linker 
DNA, and associates with the linker histone H1 (Luger et al., 1997).  
 
The nucleosome core is formed by an octamer of histone proteins around which 146 
base pairs of DNA wrap in a left-handed superhelix. The best representation of the 
nucleosome to date was obtained using high-resolution X-ray crystallography (Figure 
1.2). The core histone octamer contains two copies of each histone H2A, H2B, H3 
and H4. Two H3-H4 pairs form a tetramer through the interaction between the two H3 
molecules. Two H2A-H2B dimers then interact with the H3-H4 tetramer through a 4-
helix bundle between H2B and H4 (Luger et al., 1997).  
 
 
%Figure 1.2 Crystal structure of the nucleosome core  
High resolution X-ray crystallography allowed visualisation of the nucleosome 
structure in 1997. The histone core octamer results in the association of a 2x(H3-
H4) tetramer and two (H2A-H2B) dimers. 146 base pairs of DNA wrapped around 
the histones to form the nucleosome. Importantly, N-terminal tails of histones that 
extend out of the nucleosome core are not visible due to their unstructured 
nature; Two strands of DNA (green and orange), H4 (green), H3 (blue), H2A 
(yellow), H2B (red); Face on view (left), side on view (right).  
Taken from Luger et al., 1997.           
&A fifth histone protein, the lysine-rich histone H1, was found to sit on top of the 
nucleosome outside the core octamer and to associate with the DNA at the entry/exit 
sites of the nucleosome. H1 was found to play a role in the stabilisation of compact 
chromatin fibre as an H1-depleted fibre could still fold into some higher order 
structures in the presence of NaCl (Hansen et al., 1989). However, H1 was found to 
be indispensible for proper mouse development (Fan et al., 2003) and for the 
compaction of metaphase chromosomes (Maresca and Heald, 2006).  
 
Finally, the portion of free DNA between adjacent nucleosomes was called the linker 
DNA. The length of linker DNA partly dictates nucleosome positioning and is 
considered as an important factor in chromatin function. In fact, it is likely that the 
position of nucleosomes in the chromatin fibre is a key determinant for the 
accessibility of various DNA-binding proteins and therefore affects gene regulation. 
For instance, a high resolution study in yeast showed that gene expression 
correlated inversely with nucleosome occupancy around the transcription start site 
(Lee et al., 2007c). The insulator-binding protein CTCF was also found to position 
nucleosomes around its binding site (Fu et al., 2008). What determines nucleosome 
positioning is still under debate and the DNA sequence, chromatin remodelling 
enzymes, histone modifications and transcription factors binding have been 
implicated (Arya et al., 2010).  
 
 
 
'The chromatin fibre is a dynamic structure that is associated with different levels of 
compaction (Figure 1.3). The negatively charged “naked DNA” associates with the 
positively charged histone proteins into nucleosomes linked to each other by a  
portion of linker DNA. At low salt concentrations, electron microscopy revealed this 
array as a “beads on a string” structure (Olins and Olins, 1974). However, when the 
ionic concentration was raised, reducing DNA-DNA repulsion, the chromatin was 
shown to fold into more compacted secondary structures, including the “30 nm fibre” 
(Thoma et al., 1979) and the 300nm fibre (Widom, 1986). Finally, a further increase 
in Mg2+ concentration was shown to induce the 300nm fibres to interact with each 
other side-by-side and end-to-end (Widom, 1986). How higher order chromatin 
structures are formed and stabilized remains unclear. Histone H1 phosphorylation, 
topoisomerase II and condensin complexes have been implicated in metaphase 
chromosome formation but mechanisms have not been fully described (Belmont, 
2006).  
 Early light and electron microscopy studies identified two types of chromatin in the 
nucleus. The heterochromatin was shown to remain compact throughout the cell 
cycle and the euchromatin was described as less condensed during interphase. The 
heterochromatin was therefore traditionally defined as the silenced regions of the 
genome in opposition to the open-to-transcription euchromatin. The picture became 
more complex when the heterochromatin was divided into two types, constitutive and 
facultative heterochromatin, where constitutive heterochromatin usually corresponds 
to specific regions such as centromeres or telomeres. On the other hand, regions of 
facultative heterochromatin vary between cell types and are regulated, for instance, 
by differentiation processes (Dimitri et al., 2005). The inactive X-chromosome in 
(Figure 1.3 The different levels of chromatin compaction 
!"#$%&' !)
The chromatin fibre is not a static structure and can be more or less compacted, 
as one of its major functions is to package the DNA into the nucleus and regulate 
binding protein access. Although chromatin is very dynamic, several layers of 
chromatin structure have been identified including the “beads on a string” fibre, 
the 30nm, 300nm and 700nm fibres as well as the very compacted metaphase 
chromosome. Histone H1 binds to the external face of the nucleosome in order to 
stabilise the 30nm fibre. However, how high levels of compaction are established 
is not fully understood yet.   
)female mammals would be one example of facultative heterochromatin. It is 
important to note that transcription is not a constant process so specific regions of 
chromatin are unlikely to stay in a unique conformation but must constantly adapt to 
cellular needs (Dimitri et al., 2009).  
  
1.2.2 Chromatin modifications     
A series of modifications to the DNA itself and the histone proteins have been 
characterised and are termed “epigenetic modifications”. Many studies have 
correlated these “marks” with gene activity, and several mechanisms describe how 
specific modifications induce transcriptional activation or silencing. Thus, it seems 
that the chromatin is not a simple packaging tool but also a platform for signalling that 
regulates gene expression.   
 
1.2.3.1 Histone modifications 
All histone proteins possess unstructured N-terminal tails that extend out from the 
nucleosome core. These exposed tails are subject to a wide variety of post-
translational modifications such as acetylation, methylation, phosphorylation, 
ubiquitination or ADP-ribosylation (Figure 1.4.a). Specific histone modifications are 
deposited on specific residues. For instance lysines (K) can be acetylated, 
ubiquitinated or sumoylated, while serines (S) are phosphorylated. Methylation 
occurs on both lysines and arginines (R) and at different levels as a residue can be 
mono-, di- or trimethylated (Kouzarides, 2007). Histone modifications alter 
transcription via direct or indirect effects. For instance, acetylation was shown to 
loosen the chromatin fibre by neutralising the positive charge of lysines. Thereby the 
*association of histones with DNA is weakened, allowing transcription factors and 
RNA polymerase to bind regulatory sequences (Tse et al., 1998). Histone 
modifications can also indirectly lead to changes in gene expression as they are 
specifically recognised by proteins that will then impact on the function of the 
adjacent chromatin (Taverna et al., 2007) (Figure 1.5.).   
Mass spectrometry identified more than 30 modifications in the core domains of 
histones. Although their roles is still unknown, they are suspected to impact on 
chromatin structure and transcription, for instance by altering the interaction between 
histones and DNA (Mersfelder and Parthun, 2006).   
 
1.2.3.2 DNA methylation 
Another major epigenetic modification, DNA methylation, has been consistently 
associated with transcriptional silencing. In eukaryotes, addition of a methyl group 
occurs on the cyclic carbon 5 of cytosine, predominantly at symmetrical CpG 
dinucleotides (Figure 1.4.b). However, evidence of non-CpG methylation was found 
in embryonic stem cells (Ramsahoye et al., 2000). The distribution of DNA 
methylation in the genome is uneven, as significant numbers of short regions of DNA 
are highly enriched in CG and often unmethylated when compared to bulk DNA. 
These so-called “CpG islands” mark the 5’ end of genes as they generally cover a 
portion of the promoter and the first exon. A little less than half of all genes are 
associated with CpG islands in mouse, and are either housekeeping genes or tissue 
restricted (Cross and Bird, 1995). Although CpG islands remain mostly unmethylated 
regardless of transcription activity, some important exceptions including methylation 
of the inactive X-chromosome or CpG islands associated with imprinted genes 
"+
(Ideraabdullah et al., 2008). Like histone modifications, DNA methylation regulates 
transcription both directly or indirectly and is generally associated with silencing. For 
instance, methylated CpG is able to block the binding of certain transcription factors 
like c-Myc or E2F (Campanero et al., 2000). In addition, a family of proteins that 
contain a methyl-CpG-binding domain (MBD proteins) play a role in silencing by 
targeting chromatin remodelling complexes to regulatory regions (Lopez-Serra and 
Esteller, 2008).    
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Figure 1.4 Modifications of histone tails and deoxy-cytosines 
a. Histone tails are the subjects of many post-translational modifications that 
occur on specific residues. Lysines can be acetylated, methylated or 
ubiquitinated. Phosphorylation occurs on serines and methylation on both lysines 
and arginines. Although modifications are shown only on one copy, they can take 
place on both copies of each histone.  
Adapted from Spotswood and Turner, 2002. 
b. DNA can be modified and more specifically methylated. The Majority of 
methylation occurs at cytosine residues and is catalysed by DNA 
methyltransferases (DNMTs).       
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Figure 1.5 Direct and indirect effects of histone modification 
Histone modifications affect transcription via direct or indirect effects. (a) 
Acetylation was shown to loosen the chromatin fibre by neutralising the positive 
charge of lysines. As a result, the association of histones with DNA is weaker and 
transcription factors or the RNA polymerase can bind to regulatory sequences. 
(b) Histone modifications can also indirectly change gene expression when being 
specifically recognised by proteins that will for instance promote chromatin 
remodelling.  
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1.2.3.3 Histone variants 
The incorporation of histone variants, as opposed to the canonical histones (H2A, 
H2B, H3 and H4), into the chromatin fibre is an additional well-established epigenetic 
phenomenon. Eukaryotic cells contain variants of histone H3 and H2A and an 
essential characteristic of those variants resides in their ability to distinguish 
chromatin states (Jin et al., 2005). For example, H2A.X is phosphorylated at DNA 
double-strand breaks sites while H2A.Z and H3.3 are found in regions of active 
transcription. Furthermore, MacroH2A was involved in heterochromatin formation and 
the histone variant CENP-A was shown to localized at centromeres (Jin et al., 2005). 
Mechanisms of histone variant incorporation at specific sites are now well studied as 
they could provide an explanation for the inheritance of expression patterns (Henikoff 
et al., 2004).     
 
1.2.3.4 Non-coding RNA 
Finally, being not directly associated with genomic variation, the mechanisms by 
which non-coding RNA (ncRNA) regulates transcription are also classified as an 
epigenetic phenomenon. It is now clear that a vast proportion of the mammallian 
genome does not code for proteins. However, the idea that non protein-coding 
portions of DNA are important regulatory regions is becoming well accepted. Many 
studies have provided evidence for a role of ncRNA in mRNA degradation and 
regulation of translation as well as X-chromosome inactivation or gene imprinting. 
Mechanisms are not fully understood yet, but specific ncRNA were recently shown to 
recruit chromatin modifiers like DNA methyl transferases (Zhou et al., 2010).       
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1.3 Histone modifications and transcription         
1.3.1 Deposition of histone modifications 
Large families of specific enzymes are responsible for the deposition or removal of 
histone modifications. The enrichment of each mark is therefore the result of a 
dynamic process involving the activity of two enzymes that catalyse opposite 
reactions (Table 1.1 and 1.2).    
  
1.3.1.1 Role of enzymes 
Acetyl groups are deposited on lysine residues by histone acetyl-transferases (HAT) 
and removed by histone deacetylases (HDAC). HATs and HDACs have been 
classified into different groups according to sequence homology or biological 
function. Two groups of HAT, A (nuclear) and B (cytoplasmic), have been classified 
into at least three families: The “GNAT” (including the cytoplasmic Hat1, the yeast 
member Gcn5 and its human homologue PCAF), the “MYST” (including MOZ, 
ybf2/Sas3, Sas2 and Tip60) and the “p300/CBP” (human paralogues) families. All 
HATs use Acetyl-CoenzymeA (CoA) as a donor for the transfer of acetyl residues. 
Interestingly, Gcn5/PCAF contains a bromodomain responsible for the recognition of 
the acetyl-lysine and some members of the MYST family contain a chromodomain 
that binds to non-coding RNA. Finally, the different HATs are not highly specific but 
do show preferential activity for certain histone isoforms and lysine residues 
(Marmorstein, 2001).  
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New 
nomenclature 
Human Drosophila S. cerevisiae Targeted residue 
Histone acetyltransferase  
KAT1 HAT1 CG2051 Hat1 H4K5,12 
KAT2   dGCN5/PCAF Gcn5 H3K9,14,18,23,36; H2B; yHtzl 
KAT2A hGCN5     H3K9,14,18; H2B; H4K8 
KAT2B PCAF     H3K9,14,18; H2B 
KAT3   dCBP/NEJ   H4K5,8; H3K14,18 
KAT3A CBP     H2AK5; H2BK12,15 
KAT3B P300     H2AK5; H2BK12,15 
KAT4 TAF1 dTAF1 Taf1 H3; H4 
KAT5 TIP60/PLIP dTIP60 Esa1 H4K5,8,12,16; H2A 
KAT6   CG1894 Sas3 H3K14,23 
KAT6A MOZ/MYST3 ENOK   H3K14 
KAT6B MORF/MYST4     H3K14 
KAT7 HBO1/MYST2 CHM   H4K5,8,12; H3 
KAT8 HMOF/MYST1 dMOF Sas2 H4K16 
KAT9 ELP3 dELP3/CG15433 Elp3 H3 
KAT10     Hap2 H3K14; H4 
KAT11     Rtt109 H3K56 
KAT12 TFIIIC90     H3K9,14,18 
KAT13A SRC1     H3; H4 
KAT13B ACTR     H3; H4 
KAT13C P160     H3; H4 
KAT13D CLOCK H3; H4 
Histone methyltransferase     
KMT1   Su(Var)3-9   H3K9 
KMT1A SUV39H1     H3K9 
KMT1B SUV39H2     H3K9 
KMT1C G9a     H3K9 
KMT1D EuHMTase/GLP     H3K9 
KMT1E ESET/SETDB1     H3K9 
KMT1F CLL8       
KMT2     Set1 H3K4 
KMT2A MLL1 Trx   H3K4 
KMT2B MLL2 Trx   H3K4 
KMT2C MLL3 Trr   H3K4 
KMT2D MLL4 Trr   H3K4 
KMT2E MLL5     H3K4 
KMT2F hSET1A     H3K4 
KMT2G hSET1B     H3K4 
KMT2H ASH1 Ash1   H3K4 
KMT3     Set2 H3K36 
KMT3A SET2     H3K36 
KMT3B NSD1     H3K36 
KMT3C SYMD2     H3K36 
KMT4 DOT1L   Dot1 H3K79 
KMT5A Pr-SET7/8 PR-set7   H4K20 
KMT5B SUV4-20H1 Suv4-20   H4K20 
KMT5C SUV4-20H2       
KMT6 EZH2 E(Z)   H3K27 
KMT7 SET7/9     H3K4 
KMT8 RIZ1     H3K9 
Table 1.1 Acetylation and methylation of lysine residues 
Names of each modifying enzyme are indicated for several species (Human, 
Drosophila and S.cerevisiae) as well as the common nomenclature. Marks 
indicated in green and red have been associated with active and repressed 
transcription respectively (H = histone; K = Lysine; KAT = Lysine acetyl-
transferase; KMT = Lysine methyl-transferase).  
Adapted from Allis et al., 2007    
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Table 1.2 Deacetylation and demethylation of lysine residues 
New 
nomenclature 
Human Drosophila S. cerevisiae Targeted residue 
Histone demethylases    
KDM1 LSD1/BHC110 Su(var)3-3 H3K4me1/2; H3K9me1/2 
KDM2     Jhd1 H3K36me1/2 
KDM2A JHDM1a/FBXL11 H3K36me1/2 
KDM2B JHDM1b/FBXL10     H3K36me1/2 
KDM3A JHDM2a H3K9me1/2 
KDM3B JHDM2b     H3K9me 
KDM4 Rph1 H3K9me2/3; H3K36me2/3 
KDM4A JMJD2A/JHDM3A     H3K9me2/3; H3K36me2/3 
KDM4B JMJD2B H3K9me2/3; H3K36me2/3 
KDM4C JMJD2C/GASC1     H3K9me2/3; H3K36me2/3 
KDM4D JMJD2D H3K9me2/3 
KDM5   Lid Jhd2 H3K4me2/3 
KDM5A JARID1A/RBP2 H3K4me2/3 
KDM5B JARID1B/PLU-1     H3K4me1/2/3 
KDM5C JARID1C/SMCX H3K4me2/3 
KDM5D JARID1D/SMCY     H3K4me2/3 
KDM6A UTX     H3K27me2/3 
KDM6B JMJD3 H3K27me2/3 
a 
b 
a. Based on sequence homology, HDACs were classified into four groups. The 
subcellular location of each enzyme as well as the phenotype of knockout mice 
are indicated. 
Adapted from Mund and Lyko, 2010.  
b. Marks indicated in green and red have been associated with active and 
repressed transcription respectively (KDM = Lysine demethylase). 
Adapted from Allis et al., 2007.    
Subcellular location Knockout mice phenotype 
Histone deacethylases   
Class I HDAC1 nucleus E10.5 proliferation defects 
  HDAC2 nucleus P1 cardiac malformation 
HDAC3 nucleus E9.5 gastrulation defects 
  HDAC8 nucleus P1 craniofacial defects 
Class IIa HDAC4 nucleus/cytoplasm chondrocyte differentiation defect 
HDAC5 nucleus/cytoplasm cardiac hypertrophy after stress 
  HDAC7 nucleus/cytoplasm E11 endothelial dysfunction 
HDAC9 nucleus/cytoplasm cardiac hypertrophy after stress 
Class Iib HDAC6 mainly cytoplasm increased tubulin acetylation 
HDAC10 mainly cytoplasm not known 
Class III SIRT1 nucleus defects in spermatogenesis/germ cell function 
  SIRT2 mainly cytoplasm no obvious phenotype 
SIRT3 mitochondria no obvious phenotype 
  SIRT4 mitochondria no obvious phenotype 
  SIRT5 mitochondria no obvious phenotype 
SIRT6 nucleus premature aging 
  SIRT7 nucleolus reduce lifespan, cardiac hypertrophy 
"(
Based on sequence similarity and cofactor dependency, 18 HDACs were divided into 
the “classical” and the “sirtuin” families (Haberland et al., 2009). Class I (HDACs1, 2, 
3, 8), class IIa (HDACs 4, 5, 7, 9), class IIb (HDACs 6, 10) and class IV (HDAC11) 
belong to the classical family and require Zn2+ as an acetyl group acceptor. The class 
III enzymes (SIRT1-7) belong to the sirtuin family and need NAD+ for deacetylase 
activity (Yang and Seto, 2007). HDAC enzymes have little specificity for specific 
histones or lysine residues. However, establishment of knockout cell lines or mice 
have shown that the various isoforms are expressed in different tissues and at 
different times in development. For instance, HDAC4 plays a crucial role in 
skeletogenesis while HDAC 5 and 9 are important for cardiovascular development 
(Haberland et al., 2009).      
The methylation state of the histone tails also depends on the antagonistic actions of 
large families of enzymes. Lysine residues are methylated by lysine methyl-
transferases (KMTs) that contain a conserved SET-domain responsible for the 
transfer of a methyl group from S-adenosyl-L-methionine (SAM) leading to the 
production of S-adenosyl-L-homocysteine (SAH). SET-domain containing enzymes 
have been classified into seven main families (SUV39, SET1, SET2, EZ, RIZ, SMYD 
and SUV4-20) according to sequence homology and function. Unlike HATs, KMTs 
are residue-specific. For instance the SUV39 family of enzymes is responsible for 
H3K9 methylation while the SET1 family induce methylation of H3K4 residues (Dillon 
et al., 2005). Although arginine methylation has been less studied, enzymes 
implicated in the process were identified. Peptidylarginine methyltransferases 
(PRMTs) have been classified into four types, which are all able to monomethylate 
arginines. In addition, type I and type II PRMTs respectively catalyse asymmetric and 
")
symmetric dimethylation of arginines. PRMTs were shown to target proteins involved 
in gene regulation including histones H3, H4 and H2A (Bedford, 2007).  
Lysine methylation has been considered as a dynamic modification since the 
discovery of lysine demethylases (KDMs), although not all residues have had a 
demethylase identified so far. The first group of KDMs contains the flavin-dependent 
enzymes LSD1 that demethylates H3K4me1/2 (Shi et al., 2004) and H3K9me1/2 
(Metzger et al., 2005) and LSD2 that is specific for H3K4me1/2 (Karytinos et al., 
2009). A second family of KDMs is characterised by a Jumonji C (JmjC) domain and 
an oxygenase activity dependent on Fe(II) and !-ketoglutarate. Several members 
were shown to remove all three histone lysine-methylation states on H3K9 and 
H3K36 (Klose et al., 2006). Very little is known about arginine demethylation. The 
Jumonji domain-containing 6 protein (JMJD6) was described as a H3R2 and H4R3 
demethylase (Chang et al., 2007) and PADI4 was shown to antagonise arginine 
methylation on H3 through deimination of residues (Cuthbert et al., 2004).  
 
As previously mentioned, in addition to acetylation and methylation, histone proteins 
are subjects to a wide variety of post-translational modifications. Kinases and 
phosphatases respectively add and remove phosphate groups on serine, threonine 
and tyrosine residues while ubiquitin-ligases and de-ubiquitin enzymes control lysine 
ubiquitination levels on H2A and H2B (Bannister and Kouzarides, 2011). 
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1.3.1.2 Regulation of enzymes 
Most modifying enzymes depend on cofactors that are products of the cellular 
metabolism. For instance, HATs transfer acetyl groups that come from acetyl-CoA. 
This compound is produced during the pyruvate decarboxylation reaction before 
entering the citric acid cycle. The availability of acetyl-CoA therefore depends on 
glucose metabolism, pyruvate being a product of glycolysis (Spriet and 
Heigenhauser, 2002). Histone methylases and DNA methyl-transferases on the other 
hand use SAM as a cofactor. Methionine synthetase, responsible for the conversion 
of homocysteine into methionine, uses methylated tetrahydrofolate (MTHF) as a 
source of methyl group. MTHF is a folate derivative, providing another link between 
gene expression and external signals (here dietary folate intake) (Loenen, 2006). 
Demethylation involves Fe2+ as a cofactor, showing again the dependence of 
enzymes on nutrient intake and the basic metabolism. In addition deacetylation was 
shown to be NAD+-dependent, whereas phosphorylation was shown to be ATP-
dependent, both molecules being important cofactors in many metabolic reactions.       
 
Enzymes that catalyse deposition and removal of histone modifications are very often 
found in conserved multi-subunit complexes where the associated proteins usually 
regulate their enzymatic activity, substrate recognition or cofactor binding. For 
instance, Class I HDACs assemble in at least four repressor complexes: Sin3, NuRD, 
CoREST and NCor/SMRT. The Sin3 complex contains among others HDAC1 or 2 
along with the histone binding protein RbAp46/48, the histone demethylase KDM5A 
and SAP30 that mediates interaction with DNA-binding proteins. HDAC1 and 2 also 
interact with the methyl-CpG binding domain protein MBD3, the histone demethylase 
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LSD1 and the chromatin remodeler CHD4, a component of the NuRD complex. Other 
HDACs assemble complexes (e.g. HDAC3 with JMJD2 in the NCor/SMRT complex) 
or are able to bind directly to transcription factors (e.g. HDAC4 represses Myocyte 
enhancer factor 2 (MEF2)) (Youn et al., 2000).  
Similarly, HAT complexes have been identified and they mainly contain enzymes 
from the GNAT and MYST families. For instance in Saccharomyces cerevisiae, 
SAGA (PCAF in human) or SLIK complexes associate with the HAT Gcn5, whereas 
members of the MYST family are found in the NuA4 or SAS complexes (TIP60 in 
human and MSL in Drosophila). Those complexes play important roles in gene 
activation or DNA repair through interaction with histone modifications or histone 
variants (Lee and Workman, 2007).   
 
Enzymes regulating acetylation levels have been implicated in several diseases. In 
fact, the identification of specific targets of HATs and HDACs revealed their role in 
cell proliferation, inflammatory response, learning and memory, neurodegeneration or 
viral infections. For this reason, small molecules that modulate HAT and HDAC 
activities have been extensively studied for potential therapy. A large number of HAT 
inhibitors were identified including the natural products curcumin, garcinol or 
anacardic acid (Dekker and Haisma, 2009). In addition, a few molecules were shown 
to activate HATs, probably through structural alteration (nemorosome, (Selvi et al., 
2010). The study of epigenetic profiles in cancer cell lines revealed important 
alterations of DNA methylation or histone modification associated with alterations of 
gene expression including silencing of some tumour suppressor genes. As a result, 
several small molecules modulating activity of DNMTs or HDACs are currently being 
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tested in clinical trials or have been approved for cancer therapy (Mund and Lyko, 
2010). The best-characterised DNMT inhibitor, 5-azacytidine was approved for the 
treatment of myeloid leukaemia. HDAC inhibitors have been classified into five 
different groups with different HDAC-specificities. For example, Trichostatin A (TSA) 
and Suberoylanilide hydroxamic acid (SAHA) belong to the hydroxamic family and 
inhibit all HDACs. Romidepsin belongs to the cyclic tetrapeptide family and inhibits 
HDAC1 and 2, whereas the short-chain fatty acids Valproic acid (VPA) and phenyl 
butyrate inhibit class I and IIa HDACs. Finally, HDAC1 and 3 are inhibited by the 
benzamide Etinostat and the synthetic benzamide N-acetyldinaline (Mund and Lyko, 
2010) (Figure 1.6).  
 
It is important to note that many mechanisms regulate modifying enzymes. For 
instance, the autoacetylation of HATs as well as post-translational modifications 
including phosphorylation or methylation. In addition, SIRT2 was shown to 
deacetylate p300, whereas HDAC3 targets PCAF (Selvi et al., 2010).  
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1.3.1.3 Valproic acid 
Valproic acid (VPA) is a branched short-chain fatty acid that was first synthesized in 
1882. Used as a solvent for organic compounds until 1963, it was found to prevent 
pentylenetetrazol-induced convulsions in rodents (Meunier et al., 1963). Since then, 
this compound and its derivatives have been widely used as anti-epileptic drugs. The 
mechanism of VPA action remains uncertain, but for epilepsy, two main pathways 
have been identified. VPA is believed to alter the activity of the neurotransmitter 
GABA (Mesdjian et al., 1982) and to inhibit the activity of several ion channels (Tian 
and Alkadhi, 1994). VPA has been employed in many clinical trials for the treatment 
of various neurological disorders, but showed very little benefit, however it is an 
efficient drug for the treatment of several myeloid and lymphoid malignancies as well 
as some solid tumours (Chateauvieux et al., 2010).    
In 2001, it was shown that VPA induces hyperacetylation of the N-terminal tail of 
histone H3 and H4. VPA was found to inhibit some Histone deacetylase (HDAC) 
enzymes, likely through binding to the catalytic site. Furthermore, it was shown to 
induce the differentiation and apoptosis of carcinoma cells in vitro and in vivo. Being 
well tolerated and very stable, VPA appears to be a promising drug for cancer 
treatment (Gottlicher et al., 2001). VPA inhibits Class I and class IIa HDACs. 
Interestingly, it increases the expression of HDAC9 and the class IV HDAC11 in 
human leukemic HL60 cells (Bradbury et al., 2005). HDAC expression is enhanced in 
many cancer types and in addition to targeting these proteins, VPA induces 
apoptosis and cell cycle arrest (Bolden et al., 2006). 
 
#%
1.3.2 Distribution of histone modifications 
The use of chromatin immunoprecipitation (ChIP), coupled to high throughput 
technologies like microarrays (ChIP-chip) or next generation sequencing (ChIP-seq), 
has allowed the construction of maps of histone modifications on a “typical gene” 
(Figure 1.7). It is important to remember that the result of a ChIP depends on the 
optimization of the technique as well as the antibody specificity or how the chromatin 
is prepared (for instance fixed or unfixed). ChIP also generally involves an 
asynchronous population of cells and can not determine if two different modifications 
occur on the same histone, or the same nucleosome or even in the same cells. 
However, many studies showed consistent data and allowed correlations between 
the presence of specific histone marks and the transcriptional state of a gene (Lee 
and Mahadevan, 2009). 
 
An early study on yeast using ChIP-chip revealed that nucleosome occupancy 
correlates negatively with transcription while H3K9ac, H3K14ac, H3K4me3 target 
promoters of active genes. In addition, H3K36me3 was detected in the bodies of 
active genes (Pokholok et al., 2005). Subsequent ChIP coupled with serial analysis 
of gene expression in primary human T cells confirmed that H3K9ac and H3K14ac 
co-localise with H3K4me3 at the promoter of constitutively active genes or T cell-
specific genes, and that H3K27me3 was present on silent genes. Interestingly, 
H3K4me3 and H3K27me3 were sometimes found together on genes (Roh et al., 
2006). In 2007, the first ChIP-seq allowed large scale mapping, at single nucleosome 
resolution, of 20 histone modifications as well as the histone variant H2A.Z, RNA 
polymerase II (RNA polII) and CTCF (Barski et al., 2007). Positive correlations with 
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transcription were observed for RNA pol II occupancy and H3K4me1/2/3. However, 
RNA pol II and H3K4me3 were also found on 37% and 54% of silent promoters 
respectively, indicating that those marks are not exclusive to active transcription. 
Interestingly, the methylation state of H3K4 was shown to decrease progressively 
from the transcription start site (TSS) into the gene body. In addition, positive 
correlations with transcription were established for H3K27me1, H3K9me1, 
H3K36me3, H3K20me1 and H2A.Z. In contrast, broad “blankets” of H3K27me3 were 
detected over silent genes as well as peaks of H3K9me2/3. Finally, CTCF was 
shown to separate regions of different chromatin states (Barski et al., 2007).  
In embryonic stem (ES) cells, the active mark H3K4me3 and the repressive mark 
H3K27me3 were found to co-localise on certain promoters called “bivalent domains”, 
and are believed to allow a “poised” state for subsequent activation or silencing 
(Bernstein et al., 2006; Mikkelsen et al., 2007). In another study in C. elegans using 
ChIP-chip, H3K36me3 was showed to localise to the body of transcribed genes. 
More precisely, the enrichment was found in exonic regions in opposition to intronic 
regions, and has been confirmed in mouse and human (Kolasinska-Zwierz et al., 
2009). In addition, enhancers were shown to be highly enriched in H3K4me1, H2A.Z 
and H3K27ac. However, analysis of ENCODE (Encyclopedia of DNA Elements) 
data showed that the chromatin state of enhancers is highly cell specific compared 
with promoters or insulators (Barski et al., 2007; Heintzman et al., 2009). 
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Figure 1.7 Distribution of histone modifications 
The use of chromatin immunoprecipitation coupled with microarrays (ChIP-chip) 
or sequencing (ChIP-seq) allowed the construction of maps of typical histone 
modifications on active and inactive genes. 
Adapted from Barski et al., 2007.     
TSS 
#(
1.3.3 Effect of histone modifications on chromatin structure and transcription 
1.3.3.1 Charge neutralisation 
The best-characterised example of chromatin modulation due to a change of charge 
is histone acetylation. This neutralises the positive charge of lysines and therefore 
reduces the association of DNA with the histone tails, thereby increasing the DNA 
accessibility to non-histone proteins. This is consistent with reconstitution of 
nucleosome arrays which showed that high levels of acetylation inhibited higher 
order folding of the chromatin, and increased transcription (Tse et al., 1998). In 
addition, arrays containing recombinant histone H4 homogeneously acetylated at 
lysine 16 could not fully condense into the 30mm fibre in vitro (Robinson et al., 2008; 
Shogren-Knaak et al., 2006), consistent with the idea that H4K16 has a unique 
impact on chromatin folding (Dorigo et al., 2003). In addition, microarray analyses 
performed after histone H4 was mutated at lysine 5, 8, 12 and 16 in yeast, found that 
the global changes in transcription induced by mutation of K16 did not correlate with 
the transcriptional outcomes of other mutations, reinforcing the special role of 
H4K16ac (Dion et al., 2005).  
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1.3.3.2 Binding histone modifications 
Many chromatin-associated proteins possess particular domains able to recognise 
and bind specific modifications. For instance, bromodomains are capable of 
interaction with acetyl residues while methyl marks are recognised by a wide range of 
domains including chromodomains, Tudor domains or PHD fingers. The family of 14-
3-3 proteins has been implicated in phosphoserine-binding. Along with the diversity 
of histone modifications, the diversity of “reader” domains  provide a new explanation 
for the multiple outcomes of chromatin marks (Taverna et al., 2007). In fact, reader 
domains give a chance for modifying enzymes and chromatin-binding proteins to 
communicate. Thereby, a series of modifications can act together to regulate 
transcription in a specific manner (Jenuwein and Allis, 2001; Spotswood and Turner, 
2002).    
 
All chromatin remodelling complexes, which move nucleosomes to regulate DNA 
accessibility, recognize histone modifications and interact with chromatin modifiers 
(Clapier and Cairns, 2009). For instance, the member of the SWI/SNF complex swi2 
possesses a bromodomain required for acetylated nucleosome displacement 
(Chandy et al., 2006). In addition, the initiation complex component TAFII250 
contains a bromodomain that specifically binds to acetylated H4 on lysines 5 and 12, 
suggesting a crucial role of acetylation in transcriptional initiation (Jacobson et al., 
2000). Finally, the ATP-remodeler CHD1 that belongs to the HAT SAGA complex 
contains two N-terminal chromodomains that recognise methylated H3K4. This 
complexity supports the idea of cross-talk between different histone marks and a 
code for transcription (Pray-Grant et al., 2005).    
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The formation of heterochromatin for gene silencing or chromosome segregation also 
necessitates the recognition of specific histone modifications. The heterochromatin 
protein HP1 is a fundamental factor in chromatin packaging and possesses a N-
terminal chromodomain that specifically binds to H3K9me2/me3 (Bannister et al., 
2001). Biochemical analysis indicates that HP1 interacts with SUV39H1, the enzyme 
responsible for H3K9 methylation. However G9a, another enzyme inducing H3K9 
methylation, did not recruit HP1, suggesting a silencing mechanism independent of 
HP1 (Stewart et al., 2005). Interestingly, the histone code hypothesis was well 
illustrated by the description of a “methyl-phospho” switch. Methylation often occurs 
in ARKS motifs where a serine residue adjacent to a modified lysine can be 
phosphorylated. In fact, the phosphorylation of H3S10 by Aurora B type kinases was 
shown to block HP1 binding during M-phase of the cell cycle (Fischle et al., 2005; 
Fischle et al., 2003). However, a more complex picture appeared when the role of 
H3K14ac was described in HP1 eviction (Cheung et al., 2000) whereas H3S10p and 
H3K9me were shown to co-localise and not prevent HP1 binding. These studies 
showed that HP1 could bind to all but H3K9me-S10p-K14ac peptides (Mateescu et 
al., 2004) (Figure 1.8).  
 
All these studies strongly suggested a role for histone modifications as binding sites 
in transcription activation or heterochromatin formation. In addition, the grouping of 
similar proteins that recognise different histone marks supports the hypothesis of a 
histone code.  
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Figure 1.8 Crosstalk between histone-binding proteins 
Histone modifications are recognised by specific motifs of binding proteins. 
Different proteins bind to different modifications. Therefore, when protein readers 
interact with each others, they lead to cross-talk between histone marks. For 
instance, the complex SWI/SNF recognises H3K14ac and, using ATP energy, 
displaces nucleosomes to favour transcription. In addition, TAFII250 lead to the 
assembly of RNA polII machinery when bound to H4K12,K5ac. H3K14ac together 
with H3S10P inhibit HP1 binding to H3K9me3, implicated in heterochromatin 
formation. HP1 interact with the SUV39H1 methylase and recognises 
H3K9me2/3.  
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1.4 Embryonic stem cells 
In 1981, two groups independently established the first mouse ES cell lines derived 
from the inner cell mass of late blastocysts (Evans and Kaufman, 1981; Martin, 
1981). Since then, gene targeting experiment in ES cells have become a major tool 
for the study of gene function and gene mutation in living mice (Capecchi, 2005). 
Embryonic stem (ES) cells are characterised by two main features: the capacity for 
prolonged self-renewal and the potential to differentiate into almost any cell type. In 
fact, ES cells injected into tetraploid blastocysts (required for extra-embryonic tissue 
formation) give rise to an entire embryo, confirming their pluripotent nature. This also 
shows that ES cells are pluripotent and not totipotent as they need the blastocyst 
structure to generate a chimeric animal (i.e. They can’t generate extra-embryonic 
tissues) (Nagy et al., 1993). The pluripotent nature of ES cells, can now be 
reproduced in culture due to many early studies monitoring ES cell differentiation 
pathways and identifying specific markers. Based on those studies, protocols that 
involve the spatial rearrangement of cells in culture and exposure to specific factors 
were described in order to drive differentiation of ES cells down defined lineages 
(Figure 1.9) (Murry and Keller, 2008).  
   
For many reasons ES cells constitute an invaluable tool which could potentially lead 
to the understanding of mechanisms governing pluripotency and differentiation. 
Differentiation of ES cells in culture offers the possibility to study the establishment 
and long-term maintenance of specific gene expression programmes that define cell 
identity. A full understanding of pluripotency and cell fate is crucial for the 
development of regenerative medicine. Also, ES cells have allowed better 
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Figure 3 | Stochasticity of gene expression, developmental potency and lineage commitment. Th  stochasticity 
of gene expression and mutual interactions between lineage-determining transcription factors with antagonizing 
functions gradually lead to the first cell lineage decisions. These transcription factors include OCT4 (which is encoded  
by Pou5f1)74,119, the homeobox protein NANOG74, SRY box-containing factor 2 (SOX2)120, Sal-like protein 4 (SALL4)121, 
STELLA (also known as DPPA3)122, caudal-type homeobox 2 (CDX2)74,123, eomesodermin (EOMES)75,124 and ELF5 (REFS 90,91). 
This process is accompanied by epigenetic programming events that impose a permissive (or non-permissive) environment 
for cell fate or might predispose a cell towards a particular lineage. It is feasible that the expression of each transcription 
factor oscillates between a minimum and maximum level, and positive or negative interference of such transcriptional 
‘noise’ introduces a developmental bias in individual blastomeres (indicated by the cell shading). Expression of key 
transcription factors remains mosaic in individual blastomeres until the blastocyst stage, when the embryonic (the inner  
cell mass (ICM), epiblast and derived embryonic stem (ES) cells) and trophoblast (the trophectoderm (TE) and derived 
trophoblast stem (TS) cells) lineages are established. De novo DNA methylation is initiated between the morula (16-cell 
stage) and blastocyst stage7. Lineage fixation coincides with methylation of Elf5 in the ICM, which establishes a tight 
epigenetic boundary between the embryonic and trophoblast lineages91. Methylation of Stella occurs in the same overall 
time window (although probably slightly later than Elf5) and might have a similar gatekeeper function to establish the 
post-implantation epiblast77.
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understanding of tumour formation as cancer cells often present a stem cell-like 
phenotype. Indeed, the first embryonic cell lines were derived from mouse 
teratocarcinomas (Solter, 2006), and embryonal carcinoma cells allowed the 
identification of alkaline phosphatase activity as a marker of undifferentiated cells 
(Berstine et al., 1973) or the increase of SSEA-1 expression at an early stage of 
differentiation (Solter and Knowles, 1978).  
 
1.4.1 Genetic regulation of pluripotency 
In vivo, pluripotency is a transitional state, and very early in development most of the 
cells that compose an embryo are engaged in a differentiation pathway. However 
during this short period of time, cells have to maintain the pluripotent state and a high 
rate of proliferation. Interestingly, many studies have shown that gene expression in 
ES cells is very variable and “noisy”, leading to heterogeneous populations poised for 
a range of lineage specification. It is therefore difficult to define what makes a cell 
pluripotent (Silva and Smith, 2008). 
 
Nevertheless, gene expression networks have been described in ES cells. In 2006, it 
became possible to generate induced pluripotent stem (IPS) cells. Transfection in 
mouse fibroblasts led to the conclusion that only four transcription factors were 
required for reprogramming: Sox2, Oct3/4, Klf4 and c-Myc. IPS cells showed high 
similarity to ES cells and were able to differentiate into mouse embryos when injected 
into blastocysts (Takahashi and Yamanaka, 2006). A well-known signalling pathway 
in ES cells is initiated by the cytokine Leukaemia inhibitory factor (LIF) that acts via 
the glycoprotein-130 receptor to promote a JAK-STAT3 signalling cascade playing a 
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crucial role in maintenance of undifferentiated state (Raz et al., 1999). In culture, LIF 
is sufficient to maintain pluripotency of ES cells but also proliferation by targeting the 
transcription factor c-Myc (Cartwright et al., 2005).  
Deletion of Sox2 induced ES cells to differentiate, showing that Sox2 is indispensable 
for maintaining pluripotency. Sox2 and Oct4 bind together on enhancers linked to 
pluripotency associated genes like lefty1 or fgf4. The elimination of Sox2 did not 
affect those genes, possibly because of redundant members of the Sox family. 
However, Oct4 was down-regulated in Sox2-null ES cells, suggesting a role for Sox2 
in maintaining Oct4 expression (Masui et al., 2007). In fact, the transcription factor 
Oct4 has been extensively studied due to its major role in pluripotency maintenance. 
Oct4 overexpression initiates differentiation into primitive endoderm whereas 
repression leads to the trophectodermal lineage (Niwa et al., 2000). Finally, Nanog 
was identified as another major player in pluripotency maintenance. When 
constitutively expressed in ES cells, it is able to maintain pluripotency without LIF. In 
addition, loss of pluripotency and extraembryonic ectodermal differentiation was 
observed in Nanog-null ES cells (Mitsui et al., 2003).    
 
Although a pool of transcription factors was shown to be indispensable for 
pluripotency maintenance in ES cells, how they are regulated and how they regulate 
their targets is still under investigation. As mentioned earlier, Sox2 is a positive 
regulator of Oct4 (Masui et al., 2007). In addition, together with FoxD3, Nanog was 
found to be another enhancer of Oct4 expression, and is repressed by Oct4 itself. 
The suggested negative feedback loop was confirmed when overexpression of 
Nanog or FoxD3 did not change Oct4 expression. On the other hand, Oct4 was 
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shown to bind Nanog promoter for a dose-dependant regulation. In fact, Oct4-siRNA 
initially raised Nanog expression but an increase in siRNA transfection led to Nanog 
downregulation (Pan et al., 2006). As a final example, ChIP-chip experiments gave 
evidence that Klf4, Klf2 and Klf5 bind to several pluripotency-associated genes and 
an enhancer that interacts with those factors was found near Nanog promoter (Jiang 
et al., 2008).  
Several high-throughput studies have tried to identify targets of the master regulators 
of pluripotency. Chromatin immuno-precipitation (ChIP) is a technique by which 
specific antibodies separate bulk chromatin according to the presence or not of 
specific histone modifications or non-histone proteins. Bound and unbound (or input) 
fractions of chromatin are then analysed by qPCR, microarrays or sequencing in 
order to measure enrichment. ChIP combined with DNA microarray experiments 
performed using human ES cells, revealed that Oct4, Sox2 and Nanog share a 
significant number of targets. The three transcription factors were shown to co-
localise on 353 promoters of protein-coding genes and to actively regulate those 
targets. In fact, half of the co-occupied genes were transcriptionally active including 
some participating in pluripotency maintenance while the other half corresponded to 
inactive genes, mostly transcription factors involved in differentiation pathways 
(Boyer et al., 2005).  
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1.4.2 Chromatin structure in ES cells 
Because it is now well accepted that chromatin structures are associated with the 
transcriptional activity of genes, the purpose of many recent studies has been to 
describe a putative epigenetic signature of ES cells. The challenge for those cells is 
to maintain pluripotency while preparing for differentiation, to repress developmental 
genes but keep them poised for transcription.  
Interestingly, the reprogramming of primary human fibroblasts was shown to occur 
via the injection of only two transcription factors (Oct4 and Sox2) complemented with 
Valproate (VPA) treatment. The IPS cells then generated were able to regain an ES 
cell-like DNA methylation profile and global expression pattern and to differentiate 
into the three germ lineages (Huangfu et al., 2008). The fact that the HDAC inhibitor 
VPA was able to increase the efficiency of reprogramming supports the idea that 
chromatin structure is an important specifier of ES cell identity. Indeed, chromatin in 
ES cells was described as being less compact and acetylation on histones H3 and 
H4 have been shown to decrease during differentiation. ES cells seem to present a 
more diffuse heterochromatin structure as HP1 and H3K9me3 immunostaining 
appeared in large and poorly defined regions. However the clustering of these 
heterochromatin components in visible foci was observed during differentiation 
(Meshorer et al., 2006). In addition, FRAP (fluorescence recovery after 
photobleaching) experiments suggest that the exchange rate of HP1, H1, H2B and 
H3 was higher in undifferentiated cells compared to differentiated ES cells, showing 
that those proteins are loosely bound to ES cell chromatin, supporting the idea of an 
open, accessible chromatin structure in ES cells (Meshorer et al., 2006).  
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Early replication during the S-phase of the cell cycle has been associated with gene 
rich transcriptionally active regions with high levels of histone acetylation. Following 
BrdU incorporation, it was observed that the number of genes replicating late 
increased during ES cell differentiation. Interestingly, early replication in ES cells or 
at a later stage during differentiation did not always correlate with transcription 
activity but did reflect lineage potential (Azuara et al., 2006).   
 
Supporting the idea of a prepared chromatin structure, the most unusual chromatin 
signature in ES cells is the existence of “bivalent domains” (Bernstein et al., 2006). In 
this study, highly conserved non-coding element-rich regions enriched for important 
developmental transcription factors were analysed. It was often observed that large 
blankets of the repressive mark H3K27me3 co-localised with peaks of the activating 
mark H3K4me3. Bivalent domains were often associated with low expression, 
reinforcing again the concept of poised chromatin. It was proposed that, with both 
marks on the same promoter, a gene can be either switched on or off according to 
differentiation programme (Bernstein et al., 2006). CpG-rich promoters are generally 
depleted in DNA methylation and enriched for the H3K4me3 mark, however, genes 
associated with high-CpG content promoters (HCP) are not always transcriptionally 
active. It was shown in ES cells that a significant number of HCPs were also 
associated with H3K27me3 and were therefore defined as bivalent domains. Bivalent 
HCPs were often associated with silenced markers of differentiation while HPCs only 
containing H3K4me3 were associated with housekeeping genes. In addition, ChIP 
experiments examining histone marks in ES cells, neural progenitor cells and mouse 
embryonic fibroblasts, showed that during differentiation bivalency remains or 
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resolves in the erasure of one of the marks according to lineage commitment and 
gene activity (Mikkelsen et al., 2007).   
A poised RNA polymerase II is characterised by phosphorylation on serine 5 (Ser5P) 
while an active polymerase is phosphorylated on serine 2 (Ser2P). Going again with 
the idea that bivalent genes are poised for differentiation, it was shown in ES cells 
that bivalent domains were associated with Ser5P and not with Ser2P (Stock et al., 
2007). In addition to H3K27me3 marks, the Polycomb complex deposits 
monoubiquitination on lysine 119 of H2A (H2AK119ub1) through its component 
Ring1b. This mark was shown to retain the poised polymerase on bivalent domains 
and loss of Ring1b leads to the derepression of bivalent genes in ES cells (Stock et 
al., 2007). In an additional study using human ES cells, ChIP-chip screening of the 
entire genome showed that 74% of annotated promoters were enriched for H3K4me3 
as well as H3K9ac, H3K14ac and the initiation form of RNA polymerase II (Guenther 
et al., 2007). However, enrichment of H3K36me3, a mark linked to transcription 
elongation, was only found on genes associated with detectable amounts of 
transcript. This suggests most genes in ES cells are poised for transcription 
(Guenther et al., 2007).  
Although many genes are poised for transcription in ES cells, they have to remain 
silenced for maintenance of pluripotency. Indeed, the Polycomb mark H3K27me3 
was shown to participate in the silencing of bivalent genes. An additional mark, 
H3K9me3, originally associated with heterochromatin, was also shown to be 
important for gene repression in ES cells and is observed on a large set of active and 
inactive genes, including developmental regulators, and co-localises with H3K4me3 
and H3K27me3 (Bilodeau et al., 2009). 
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Many studies looking at various knockouts of, for instance, isoforms of DNA 
methyltransferases (dnmts), Polycomb components or some histone modifiers, 
showed that histone modifications are crucial for development but not indispensable 
for ES cell phenotype maintenance. From those observations came the conclusion 
that epigenetic modifications are not necessary for pluripotency. However, it is 
possible that the knockout of one component is not enough to disturb the entire 
pluripotency network (Meissner, 2010). In addition one could argue that although 
self-renewal was not affected in those knockout cell lines or embryos, differentiation 
was not possible and pluripotency in its strictest sense was indeed disturbed by loss 
of specific marks.    
 
1.4.3 Homeobox (Hox) genes 
Mutations in Drosophila leading to phenotypic changes, like the appearance of extra 
legs or extra wings, led to the discovery of a gene cluster that controls thoracic and 
abdominal segments. In fact, development of segment-specific body structures 
involves the regulation of two complexes of homeobox genes (hox genes) named 
Bithorax and Antennapedia. Mutations in specific genes were shown to induce 
ectopic expression of other members in the cluster and abnormal phenotype 
(homeotic transformations) (Frischer et al., 1986). Hox genes are highly conserved 
transcription factors containing a homeodomain that bind to enhancers. In 
vertebrates, 39 hox genes are divided into four clusters A, B, C and D located on 
chromosomes 6, 11, 15 and 2 in mice, probably resulting from a double duplication 
during evolution. One major feature of the hox genes is the correlation between their 
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Figure 1.10 The Hoxb cluster of genes 
The developmentally regulated hox genes are highly conserved between species. 
They are found in clusters where their physical order mimics their temporal and 
spatial expression pattern during embryonic development. In vertebrates, a 
double duplication during evolution led to the establishment of four clusters 
containing 13 homologues. In Drosophila, two clusters of homeotic genes were 
identified. The Antennapedia complex (ANT-C) contains the genes labial (lab), 
proboscipedia (pb), Deformed (Dfd), Sex combs reduced (Scr), and 
Antennapedia (Antp). In the Bithorax complex (BX-C) are found the genes 
Ultrabithorax (Ubx), abdominal-A (abd-A), and  Abdominal-B (Abd-B). 3’ genes 
are expressed early during development and in the anterior part of the embryo 
while 5’ genes are expressed later and in the posterior part of the embryo. 
Paralogues are indicated by the same colour.    
// 
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physical order along the chromosome and their expression along the antero-posterior 
axis. In addition to the so-called “spatial colinearity”, a “temporal colinearity” of hox 
gene expression was observed as the anterior 3’ hox genes are expressed early 
during the development and the posterior 5’ hox genes are expressed much later 
(Krumlauf, 1994) (Figure 1.10). Homeotic transformations confirmed the important 
role of hox genes in development. Interestingly, it was recently shown that this set of 
genes is also expressed in the adult, in order to provide a certain level of plasticity, 
as differentiation also occurs in adult organisms (Daftary and Taylor, 2006).  
 
1.4.3.1 Colinearity 
The fact that hox genes are found in clusters suggests common mechanisms of 
regulation. Studies involving loss- or gain-of-function of several hox genes gave 
some evidence for the dominance of posterior genes. In fact, when a hox gene is 
mutated, the affected segment usually develops characteristics of the segment 
immediately anterior to it. However in vertebrates, mutations generally lead to less 
dramatic effects, probably due to compensation between paralogues. Those 
observations led to the “hox code” hypothesis, proposing that morphological identities 
in vertebrates result from the activity of a unique set of hox genes (Kessel and Gruss, 
1991). For instance, the identity of the hindbrain rhombomere 4 (r4) is specified 
through auto- and cross-regulatory loops between hoxb1, hoxb2, hoxa1 and hoxa2. 
Using sequence alignment and targeted deletion, r4 restricted enhancers were 
identified near hoxa2 and hoxb2 (Tumpel et al., 2007).  
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In flies, the asymmetric distribution of hox genes allows patterning of the body. 
However, how temporal colinearity is achieved in vertebrates is still under debate and 
led to the “hox clock” hypothesis, which proposes several mechanisms. Timing of hox 
genes expression could be due to (1) passive or active chromatin remodelling along 
with progressive opening of the clusters, (2) changes in affinity of an enhancer for an 
effector molecule or (3) the action of regulatory sequence outside of the cluster 
(Kmita and Duboule, 2003).    
A multitude of studies involving LacZ-transgene insertions in ES cells along with 
implantation in blastocysts allowed the monitoring of expression of hox genes during 
development. The purpose of those experiments was to show the regulatory role of 
clustering and therefore to show that spatial distribution of hox genes on the genome 
is crucial for temporal and spatial colinearity. For example, when hoxd11 and hoxd9 
were inserted 5’ of the hoxd cluster, they showed both late ectopic expression and 
endogenous-like expression (van der Hoeven et al., 1996). Similar observations were 
made when hoxb1 and associated regulatory sequences were inserted at the end of 
the hoxd cluster. In addition the authors noticed an early induction of hoxd13 (Kmita 
et al., 2000) likely due to premature chromatin decondensation (Morey et al., 2008). 
Unfortunately, those experiments did not entirely clarify the temporal colinearity of 
hox genes as regulation appeared to depend on a combination of events including 
spatial distribution but also cis-regulators. However, it is likely that silencing 
mechanisms are in place to keep 5’ end genes silent suggesting progressive opening 
of the chromatin during development. In fact, when a specific portion at the end of the 
hoxd cluster was deleted, hoxd genes like hoxd10 and hoxd4 became early 
expressed (Kondo and Duboule, 1999).  
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As mentioned earlier, hox genes are able to respond to endocrine signals including 
retinoic acid (RA) exposure. In fact retinoic acid response elements (RAREs) were 
identified in the hoxa1, hoxb1, hoxa4, hoxb4 and hoxd4 loci (Barber and Rastegar, 
2010). Supporting the idea of a progressive open environment in ES cells exposed to 
RA, the promoters of hoxb1 and hoxb9 were successively acetylated along with and 
prior to their induction. In addition, fluorescence in situ hybridization (FISH) 
experiments showed a progressive looping movement of the hoxb cluster outside the 
chromosome territory upon induction of transcription by RA (Chambeyron and 
Bickmore, 2004). Another study examined the progressive opening of chromatin at 
the hoxd4 locus following RA exposure (Rastegar et al., 2004). ChIP experiments on 
embryonal carcinoma cells and mouse embryos were used to look at active histone 
modifications, RNA polymerase II and CBP binding on different regions of the hoxd4 
locus during gene induction. It was clear that active mark enrichment as well as CBP 
binding occurred first in the 3’ enhancer and then on the promoter along with RNA 
pol II binding, supporting the opening chromatin model (Rastegar et al., 2004).  
 
Finally, in addition to RARE-associated enhancers, several regulatory regions are 
known to influence hox gene expression. For instance, the CR3 enhancer common to 
hoxb3 and hoxb4 induces overlapping expression of those genes in r6 and r7, and is 
also implicated in hoxd4 regulation (Gould et al., 1997). Similarly, a cluster of 
enhancers covering 40kb identified upstream of the hoxd cluster was shown to 
control the expression of several unrelated genes including hoxd genes, Evx2 and 
lunapark (Spitz et al., 2003).  
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1.4.3.2 Polycomb/Trithorax regulation of hox genes 
As previously mentioned, bivalent domains are present in ES cells, possibly allowing 
a gene to be both silent and poised for activation. A bivalent gene is characterised by 
the presence of both activating (H3K4me3) and repressing (H3K27me3) marks, 
deposited by the Trithorax (Trx) and the Polycomb (PcG) protein complexes 
respectively (Bernstein et al., 2006).  
 
Polycomb proteins were originally discovered in Drosophila as negative regulators of 
Hox genes during segmentation (Lewis, 1978). Since then, an abundant literature 
has described a number of Polycomb complexes, as well as the antagonistic 
Trithorax group of proteins (Beisel and Paro, 2011; Kerppola, 2009; Margueron and 
Reinberg, 2011; Ringrose and Paro, 2004; Schuettengruber and Cavalli, 2009; 
Schuettengruber et al., 2007; Simon and Kingston, 2009; Simon and Tamkun, 2002).   
Polycomb proteins associate in two main complexes: Polycomb repressive 
complexes 1 and 2 (PRC1 and PRC2). The PRC2-type complex contains four core 
subunits: E(z), Esc/Escl, Su(z)12 and Nurf-55 in Drosophila. The signature activity of 
PRC2 is provided by E(z) of which the SET domain catalyzes di- and tri-methylation 
of H3K27 and H1K26. Esc and Su(z)12 are required for E(z) methyl-transferase 
activity and Nurf-55 is a histone binding protein. Many mammalian homologues have 
been found, providing a diversity of function for PRC2. For instance, the Esc 
homologue EED generates four isoforms from alternative translation initiation sites. 
The main PRC2 complex contains EED1 while the alternative complex PRC3 
contains EED3/4 that methylates H3K27 only in the absence of H1 (Kuzmichev et al., 
2004). EED2 is found in PRC4, active in undifferentiated cells. PRC4 preferentially 
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methylates H1 and contains the SIRT1 H1K26 deacethylase (Kuzmichev et al., 
2004). In addition, there are two mammalian E(z) homologues, EZH1 and EZH2. 
Immunoprecipitation and ChIP-chip confirmed that both isoforms associate with the 
other core components and target the same set of genes. However, EZH1 showed 
less methyltransferase activity and fewer binding sites. Furthermore, EZH2 was 
found in proliferative tissues while EZH1 was present in differentiated tissues where it 
inhibits transcription and compacts the chromatin fibre (Margueron et al., 2008). 
Finally in Drosophila, Pcl was co-purified with PRC2 core components and Pcl 
mutants show a decrease in H3K27me3 levels and the derepression of target genes 
(Nekrasov et al., 2007). The mammalian homologue PHF1 was also shown to be 
required for the production of high H3K27me3 levels (Sarma et al., 2008). In 
Drosophila, PRC1 is composed of Pc, dRing, Psc and Ph. Importantly, Pc possess a 
chromodomain that recognises H3K27me3 and dRing is an E3 ubiquitin ligase that 
induces mono-ubiquitylation of H2AK119. Again, many homologues were 
characterised in mammals. In 2006, the polycomb protein Pho was identified in two 
complexes: PhoRC and Pho-dINO80. PhoRC (Pho-repressive complex) is composed 
of Pho, Phol and dSfmbt. Loss of hox gene silencing was observed in Pho/Phol 
double mutants as well as in dSfmbt mutants. ChIP experiments confirmed the co-
localisation of the three components and the MBT (malignant brain tumor) repeats of 
dSfmbt are able to bind H3K9me1/2 and H4K20me1/2 (Klymenko et al., 2006). Two 
years later the dRAF (dRing-associated factor) complex was characterised. When 
dRing was immunoprecipitated from Pc-depleted extracts, Psc and some additional 
proteins were copurified including Raf1, the fly homologue of KDM2 that specifically 
demethylates H3K36me2. KDM2 enhances dRing activity but also Pc activity, 
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suggesting a cooperation between PRC1 and dRAF (Lagarou et al., 2008). Finally, 
the PR-DUB (Polycomb repressive deubiquitinase) complex was recently discovered, 
composed of the ubiquitin hydrolase Calypso and Asx and is required for long-term 
repression of hox genes. Calypso specifically targets H2A and derepression of the 
hox gene Ubx was observed in Calypso knockouts (Scheuermann et al., 2010) 
(Table 1.3).       
Similarly, Trithorax complexes are composed of a heterogeneous panel of proteins. 
Importantly, the two Trithorax complexes TAC1 and MLL mediate the tri-methylation 
of H3K4, a mark associated with active transcription. The Trithorax complex BRM, 
related to the SWI/SNF complex, induces ATP-dependant chromatin remodelling. 
Finally, the ASH1 complex is responsible for H3K36 di-methylation, a mark 
associated with transcription elongation (Schuettengruber et al., 2007) (Table 1.4).   
 
How Trithorax and Polycomb proteins are targeted to specific loci is still under 
debate. In Drosophila, the DNA sequence itself has been implicated with the 
discovery of Polycomb/Trithorax response element (PRE/TRE) sequences (Ringrose 
and Paro, 2007). PRE/TRE are composed of various binding motifs, including Pho, 
Zeste, Gaf, dsp1, Grh or Sp1 binding sites, allowing partner proteins to target 
complexes to specific positions. A PRE/TRE sequence requires a high density of 
motifs, however the composition of motifs is variable. How PRE/TRE are regulated to 
be activated in a tissue or time-specific manner is still under debate (Ringrose and 
Paro, 2007). PRE/TRE sequences have not been found in mammals so far, with the 
exception of two studies that described sequence-based Polycomb recruitment. A 
vertebrate PRE named PRE-kr was identified in mouse and showed 
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Polycomb 
complexes 
Drosophila  Mammalian function 
PRC2 E(z) EZH2 
Histone methyltransferase containing a SET 
domain specific to H3K27me2/3 and H1K26me 
  EZH1 Compaction chromatin 
Esc/Escl EED1 Required for enzymatic activity of PRC2 
  EED2 (PRC4) Active in undifferentiated cells 
  EED3/4 (PRC3) Active in the absence of H1 
Su(z)12 SUZ12 Required for enzymatic activity of PRC2 
Nurf-55 (Caf1) RbAp48/RBBP4 
Histone binding proteins 
  RbAp46/RBBP7 
Pcl PHF1 
Enhancer of the H3K27 methylase activity of 
PRC2 
MTF2 
  PHF19 
Rpd3 HDAC2 Histone deacetylase 
Sir2 SIRT1 H1K26 deacethylase 
  JARID2 PRC2, PRC1, poised PolII recruitment 
    AEBP2 Zinc finger protein. PRC2 recruitment 
PRC1 dRing/Sce RING1B/RNF2 
Histone ubiquitinase H2AK119 specific 
  RING1A/RNF1 
Pc CBX2/HPC1 
Chromodomain protein reader of H3K27me3 
CBX4/HPC2 
CBX8/HPC3 
CBX6 
  CBX7 
Psc PCGF4/BMI1 
Enhancer of Ring activity 
PCGF2/Mel18 
PCGF6/MBLR 
  PCGF1/NSPc1 
Ph PHC1 
Zinc-finger protein PHC2 
    PHC3 
PhoRC Pho YY1 
Recruitment PRC2 
Phol YY2 
  Sfmbt 
L3MBTL2/
SFMBT 
RAF  Psc PCGF1/NSPc1 
Enhancer of Ring activity 
  PCGF2/Mel18 
  PCGF6/MBLR 
  PCGF1/NSPc1 
dRing/Sce RING1B/RNF2 
H2AK119 ubiquitinase   
  RING1A/RNF1 
Kdm2 KDM2B/FBXL10 H3K36me2 demethylase   
    BCOR   
PR-DUB Calypso BAP1 Deubiquitine enzyme 
ASX ASXL1 Enhance calypso activity 
Table 1.3 Polycomb protein complexes 
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Trithorax 
complexes 
Drosophila  Mammalian function 
BRM Brm BRM/SMARCA2 
ATP-dependant chromatin remodelling. 
Related to the SWI/SNF complex 
  BRG1/SMARCA4 
Osa BAF250/mARID1A/ELD 
Mor BAF170/SMARCC2 
  Snr1 BAF47/SMARCB1/SNF5 
ASH1 Ash1 ASH1L 
H3K36 methyltransferase 
(or) Ash2 ASH2L 
  CBP   Histone acetyltransferase 
TAC1 Trx MLL1-3 H3K4 methyltransferase 
CBP   Histone acetyltransferase 
  Sbf1   Antiphosphatase 
MLL MLL1/TRX1 
H3K4 methyltransferase MLL2 
MLL3 
WDR5 WD repeat protein. Helps complex assembly 
ASH2L Enhancer of MLL 
SWD1/RBBP5   
CFP1 
Table 1.4 Trithorax protein complexes 
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affinity for PRC1 (Sing et al., 2009). An additional 1.8kb region was discovered 
between HOXD11 and HOXD12 and named D11.12. Interestingly, luciferase 
expression was reduced in a construct containing the D11.12 sequence but this 
required the binding site specific to YY1, a mammalian homologue of Pho, and the 
presence of BMI1 or EED. Ectopic integration of D11.12 led to the enrichment of 
BMI1, SUZ12 and H3K27me3 (Woo et al., 2010). Finally, in line with the sequence-
based recruitment of Polycomb complexes, EZH2 occupies 2461 promoters in 
mouse ES cells and 88% of these binding sites correlate with CpG islands (Ku et al., 
2008).  
Although it was shown that Polycomb proteins could be recruited by specific short 
sequences, this mode of targeting has not been proven to be predominant in 
mammals. On the other hand, a variety of associated proteins could be partly 
responsible for Polycomb binding in vertebrates. For instance the Pho homologue 
YY1 associates with EZH2 in mouse undifferentiated myoblasts at silent muscle-
specific genes. The use of RNAi against YY1 impaired EZH2 recruitment and 
H3K27me3 enrichment (Caretti et al., 2004). Two additional proteins were shown to 
co-localise with PRC2 at most Polycomb targets in ES cells, JARID2 and AEBP2. 
JARID2 contains an ARID domain that binds AT-rich sequences and is required for 
PRC1 and RNA Pol II recruitment (Landeira et al., 2010). AEBP2 is a zinc finger 
protein that binds a specific DNA motif (Kim et al., 2009).    
  
The role of ncRNA in polycomb recruitment was recently extensively studied. To 
date, several examples have suggested a crucial role of ncRNA mechanisms in 
silencing. X-chromosome inactivation in female cells is initiated by the mono-allelic 
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expression of a long, non-coding RNA, Xist that accumulates in cis on the X-
chromosome. In mouse, a small 1.6kb-RNA within Xist named Repeat A is suspected 
to target PRC2 as its depletion led to a decrease in H3K27me3 (Zhao et al., 2008). 
Importantly, hox genes were also identified as ncRNA targets with the discovery of 
HOTAIR and ANRIL. HOTAIR is one of the 231 ncRNA transcribed within the four 
hox loci, found in human primary fibroblasts. All four hox loci were characterised for 
expression as well as enrichment in H3K27me3, SU(Z)12 and RNA pol II. ncRNAs 
were found differentially expressed in the various tissues with opposite chromatin 
states. HOTAIR is a 2.2kb ncRNA that was identified between hoxc11 and hoxc12, 
expressed in the foreskin. Abrogation of HOTAIR led to the derepression of hox 
genes, the decrease of H3K27me3 enrichment and the loss of Su(z)12 binding in the 
HoxD cluster, as HOTAIR directly interacts with SU(Z)12 (Rinn et al., 2007). It was 
later confirmed that the 5’ domain of HOTAIR binds to PRC2 while the 3’ domain 
binds to LSD1, responsible for H3K4 demethylation (Tsai et al., 2010). Lastly, an 
antisense ncRNA was identified in the Ink4b/ARF/Ink4a tumour suppressor locus and 
named ANRIL. The PRC1 member CBX7 was shown to bind H3K27me3 as well as 
ANRIL, this last interaction being essential for gene repression (Yap et al., 2010).     
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Hox genes were identified as bivalent domains (Bernstein et al., 2006) and large-
scale studies have confirmed the bivalent state of hox gene clusters (Figure 1.11) 
(Raney et al., 2011). Polycomb and trithorax proteins play a major role in the 
regulation of those genes. However, their mechanisms of action are not fully 
understood.  
It is generally accepted that PRC2 generates high levels of H3K27me3 and provides 
a docking site for PRC1 which then catalyses mono-ubiquitination of H2A. Yet, it 
should be noted that two types of bivalent domains were identified, some carrying 
both PRC2 and PRC1 and some carrying PRC2 only, suggesting different 
mechanisms of action. It was observed that PRC1-positive domains are better 
conserved between mouse and human, correspond to developmental regulators and 
retain more H3K27me3 upon differentiation (Ku et al., 2008). As previously 
mentioned, the PRC1 member RING1B generates mono-ubiquitination of H2A that 
recruits RNA pol II in a poised state and therefore blocks transcription (Stock et al., 
2007). Furthermore, the cooperative complex dRAF brings to action the component 
KDM2B that specifically demethylates H3K36me2, a mark associated with 
transcription elongation (Lagarou et al., 2008). In addition, when PRC1 was 
characterised, it was shown to compete and block the action of the remodelling 
complex SWI/SNF (Shao et al., 1999). In fact, electron microscopy later confirmed 
that a recombinant PRC1 complex was able to compact nucleosomal arrays (Francis 
et al., 2004). Another member of PRC1, BMI1, was identified as an important player 
in the silencing process by interacting with DNMT associated protein (Dmap) and 
DNA methyltransferase1 (Dnmt1), responsible for CpG methylation generally 
associated with repressed transcription. Knockdowns of BMI1 or Dmap in MEFs led 
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Figure 1.11 Hox genes ENCODE data 
(Insulator) 
(Active) 
(Elongation) 
(Silent) 
(Active) 
The ENCODE (Encyclopaedia of DNA elements) project maps functional 
elements all over the human genome. Here are represented ChIP-seq data 
obtained for the Hoxb cluster including CTCF occupancy along with active marks 
(H3K4me3; H3K27ac), the elongation mark H3K36me3 and the silencing 
polycomb mark (H3K27me3). Three cell lines were compared: human ES cells 
(green), human skeletal muscle myoblasts (purple) and human lung fibroblasts 
(orange).    
In ES cells, the hoxb genes are silent and the hoxb cluster is mostly occupied by 
large blankets of H3K27me3. Peaks of H3K4me3 were detectable in some 
promoters but the elongation mark H3K36me3 was totally absent. Strikingly in 
differentiated cells, H3K4me3 and H3K27me3 became almost completely 
exclusive marks. Along with H3K4me3, the enrichment of H3K27ac and 
H3K36me3 increased, suggesting active transcription at those loci.             
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to hox loci derepression (Negishi et al., 2007). Similarly, the PRC2 member EZH2 co-
precipitates with Dnmt1, 3a and 3b, and has been shown to target Dnmts and induce 
CpG methylation at promoters (Vire et al., 2006). Finally, the H3K4 demethylase 
RBP2 was co-purified with PRC2 members and shown to co-localise with SUZ12 and 
EZH2 at PRC2 target genes. PRC2 recruits RBP2, as knockdown of SUZ12 
decreased EZH2 and RBP2 recruitment. On the other hand, induction of EED 
increased EZH2, SUZ12 and RBP2 recruitment as well as H3K27me3 enrichment 
while H3K4me3 levels were reduced (Pasini et al., 2008).     
An elegant model system using ES cells, neuronal progenitors and glutamatergic 
pyramidal neurons allowed the analysis of DNA methylation, polycomb and trithorax 
mark enrichments as well as RNA pol II binding and activity during differentiation. As 
expected, DNA methylation levels increased on the promoters of genes associated 
with pluripotency or for instance the germline. However a small proportion of 
promoters showed a decrease in DNA methylation, correlating with RNA pol II 
binding and loss of H3K27me3 enrichment. This small group of genes was usually 
involved in neuronal development, ion transport or neurotransmitter regulation (Mohn 
et al., 2008). In another study, the HoxD cluster was analysed at different stages of 
mouse-tail bud development. As late hox genes were induced, RNA pol II binding, H3 
acetylation and H3K4me3 increased while enrichment of H3K27me3 was lost 
(Soshnikova and Duboule, 2009). It was therefore confirmed that in order to get 
lineage-specific gene expression during differentiation, bivalency has to resolve into 
one or the other mark.  
The mechanisms described so far for polycomb silencing involved the inhibition of 
chromatin remodelling and transcription elongation and recruitment of Dnmts. In 
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contrast, trithorax group proteins act during differentiation to allow the transcription of 
target genes. In fact, MLL1 is required for neurogenesis in mouse postnatal brain. If 
MLL1 is knocked out, the neurogenesis regulator Dlx2 is not induced and is occupied 
by H3K27me3 in the subventricular zone contrary to what was observed in wild type 
mice (Lim et al., 2009). Under retinoic acid treatment, the human demethylase UTX 
interacts with the MLL complex and specifically targets H3K27me2/3. Indeed, RA 
treatment leads to increased UTX occupancy and H3K4me3 enrichment as well as a 
diminution of H3K27me3 and SUZ12 binding. siRNA against UTX raised 
H3K27me2/3 levels and PRC1 occupancy on several hoxa and hoxc genes, 
correlating with loss of expression (Lee et al., 2007b). Similarly, JMJD3, a H3K27 
demethylase was shown to associate with the MLL complex. During macrophage 
transdifferentiation, NFkB activates JMJD3 that then demethylates polycomb target 
genes including late Hoxa (De Santa et al., 2007). Like Polycomb complexes, 
Trithorax proteins influence DNA methylation levels. In fact, the CXXC domain of 
MLL binds to unmethylated CpG and prevents DNA methylation as observed on the 
hoxa9 locus (Erfurth et al., 2008). 
Finally, the active transcription-associated histone variant H2A.Z seems to play a role 
in bivalency. H2A.Z colocalises with SUZ12 in undifferentiated cells but during 
differentiation, induced genes become enriched in H2A.Z and lose the polycomb 
mark (Creyghton et al., 2008). H2A.Z was also shown to inhibit DNA methylation in 
Arabidopsis thaliana (Zilberman et al., 2008).   
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1.4.3.3 Maintenance of Polycomb/Trithorax marks   
One of the big challenges of epigenetic research is to understand how epigenetic 
patterns are transmitted from one cell to another during mitosis. The passage of the 
replication machinery and extreme chromatin condensation during mitosis are both 
likely to disrupt DNA/protein interactions and histone mark distribution. However, 
polycomb and trithorax complexes are indispensible for the long-term maintenance of 
hox gene expression and therefore must be retained on allocated target loci after cell 
division. Little is known about the inheritance of Polycomb/Trithorax marks but 
several studies have described possible mechanisms.  
In the case of a DNA sequence-based recruitment, it would be easy to imagine the 
role of specific motifs in Polycomb/Trithorax retargeting after mitosis. PRE/TREs 
have been identified in Drosophila and are believed to play a major role in memory. 
But PRE/TREs have been only rarely found in mammals so are unlikely to provide a 
memory system. Instead, targeting factors that associate with complexes or ncRNA 
could help binding to chromatin after cell division. In addition, CpG islands are 
suspected to play a role in inheritance, as this is where most PRC2 members bind. 
However, it is important to note that only a minority of CpG islands bind EZH2 and 
H3K27me3, suggesting the need for other factors to retain Polycomb binding (Ku et 
al., 2008).  
PCNA (proliferative cell nuclear antigen) is an important protein that helps 
progression of the DNA polymerase during replication. Immuno-fluorescence staining 
revealed colocalisation of EZH2, PCNA and BrdU in human fibroblasts during S 
phase. Moreover, the study showed that EZH2, EED and SUZ12 together bind 
H3K27me3, providing a new model where the polycomb mark is copied on new 
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histone during DNA replication. When a construct containing five Gal4 binding sites 
linked to a luciferase reporter was stimulated by GAL4-EED, enrichment of EED, 
EZH2, SUZ12 and H3K27me3 were raised while RNA pol II binding was lost. 
Importantly, six days following GAL4-EED washout, luciferase remained silent and 
levels of H3K27me3 stayed high. This phenomenon was abolished when siRNAs 
were used against EZH2 or SUZ12 (Hansen et al., 2008). The PRC1 core complex 
was shown to bind a DNA template containing a replication origin and be still 
associated to it after replication. Moreover, when competitor DNA was incubated with 
PRC1-prebound templates, PRC1 did not relocate during replication. Finally, ChIP 
was performed every 10 minutes during S phase and levels of Psc and Pc were 
constant at three different PREs of the Bithorax complex (Francis et al., 2009). 
Constant binding to chromatin of PRC2 members was confirmed in mouse embryonic 
fibroblasts. Cytological approaches revealed constant H3K27me3 enrichment during 
all phases of mitosis as well as SUZ12 and EZH2 colocalisation with the polycomb 
marks. However, staining of PRC1 member BMI1 became very weak during mitosis 
and progressively re-localised with H3K27me3 during G1 (Aoto et al., 2008). 
Dissipation of BMI1 during S-phase had already been observed and is associated 
with BMI1 phosphorylation (Voncken et al., 1999). 
Unlike SETD1A, Pol II or LSD1, the two subunits MLL-C and MLL-N colocalise with 
condensed chromatin and promote rapid reactivation of target genes after mitosis. 
ChIP experiments also highlight the presence of other members of the MLL complex 
during M-phase, including RbBP5 and ASH2L. Finally, when MLL was knocked 
down, target genes were less rapidly activated after mitosis (Blobel et al., 2009) 
(Figure 1.12).  
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Figure 1.12 Regulation of “Bivalency” 
Polycomb and Trithorax proteins regulate many genes in ES cells and during 
development, including the Hox genes. Polycomb members EZH2 and RING1A/B 
deposit the silencing-associated marks H3K27me3 and H2AK119ub1 whereas 
Trithorax member MLL deposits the activating mark H3K4me3. Multiple 
associated proteins and non-coding RNA (ncRNA) help target the complexes to 
specific genes. In ES cells, poised genes are enriched for both active and 
repressive modifications a state named “bivalency”. During development, 
bivalency often resolves into one or the other mark according to the loci’s 
transcriptional status. (Single-headed arrows indicate mark deposition and 
double-headed arrows indicate interaction). 
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1.5 Epigenetic inheritance 
A widely accepted definition of epigenetic phenomena says that it corresponds to “a 
change in the state of expression of a gene that does not involve a mutation but that 
is nevertheless inherited in the absence of the signal that initiated the change”. 
Therefore, epigenetic modifications like histone marks or DNA methylation should 
survive DNA replication and cell division. However, little is known about how 
chromatin states are transmitted between cell generations, and whether histone 
modifications are actively replicated is still under debate (Ptashne, 2007). 
 
1.5.1 Chromatin assembly  
Replication is the process by which the double-stranded DNA molecule is faithfully 
duplicated in order to produce enough genetic material for both daughter cells after 
mitosis. We now know that the DNA molecule assembles into chromatin through its 
association with histone proteins. Therefore, not only the genomic sequence has to 
be copied during replication but the all of the chromatin fibre in its specific state. 
Replication leads to the dilution of preassembled histones via the incorporation of 
newly synthesised histones. DNA replication progresses in a semi-conservative 
manner where each new double strand DNA contains one mother strand. However, 
how old and new histones are distributed during replication is still a mater of debate. 
Three putative models have been described: (1) “old” histones are randomly 
distributed between the two new chromatin fibres, (2) “old” histones are distributed in 
a semi-conservative manner so the two halves of a nucleosome go to different 
nascent fibre and (3) the “asymmetric model” in which all H3/H4 tetramers go to one 
chromatin fibre or the other (Figure 1.13) (Probst et al., 2009).     
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regulates the nucleosome assembly that is dependent on 
CAF1 and the yeast-specific histone chaperone Rtt106 
(REFS 56,57). Whereas the presence of the H3K56ac mark 
has been reported in humans58, its abundance seems 
limited and its association with new histone deposi-
tion is not documented. Furthermore, homologues of 
Rtt106 and the Lys acetyltransferase Rtt109 (also known 
as Kat11), which acts on H3K56, have yet to be identi-
fied in humans. So, whether H3K56ac or an unidentified 
modification have similar roles in mammals remains to 
be investigated.
Notably, newly synthesized histones H3 and H4 are 
present as dimers in pre-deposition complexes with 
histone chaperones59 (FIG. 2a). Although this principle is 
clearly established for newly synthesized histones, the 
fate of parental H3–H4 histone dimers that are thought 
to be deposited as tetramers on the daughter strands 
might also have to be reconsidered. The fact that histones 
H3 and H4 exist as stable tetramers in solution in the 
absence of DNA60 argues against the existence of parental  
H3–H4 dimers. However, structural data now show that 
the association of ASF1, and potentially also p48 and 
p55, with histones is incompatible with a tetrameric 
structure61–65. In addition, the fact that some histones 
carrying parental marks can be detected in association 
with ASF1 under conditions in which the helicase and 
the polymerase are uncoupled23 supports the hypothesis 
that ASF1 is involved in tetramer splitting and that it 
functions as an acceptor of recycled parental dimers. 
Therefore, it is indeed possible that parental tetramers 
(with their own marks) are split and redistribute onto 
daughter strands as dimers. This affects histone dynamics  
at the fork and might produce either mixed tetra mers 
that comprise parental and new dimers (FIG. 2b), or 
nucleo somes that comprise only old histones if paren-
tal dimers reassociate. This second scenario requires 
either that the old dimers are held in close contact or 
away from the new ones, or that some recognition event 
ensures that the correct old dimers are brought back 
together in the same particle. The spatial organization 
of DNA at the fork might facilitate these mechanisms 
(FIG. 1a).
If modifications on the new histones are guided by 
modifications of parental histones, the way in which 
parental histones are distributed to the daughter strands 
will determine the degree of conservation of histone 
marks. Current models suggest that the distribution 
of both parental and newly synthesized histones onto 
daughter strands occurs in a random fashion (FIG. 3a). To 
avoid the dilution of histone marks, the maintenance of 
modifications could be achieved by using a neighbour-
ing histone as a template. A possible mechanism could 
be envisaged in which the parental mark is recognized 
by a chromatin-binding protein, or reader protein66, that 
in turn recruits a chromatin modifier, or writer protein. 
This has been suggested for the self-reinforcing loop 
in the maintenance of heterochromatin protein 1 (HP1) 
at pericentric heterochromatin67–70 (see below). Such a 
mechanism probably operates in repetitive regions 
in which long arrays of nucleosomes carry the same 
marks, but cannot apply to regions in which particular 
Figure 3 | Fate of old and new H3–H4 dimers and their marks at the fork. Three 
possibilities for the distribution of parental histones are presented. In each case, the 
parental mark is recognized by a chromatin-binding protein, or reader protein, that in turn 
recruits a chromatin modifier, or writer protein. a | Random histone distribution. Parental 
histone H3 and H4 with marks (unsplit or reassociated dimers) are distributed randomly 
onto daughter strands and chromatin density is restored by the deposition of new H3–H4 
dimers. To avoid the dilution of histone marks, active maintenance requires first a 
deacetylation step, which involves a histone deacetylase (HDAC), followed by histone 
modification that is guided by neighbouring parental nucleosomes (an interparticle 
process). b | Semi-conservative histone distribution. Parental dimers with marks segregate 
evenly onto each daughter strand and nucleosomes are completed by the deposition of 
new H3–H4 dimers. After deacetylation, ‘hemimodified’ nucleosomes provide a template 
for the transmission of parental marks to newly deposited H3–H4 dimers (an intraparticle 
process). c | Asymmetric histone distribution. Parental H3–H4 dimers with marks are 
redistributed onto daughter strands in an asymmetric manner. This is possibly dictated by 
the intrinsic strand bias that is introduced during DNA replication, and induces a switch 
from one chromatin state to another. The maintenance of histone modifications requires 
interstrand crosstalk.
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Figure 1.13 Distribution of “old” and “new” H3/H4 dimers during replication 
The fate of “old” and “new” H3/H4 histone dim rs during replication is not well 
understood. Three pote tial mechanisms have bee  escribed so far. Parental 
histones could be randomly distributed on both daughter strands (a) or equally 
distributed according to the semi-conservative model (b). Finally, the asymmetric 
model predicts the ld histones to incorpor te exclusively on one daughter rand 
and therefore requires interstrand crosstalk for maintenance of modifications (c). 
In fact, in each model, parental mo ifi ati n  are recognised by reader proteins 
that then recruit chromatin modifiers for the deposition of appropriate mark  o  
newly incorporated histones.  
Taken from Probst t al., 2009  
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Chromatin assembly during replication involves a wide variety of histone chaperones 
that help displace old histones and carry newly synthesised ones. How they proceed 
exactly remains unclear but it is now accepted that they play an important role in 
chromatin assembly during replication, transcription or DNA repair (Avvakumov et al., 
2011). An elegant study using HeLa cells expressing flag-tagged H3.1 allowed the 
classification of events necessary to transport newly synthesised histones into the 
nucleus. H3.1 is a H3 variant exclusively transcribed during S-phase and is 
incorporated during replication. Fractionation and mass-spectrometry found four 
complexes which were classified in their probable order of action: (I) contains the 
histone chaperone HSP70 and H3.1 that carries K9me1, (II) contains HSP90, 
another chaperone tNASP, H4 and H3.1K9me1, (III) is the most abundant complex 
and includes the chaperone sNASP, H3.1, H4K5acK12ac, the histone acetyl 
transferase HAT1 and RbAp46 and finally (IV) is thought to be involved in nuclear 
import as it contains H3.1, H4, Importin-4 and the histone chaperone Asf1 (Campos 
et al., 2010).  The role of modifications carried by new histones has not been 
elucidated. One possibility is that they increase the affinity of specific histone 
chaperones (Avvakumov et al., 2011).  
In the context of DNA repair, Asf1 was shown to transiently associate with one of the 
three subunits of chaperone Caf-1, p60 before nucleosome assembly (Mello et al., 
2002). Studies on replication suggest the chaperone CAF-1 plays a central role in 
histone deposition. During G1, the pre-replication complex binds to DNA at 
replication origins. Additional factors and activated CDKs then follow and associate 
with the helicase complex of MCM proteins and PCNA, a ring-like trimer that 
encircles the DNA and drags the DNA polymerases during replication (Moldovan et 
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al., 2007). Importantly, the Caf-1 subunit p150 was shown to interact with PCNA and 
both proteins colocalise at replication loci. Therefore, Caf-1 was strongly suspected 
to play a crucial role in newly synthesised histone incorporation during replication 
(Shibahara and Stillman, 1999).   
Asf1 is involved in the transport of new histones but also in the transport of parental 
histones as it was shown to interact with histones carrying modifications 
uncharacteristic of newly synthesised histones. In addition, this chaperone interacts 
with the helicases MCM2, 4, 6 and 7 through an H3/H4 bridge. When Asf1 was 
knocked out, a block in S-phase was observed, along with helicase activity defects. 
These results strongly suggest that Asf1 acts as an acceptor and donor of parental 
and new histones during replication through its interaction with the MCM complex 
(Groth et al., 2007). Finally, specific histone chaperones including Nap1, FACT or 
Chz1 are involved in the transport of H2A-H2B dimmers (Ransom et al., 2010).  
Because H2A/H2B are located at the periphery of the nucleosome, H3 and H4 
assemble first and disassemble last. However, the composition of newly formed 
H3/H4 tetramers is still unknown (Ransom et al., 2010).  sNASP was shown to 
dimerise and form a complex with two H3/H4 dimers. Therefore, one could think that 
Asf1 imports new H3/H4 tetramers into the nucleus (Campos et al., 2010). Yet, 
analysis of Asf1-H3-H4 stoichiometry and X-ray crystallography revealed that the 
complex exists as a stable heterotrimer and even blocks the formation of a H3/H4 
tetramer (English et al., 2006; English et al., 2005). It was therefore suggested that 
Asf1 is involved in parental H3/H4 tetramer splitting and dimer distribution, which 
provides an argument for the mixing of new and old histones into newly formed 
nucleosomes. The semi-conservative model of segregation is therefore an attractive 
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one. Modifications on the parental histones would be bound by modifiers that could 
then deposit the appropriate mark on the new histones.  However, this model does 
not fit with the fact that the daughter fibres are not synthesised at the same speed, 
and gives less opportunity for change. On the other hand, the random distribution of 
nucleosomes does not explain how a specific mark can stay restricted on one or two 
nucleosomes (Probst et al., 2009). 
 
1.5.2 DNA methylation 
DNA methylation is a well characterised modification associated with gene silencing. 
It plays a major role in gene imprinting, X-inactivation, silencing of retrotransposons 
or carcinogenesis (Watanabe and Maekawa, 2010). Importantly, patterns of DNA 
methylation and histone modifications have been positively or negatively correlated. 
For instance, CpG-rich promoters are generally enriched in H3K4me3 and depleted 
in DNA methylation (Mikkelsen et al., 2007). DNA methylation was shown to coincide 
with long regions of H3K9me2, particularly in pericentromeric chromatin, in 
Arabidopsis thaliana (Bernatavichute et al., 2008). Because DNA methylation is a 
more stable modification, a model was proposed in which DNA methylation provides 
a platform for histone modification inheritance (Blomen and Boonstra, 2011).     
 
BMI1 (PRC1) and EZH2 (PRC2) were shown to interact with Dnmt1 (Negishi et al., 
2007; Vire et al., 2006). It is widely accepted that Dnmt1 is the enzyme that maintains 
DNA methylation levels during replication. However, a study using ES cells knockout 
for dnmt1, 3a or 3b revealed a role for Dnmt3a/3b for the maintenance of methylation 
states in CpG poor regions. In fact, in the absence of Dnmt1, specific sequences, 
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including the promoters of LINE-1 repetitive elements remained methylated, but this 
was lost when Dnmt3a/3b were absent. This suggest that de novo methylation by 
Dnmt3a/3b could compensate for the poor maintenance by Dnmt1 (Liang et al., 
2002). Nevertheless, Dnmt1 was shown to rapidly methylate CG specifically on 
hemimethylated DNA (Hermann et al., 2004). Restoration of methylation levels after 
5-azacytidine treatment was impaired in the absence of Dnmt3a/3b which confirmed 
that Dnmt1 preferentially acts on hemimethylated sequences (Liang et al., 2002).  
Importantly, Dnmt1 binds to PCNA at replication foci (Chuang et al., 1997) and the 
SET and Ring finger-associated (SRA) domain protein Np95 was shown to 
accumulate at DAPI-dense heterochromatin regions in mid-to-late S-phase in ES 
cells. Immunoprecipitation of Np95 revealed its association with Dnmt1 and PCNA. 
Np95 and Dnmt1 interact, such that in Dnmt1/3a/3b triple knockout cells, where DNA 
methylation is totally absent, Np95 did not localise at heterochromatin. However in 
Dnmt1 knockout cells, Np95 could localise to heterochromatin but importantly, 
binding was independent of the cell cycle phase, suggesting that Np95 prefers hemi-
methylated DNA. In Np95 knockout cells, chromatin was generally hypomethylated 
and genes derepressed. In addition, Dnmt1 showed a diffuse distribution throughout 
the cell cycle, suggesting that targeting of Dnmt1 required interaction with Np95 
(Sharif et al., 2007). 
 
1.5.3 Heterochromatin maintenance  
The heterochromatin protein HP1 was shown to bind H3K9me2/3, a histone mark 
catalysed by the methyl-transferases SUV39H1 or SETDB1 (Bannister et al., 2001). 
During mitosis, a transient increase in H3S10p and H3K14ac levels induce the 
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eviction of HP1 (Fischle et al., 2005). However, the CAF-1 subunit p150 was shown 
to interact with HP1, suggesting a role of this histone chaperone in heterochromatin 
maintenance. Consistent with this, abolishment of the p150-HP1 interaction led to a 
cell cycle arrest during pericentric heterochromatin replication (Quivy et al., 2008). 
Furthermore, p150/CAF-1 interacts and colocalises with the methyl-CpG binding 
protein MBD1 in a complex containing HP1, providing a link between 
heterochromatin maintenance and DNA methylation (Reese et al., 2003). Indeed, it 
should be mentioned again here that p150/CAF-1 interacts with PCNA (Shibahara 
and Stillman, 1999). Finally, PCNA was shown to interact with many proteins that 
play a role in heterochromatin formation, including HDACs. HDACs themselves bind 
to Dnmt1, reinforcing the role of DNA methylation (Probst et al., 2009).  
Although DNA methylation seems to be important for heterochromatin formation, 
several studies highlight the fact that histone modifying enzymes are crucial for the 
maintenance of DNA methylation. In mouse embryonic fibroblasts, when the histone 
methyltransferase Suv39h was knocked out, Dnmt3b interaction with HP1 at 
heterochromatin foci was abolished. In addition, DNA methylation was specifically 
altered at pericentric major satellite repeats. However, H3K9me3 was not impaired in 
dnmt1 or dnmt3a/b knockout ES cells (Lehnertz et al., 2003). Furthermore, G9a 
knockout in ES cells induced a loss of DNA methylation at retrotransposons, major 
satellite repeats and CpG rich promoters. However, no decrease in H3K9me3 or HP1 
binding was observed and these regions remained silent. In addition, DNA 
methylation was rescued when a catalytically inactive G9a was transfected in 
knockout ES cells, suggesting that H3K9me3 itself is not responsible for DNA 
methylation at these loci (Dong et al., 2008).  
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1.5.4 Transcriptional memory 
Several studies have implicated nuclear organisation and specific histone variants in 
the propagation of active transcription. For instance, the Ino1 gene is activated under 
inositol starvation and the Gal1 gene is activated under galactose exposure of yeast. 
During activation, these genes are relocated to the nuclear periphery and interact 
with the nuclear core component Nup2. After the genes are repressed, they stay at 
the nuclear periphery for several cell cycle rounds and show much faster reactivation 
when stimulated. Importantly, this phenomenon of transcriptional memory required 
intact H2A.Z (Brickner et al., 2007). Gene loops that juxtapose a promoter and a 
terminator of transcribed genes were identified in yeast and mammals. Using the 3C 
technique, the authors monitored gene looping in different Gal genes during 
induction, repression and reinduction. When Gal10 is repressed, RNA pol II 
dissociates, whereas looping persists for at least 4 hours. Interestingly, in the Sua7-
1" strain where looping is abrogated, no effect was observed during initial activation 
but the kinetics of reactivation of Gal10 or Gal1p-Sen1 was impaired. This 
observation correlated with a less rapid reassociation of RNA pol II during reinduction 
and loss of Gal4. A role for looping in nuclear pore anchoring was therefore 
suggested (Laine et al., 2009). Another study confirmed that transcription induction 
by galactose exposure of a naïve Gal1 gene was slower than induction of a recently 
transcribed Gal1 (Kundu et al., 2007). This rapid reinduction was observed even after 
cell division. ChIP experiments showed that, although all components of the 
transcriptional machinery disappeared during glucose repression, RNA polII and TBP 
were recruited much faster during reinduction compared with initial induction. 
Analysis of reinduction kinetics in yeast mutants revealed that histone modifications 
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like H3K4me, H3K36me, H3K79me, H3ac or H2Bub are not essential for 
transcriptional memory. However, the SWI/SNF complex member snf2 was shown 
indispensable (Kundu et al., 2007). 
 
Although PREs have been rarely identified in mammals, their role in transcription 
memory should be noted. The scalloped (sd) gene, important for wing development 
in Drosophila, was repressed by the upstream insertion of the PRE element Fab-7. 
This silencing was the result of an interaction between the inserted and endogenous 
Fab-7, as when the endogenous Fab-7 was mutated, sd was derepressed. Moreover, 
this phenomenon was cancelled by polycomb mutations, suggesting that 
chromosome pairing stabilised polycomb silencing. Importantly, when flies were 
back-crossed in order to obtain repressive phenotypes, the derepression and loss of 
pairing remained for at least five generations. This result showed that nuclear 
architecture plays an important role in the inheritance of polycomb silencing 
(Bantignies et al., 2003). Another study using FISH and 3C confirmed that silencing 
in the BX-C locus requires many interactions between PRE and promoters in 
Drosophila. This phenomenon was observed in embryos and in ES cells. 
Interestingly, the PRE Fab-7 was shown to lose its interaction with other element in a 
cell line where AbdB was transcribed. When the PRC1 protein Pc was knocked 
down, interactions between the three bithorax genes was impaired. A month 
following restoration of Pc levels, interactions were almost completely recovered. 
Interestingly, RNAase treatment of cells did not affect interactions, suggesting no role 
for RNAs  (Lanzuolo et al., 2007). 
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H3.3 had been shown previously to mark zones of active transcription. Therefore, a 
model of transcriptional memory was suggested where H3.3 is incorporated during 
active transcription and then inherited during replication (Ahmad and Henikoff, 2002). 
Interestingly, H3.1 and H3.3 carry different post-translational modifications. In their 
cytosolic and nuclear forms, they were mostly unmodified, however, H3K9me1 
enrichment was detected on H3.1 whereas H3K9ac was found on H3.3. This is 
believed to potentiate the action of the methyl-transferase SUV39H1 on H3.1 as 
H3K9me1 is a better substrate. As expected, nucleosomal H3.3 was associated with 
active marks in contrast with H3.1. Furthermore H4 associated with H3.3 were more 
acetylated than that associated with H3.1. Finally, in an array containing 
neighbouring H3.3 and H3.1, active marks were detected on H3.1 variants, 
suggesting that H3.3 enhances active chromatin states (Loyola et al., 2006). The 
purification of tagged H3.1 and H3.3 variants and the use of mass spectrometry 
revealed two different pathways for the incorporation of these histones. H4, ASF1, 
NASP, HAT1, p48/CAF-1 and importin-4 were identified as common components of 
H3.1 and H3.3 complexes. On the other hand, p150/CAF-1 and p60/CAF-1 were only 
found to be associated with H3.1 whereas the HIRA chaperone was exclusively 
found in the H3.3 complex. Using UV-induced DNA damage, the authors showed 
that, in contrast with H3.1, the H3.3 variant is incorporated in a DNA-synthesis-
independent manner. In addition, both variants never associated in the same 
nucleosome (Tagami et al., 2004).  
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1.6 Aims 
“Epigenetic” modifications are commonly defined as events that control gene 
expression by mechanisms other than change in the DNA sequence. However, this 
term also includes the expectation that these marks are inherited as they are strongly 
suspected to define cell identities (Holliday, 2006). If histone modifications are truly 
epigenetic marks, they should therefore (1) be causative for transcription and (2) be 
inherited throughout the cell cycle, although the signal(s) that induced them has 
disappeared. Histone modifications have been widely correlated with transcription. 
However, it has not been clear so far if they are responsible for, or only a 
consequence of, transcriptional status. Furthermore, histone modifications are 
suspected to play a role in cell memory by providing a docking site for modifying 
enzymes during replication. Because modifying enzymes often bind to the mark they 
deposit, a simple model proposes that they recognise marks on parental histones 
and deposit them on the adjacent newly assembled nucleosomes.  
Therefore in this study, we decided to test the epigenetic nature of histone 
modifications and more specifically histone acetylation. Using an HDAC inhibitor, we 
design different model systems in order to: 
• Measure the impact of hyperacetylation of histone on chromatin states 
and transcriptional activity. 
• Study the long-term effects of a transient increase in histone 
acetylation. 
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2. Materials and Methods 
2.1 Mouse Embryonic Stem (ES) Cell Culture 
2.1.1 CCE/R cells  
CCE/R cells are an adherent male ES cell line. Cells were grown on gelatine-coated 
flasks (T25/75 cm2, Sarstedt) at 37°C in humidified air with 5% CO2 in Dulbecco’s 
modified eagles medium (DMEM, Gibco). The culture medium was supplemented 
with 20% foetal calf serum (Gibco), 1% penicillin/streptomycin (Gibco), 1% L-
glutamine (Gibco), 1X non-essential amino acids (Gibco), 0.25% 2-mercaptoethanol 
(Gibco) and 1U/µl Leukaemia inhibitory factor (LIF/ESGRO, Chemicon) 
(supplemented ES cells DMEM).   
Cells were split every two days, usually in a 1 to 6 ratio but this varied according to 
cell density. Briefly, cells were dislodged from the flasks using trypsin-EDTA 1X 
(Gibco). Trypsinised cells were then pipetted into the old medium in order to 
deactivate the enzyme, centrifuged for 5 minutes at 250g and resuspended in warm 
fresh medium. New flasks were coated with 0.1% gelatine for at least 20 minutes 
before the excess was removed and the cells added. 
On alternate days, cells were supplemented with warm fresh medium. 
 
2.1.2 Differentiation of ES cells 
Cells were induced to differentiate by following a method adapted from (Chambeyron 
and Bickmore, 2004). Cells were trypsinised and replated in a non-adherent plastic 
dish (Sterilin), in supplemented ES cells DMEM without LIF.  
In order to induce the expression of Homeobox (Hox) genes, 1µM Retinoic Acid (RA) 
was added into the medium after 2 days of differentiation, and until the end of the 
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experiment. After 8 days of differentiation cells were replated onto adherent plastic 
dishes (Corning) allowing the embryonic bodies to settle and continue differentiation. 
 
2.1.3 Eed/Ring1B double knock-out (dKO) ES cells:  
Cells were generated and provided by Martin Leeb, a PhD student in Anton Wutz’s 
laboratory (The Wellcome Trust Centre for Stem Cell Research,  University of 
Cambridge). The dKO ES cell line was derived by conditional deletion of Ring1B in 
Eed-/- ES cells using Tamoxifen inductible CreER transgene (Leeb et al., 2010). Both 
parental wild type ES cell and dKO ES cell lines were grown on a mono-layer of 
irradiated Mouse Embryonic Fibroblasts (MEFs) as feeder cells.  
 
2.1.3.1 Isolation of MEFs 
MEFs were extracted from E12 mouse embryos (provided by Graham Anderson, 
University of Birmingham) of which the head and internal organs had been removed. 
The bodies were cut into small pieces in a dish with a sterile scalpel. Trypsin was 
added and using a syringe and needle, cells were separated as much as possible. 
Fresh medium was then added in order to deactivate the enzyme and the mixture 
transferred into a 50ml centrifuge tube where the cells were allowed to settle.  The 
supernatant was removed and replaced by fresh media. Cells were finally transferred 
in a pre-gelatinised flask. Primary MEFs were cultured in DMEM supplemented with 
10% foetal calf serum, 1% penicillin/streptomycin, 1% L-glutamine, 1X non-essential 
amino acids and 0.25% 2-mercaptoethanol (all from Gibco).  
Cells were split when 100% confluence was reached and fed according to the colour 
of the media.   
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2.1.3.2 Irradiation of MEFs 
Cells were trypsinised and centrifuged for five minutes at 250g. Cells were then 
resuspended in fresh medium to 107 cells/ml and irradiated for 15 mins. The 
radionuclide Caesium-137 was used as a source of radiation at 2.464 grays/min.  
Following irradiation, 106 and 3x106 cells were respectively replated in a T25 and T75 
pre-gelatinised flask. Because of their fragile nature, dKO cells were cultured on a 
double density MEF layer. 
  
2.1.3.3 Culture of ES cells on feeders 
Cells were cultured on feeder cells as they were on pre-gelatinised flask with the 
same incubation conditions and medium. Again, cells were split every two days 
depending on cell confluence and fed on alternate days. When split, ES cells and 
MEFs were trypsinised and replated on a new layer of feeders. Most of the old MEFs 
wouldn’t attach to the new ones and were washed out the next day with fresh 
medium.  
 
2.1.3.4 Harvesting of ES cells grown on feeders 
Because ES cells were attached to the MEFs when grown, it was necessary to purify 
them as much as possible prior any experiment. In theory, MEFs attach to the flask 
much faster than ES cells. Therefore, cells were trypsinised and the cell suspension 
replated on a pre-gelatinised flask in order to selectively remove the MEFs.  
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To test the purification efficiency FACS analysis was used. The yield of ES cell 
purification would depend on how long the cells were replated for. In order to get the 
purest ES cell population with limited ES cell loss, we decided to replate the cells 
after trypsinisation for different periods of time and analyse the proportion of each 
population in the final cell suspension. Initially, MEFs alone and ES cells grown on 
MEFs were analysed so as to gate and quantify each population on the two-
dimensional scatter plot. While MEFs revealed a wide range of granularity and size, 
ES cells appeared to be morphologically more homogeneous. However for our 
experiment, it was possible to distinguish the two types of cells on the plots (Figure 
2.1.a). ES cells that had been grown on MEFs were then harvested and replated for 
20, 30, or 45 minutes. Some protocols advised to replate cells for shorter times but 
consecutively in different pre-gelatinised flasks. Therefore we also analysed cells 
after replatment twice for 15 minutes or 3 times for 15 minutes. The percentage of 
MEFs and ES cells in the final cell suspension for each condition were given. The 
maximum purity we were able to reach was 88% ES cells after 20 minutes in a single 
pre-gelatinised flask (Figure 2.1.b). When purification was carried out for longer, loss 
of ES cells progressively increased. However, when cells were replated for shorter 
times in multiple flasks the purity rose to approximately 87% (Table 2.1). We thus 
decided for our experiments to replate ES cells that had been grown on feeders for 
20 minutes after trypsinisation.  
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Figure 2.1 Light scatter plots of ES cells and MEFs   
a, Two-dimensional light scatter plots were obtained passing the cells through a 
flow cytometer. On the X-axis, forward light scatter indicates the size of the cells 
while the side light scatter on the Y-axis indicates the granularity of the cells. First, 
irradiated MEFs alone were analysed and the corresponding population could be 
seen on the plot. Subsequently, ES cells grown on MEFs were analysed and as 
expected a new population appeared on the plot. A gate was used to target the 
ES cell population and permit quantification.    
b, Because ES cells were grown on a layer of MEFs, it was essential to purify 
them as much as possible prior any experiments. For that, cells were trypsinised 
and replated on a pre-gelatinised flask for 20mins. Because MEFs attach to the 
flask before ES cells, the media was progressively depleted in MEFs. Cell 
populations were analysed prior and after purification. % indicate proportion of 
stem cells 
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Time of replatment Final % of ES cells Final % of MEFs 
0 min 74 26 
20 mins (no gelatine)  78 22 
20 mins 88 12 
30 mins 84 16 
45 mins 83 17 
2 x 15 mins 88 12 
3 x 15 mins 87 13 
Table 2.1 ES cell purification Yield according to the replatement time 
When ES cells grown on MEF feeders were harvested by trypsinisation, the 
resultant cell suspension contained both cell lines. It was therefore important to 
separate the two cell types as much as possible before any experiment. In order 
to optimise the harvest of ES cells grown on feeders, FACS was used to calculate 
the yield of ES cell purification after replatement of the cell suspension on gelatine 
for different periods if time. Along with purification, we observed a significant loss 
of cells. In fact in a 20 minutes time, a substancial number of ES cells had 
attached to the flask. Thus, replatement in a flask without gelatine was tested.  
!
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2.2 Cell culture monitoring 
2.2.1 Cell death and Proliferation assay 
2.2.1.1 Cell count 
Cell viability was determined using a Malassez hemocytometer. Cells were stained 
with Trypan blue and those that excluded the dye were considered viable whereas 
dead cells stained blue.  
 
2.2.1.2 Measure of proliferation 
Another assay was performed to assess cell viability, the CellTiter96® Aqueous One 
Solution Cell Proliferation Assay (or MTS assay; Promega). This calorimetric assay 
was used to determine the number of viable cells in proliferation. Briefly, the provided 
solution contains a MTS tetrazolium compound that is bioreduced by metabolically 
active cells into a colored formazan product. The assay was performed in 96-well 
plates where 10µl of the provided solution was added to 200µl of culture medium. 
Following 3 hours incubation at 37°C the quantity of formazan product, proportional 
to the number of living cells, was measured by the absorbance at 492nm. Media 
alone and dead cells (death induced by the addition of 10% DMSO) were used as a 
control.  
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2.2.2 Flow cytometry analysis 
Flow cytometry analysis was used to count and sort cells based on the phase of the 
cell cycle they were going through. In order to get significant results at least 10,000 
cells have to be analysed. For each experiment, we chose to count 50000 cells per 
condition. Cells were harvested by trypsinisation and washed 2 times in ice-cold PBS 
(137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.76mM KH2PO4, pH7.4). They were 
then resuspended for 30 minutes in 200µl of staining solution composed of 10µl 
RNAase A and 2µl of propidium iodide (100mg/ml) per 100µl of PBS. Propidium 
iodide (PI) is an intercalating dye that fluoresces more strongly when bound to DNA. 
Therefore the amount of DNA present in the cell would be proportional to the PI 
signal. It had to be used in excess so that all cells present in the sample were 
stained. PI binds all nucleic acids, so RNAase A was used to degrade RNA for the 
DNA only to be quantified. Using a FACScan flow cytometer (BD FACSCaliburTM), 
cells were then separated according to PI signal and counted. Three different 
populations were detected corresponding to the G1, S and G2-M cell cycle phases.  
The analysis was performed using WinMDi 2.9 and Cylchred software. WinMDi 2.9 is 
a Windows interface able to read Flow Cytometry Standard (.FCS) files and process 
them to built histograms and plots. Histograms were then analysed with the Cylchred 
software that allows the deconvolution of histograms and therefore a better targeting 
of each cell population (Figure 2.2).   
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Figure 2.2 Cell cycle profile using Flow Cytometry Analysis  
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a, DNA of untreated ES cells was stained with Propidium iodide (PI). Each cell 
was analysed using a flow cytometer. For each sample of about 50000 cells the 
cytometer generated an FCS file. Those files were read by the WinMDi 2.9  
software which then generated a corresponding histogram. Because the cell 
population was not synchronized, three sub-populations were detected based on 
PI fluorescence signals. Here is a typical ES cell cycle profile where most of the 
cells are in the S phase of the cell cycle.  
b, Histogram deconvolution using the Cylchred software. Each sub-population 
was specifically targeted on the histograms and the percentage of cells was 
calculated.    
(DNA content relative to fluorescence) 
(Number of cells) 
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2.2.3 Alkaline Phosphatase activity assay 
Alkaline phosphatase (AP) activity is known as a marker of pluripotency (Berstine et 
al., 1973). The enzyme activity was detected by histochemical staining of fixed 
adherent cells. Briefly, medium was removed from the flask and cells were gently 
rinsed once in ice-cold PBS and fixed for 15 minutes in neutral formaldehyde buffer 
(3.7% paraformaldehyde, 112mM NaH2PO4, 30mM NaH2PO4.H2O). Cells were then 
rinsed for 15 minutes in distilled water and incubated for 45 minutes in staining 
solution using Naphthol-AS-MX-phosphate (Sigma) as a substrate and Fast Red 
Violet LB salt (Sigma) as a coupler (0.1mg/ml Naphthol was dissolved first in 0.4% 
N,N-Dimethylformamide and then in 0.1M tris-HCl pH 8.3. Finally, 0.6mg/ml of Fast 
Red was added to the solution). Ultimately, pluripotent, AP-positive colonies 
appeared red.   
  
 
 
 
 
 
 
 
 
 
 
!
(*!
2.3 Gene transcription analysis 
2.3.1 RNA extraction and cDNA synthesis 
RNA was extracted using the RNeasy mini kit (Qiagen) according to the 
manufacturer’s instructions. An on-column DNase digestion was performed during 
the extraction in order to yield a pure RNA fraction (RNase-Free DNase Set, Qiagen). 
Nanodrop analysis then provided the concentration of RNA and the 260/280 (Nucleic 
acid/Protein) and 260/230 (Nucleic acid/Polysaccharide) ratios per sample. Ratios, 
indicating the degree of nucleic acid purification, should be in a range of 1.9-2.1.  
In order to check the integrity of the RNA, 1µg was loaded and run on a 1% (w/v) 
agarose gel.  
Agarose gel electrophoresis: TAE (40mM Tris base, 1.142% (v/v) glacial Acetic acid, 
1mM EDTA pH8) was used to dissolve the agarose powder and as an 
electrophoresis buffer. 0.5µg/ml ethidium bromide was added into the gel. After RNA 
electrophoresis two bands corresponding to the most abundant RNA molecules 
should be detected, the 18S and 28S ribosomal RNAs (Figure 2.3.a). 
cDNA was prepared from RNA, using the RT-Superscript-III Kit (Invitrogen) 
according to the manufacturer’s instructions. A standard PCR was performed using 
#-actin primers to verify cDNA quality (Figure 2.3.b).  
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a, Total RNA was extracted from ES cells and 1µg of each sample was loaded on 
a 1% agarose gel for electrophoresis. Two bands, corresponding to the ribosomal 
18 and 28S RNAs are visible. This is because they are the most abundant form of 
RNA within the cell. These bands indicate the RNA integrity. A smear would have 
indicated a general degradation.  
b, RNA was then retrotranscribed and cDNA amplified by standard PCR using !-
actin primers. Electrophoresis on 1% agarose gel shows PCR products for RT+ 
and RT-. RT- was generated by retrotranscription reaction without the superscript 
enzyme. The absence of bands indicate there is no genomic DNA contamination.  
Figure 2.3 RNA and cDNA analysis using agarose gel electrophoresis   
a 
b 
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2.3.2 Standard Polymerase chain reaction (PCR) 
This technique consists in the amplification of a specific DNA fragment, or in our 
studies cDNA fragment, revealing the presence or absence of a specific transcript. 
Primer design: Gene sequences were extracted from UCSC genome browser 
(http://genome.ucsc.edu/) and specific primers were designed using primer3 website. 
Specificity of the primer set was then verified on the Primer Blast website 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/).  
1µl of cDNA was added to 0.5µl of each primer (forward and reverse at 10µM) and to 
20µl of PCR ReddyMixTM Master Mix (Thermo scientific). This ready-to-use master 
mix contains a DNA polymerase, DNTPs, salts including 1.5mM MgCl2, reaction 
buffer and a dye facilitating the gel loading. 
The PCR was then carried out by a thermocycler using the following conditions: 
94°C - 5 minutes (Initialization)  
94°C - 15 seconds (Denaturation)  
60°C - 30 seconds (Annealing)                         
72°C - 30 seconds (Elongation)  
72°C - 5 minutes (Final elongation)  
PCR products were analysed by 1% agarose gel electrophoresis. 
 
2.3.3 Quantitative real-time PCR (qPCR) 
qPCR is a technique based on the general standard PCR principle, but using 
different fluorescent dyes and detection methods with better sensitivity. We choose to 
use the SYBR Green dye, which absorbs blue light ($max = 488 nm) and emits green 
30 Cycles 
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light ($max = 522 nm). SYBR Green binds to DNA and fluoresces when intercalated in 
DNA, so the intensity of the signal increases proportionately to the amplification.  
For each sample, 50µg of cDNA was mixed with 5µl of SYBR Mix (Qiagen), forward 
and reverse primers (400nM) and RNAse free water in a final volume of 10µl. Water 
was used as non- template control. Serial dilutions of reference cDNA (200µg, 
100µg, 50µg, 25µg, 12.5µg and 6.25µg) were also analysed, allowing the 
construction of a standard curve.  
The PCR reaction was processed by the thermocycler/detection system ABI 7900HT 
using the following conditions: 
95°C - 10 minutes (Initialization)  
94°C - 15 seconds (Denaturation)  
Tm - 30 seconds (Annealing)                         
72°C - 30 seconds (Elongation)  
95°C - 15 seconds  
60°C - 15 seconds 
95°C – 15 seconds 
For every sample, a Ct (threshold cycle) value was given. A Ct is the cycle number 
when a threshold value of fluorescence is first detected. As a consequence, the 
larger the amount of targeted cDNA, the lower the Ct value (Figure 2.4). 
The standard curve made from serial dilutions of cDNA allowed a relative 
quantification. In fact, the standard curve corresponds to Ct values versus logarithm 
of cDNA quantity. It was also used to assess the amplification efficiency of each set 
of primers. A specific annealing temperature had to be established in order to get as 
close as possible to maximal efficiency. In optimal conditions, the curve had to show 
40 Cycles 
(Dissociation) 
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a slope of -3.3 (± 0.3), which corresponds to 100% efficiency, and a correlation 
coefficient closed to 1 (Figure 2.5.a). 
Finally, the dissociation curve reflecting the last step of the reaction, when all the 
double stands dissociated, had to show a single peak, indicating that a unique PCR 
product was generated and primer dimmers were avoided (Figure 2.5.b). 
!-actin or Gapdh were used as a house-keeper genes. Primer sets used for PCR and 
qPCR are listed in Table 2.2.  
 
Statistical analysis was processed with the GraphPad software. Because a data set 
of 3 is considered a small data set, it was not possible to test the populations for 
normality. The choice between parametric (normal distribution) and nonparametric 
(population deviating from the Gaussian shape) statistical test was therefore an 
issue, parametric test not being robust enough and nonparametric test not being 
powerful enough. Nonparametric two-tailed Mann-Whitney test was usually used to 
test untreated and treated samples.   
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Figure 2.4 qPCR amplification curve   
The SYBR green reporter dye was present in the PCR reaction mix. This dye 
binds to nucleic acids and fluoresces when trapped in the double-stranded DNA 
molecule. Therefore, the intensity of the florescence signal increases 
proportionately to the amplification.  
The Passive reference Dye ROXTM was used to normalized the reporter dye 
signal. The fluorescence of this dye does not change during the reaction and thus, 
artefacts caused by changes in volumes or pipetting errors can be internally 
corrected. The Rn (normalized reporter) value equals to the fluorescence 
emission of the reporter dye divided by the fluorescence emission of the passive 
dye. The !Rn value is determined by the difference between the Rn value of a 
sample reaction and the Rn value of a reaction that does not contain any 
template.       
A Ct (threshold cycle) was determined for each sample using the amplification 
curve. A threshold value of fluorescence was fixed, preferentially in the 
exponential phase of the amplification. The Ct is the cycle number when this 
threshold value is first detected. Therefore, the larger the amount of targeted 
cDNA the lower the Ct value.  
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a, A Standard curve was generated, using 6 serial dilutions of cDNA, from which 
we could extrapolate the quantity of each unknown sample. The curve also shows 
the amplification efficiency, and is ideal when the slope equals -3.3, and the 
correlation coefficient is close to 1 (good reproducibility of the reaction).  
b, A Dissociation curve was generated at the end of the reaction when all the 
double stands dissociated. A single peak indicates a unique PCR product.  
 
 
a 
b 
Figure 2.5 Standard curve and dissociation curve   
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Table 2.2 Primers used for cDNA analysis by qPCR   
  
Forward primer Reverse primer 
Annealing   
temp (°C) 
!-actin CGTGAAAAGATGACCCAGATCA TGGTACGACCAGAGGCATACAG 58 
Gapdh CGGCCGCATCTTCTTGTGCA AGTGGGGTCTCGCTCCTGGA 54 
Oct4/pouf5 GAGGAGTCCCAGGACATGAA AGATGGTGGTCTGGCTGAAC 60 
nanog CTCATCAATGCCTGCAGTTTTTCA CTCCTCAGGGCCCTTGTCAGC 62 
klf4 CCAGACCAGATGCAGTCACAA TGGCATGAGCTCTTGATAATGG 62 
c-Myc AGCAGCTCGAATTTCTTCCA AGAGCTCCTCGAGCTGTTTG 60 
Sox2 GCGGCAACCAGAAGAACAG GTTGTGCATCTTGGGGTTCT 58 
H1f0 ACCATGACCGAGAACTCCACCTC GTGGTCACTAGGCGCTTGAT 58 
Egr1 GAGCGAACAACCCTATGAGC AGGCCACTGACTAGGCTGAA 60 
Ndrg4 CCTACCTCCAGACCGAGTGA GAAGTCCATAAGGCGTCTCG 60 
Fsd1 AAGGCTAGTTGGCTGCTGTC TCAGCAACATCTGCTTCAGG 62 
Dnmt3 GGCAATTCCTTCTCTGAAGC ACGGTTCTCCTCCTGTTCCT 60 
Pgk1 AATGTCGCTTTCCAACAAGC TTTGATGCTTGGAACAGCAG 60 
Gdf3 TCAGCTTCTCCCAGACCAGGGTTTT GCCCCGGTCCTGAACCACAG 60 
Nupr1 ACAGCCTGGCCCATCCCTGT CTCCAGCTCCGTCTCAGCGC 60 
Pprc1 GGAGGCGGCGGTACAGCTCT CTCGTCTGCCTGCCGCAACT 58 
Pnrc2 GCGGCCTCCATTTTGTCGGG ACAGCCCACGAACGAGTCACG 58 
Slc6a8 GAGACTTGGACACGCCAGAT AAAATGGGGATTCCTCCAAC 58 
Anapc7 GAGTACCGCAATGCTGTGAG TCGAGTACAGCAATGGCATC 55 
Hoxb1 CCATATCCTCCGCCGCAG CGGACTGGTCAGAGGCATC 58 
Hoxb2 CGGCGCCTCCACCCTTCAGAGACC CTTTCGGTGAGGTCCAGCAAGGC 60 
Hoxb3 CAACTCCACCCTCACCAAA GCCACCACCACAACCTTC 58 
Hoxb4 CTGGATGCGCAAAGTTCAC TCCTTCTCCAACTCCAGGAC 62 
Hoxb5 CCTCTGAGCCCGAGGAAG CCAGGGTCTGGTAGCGAGTA 60 
Hoxb6 GAGACCGAGGAGCAGAAGTG ACTGAGCTGAGACGCACTGA 62 
Hoxb7 AACCGAGTTCCTTCAACATG CGAGTCAGGTAGCGATTGTA 55 
Hoxb8 TTCTACGGCTACGACCCTCT CGTGCGATACCTCGATCCTC 60 
Hoxb9 CAGGGAGGCTGTCCTGTCTAATC CTTCTCTAGCTCCAGCGTCTGG 58 
Eed TGATTGTGTGCGATGGTTAGGCG GCCCAATGCAAGCATCTTTTGCCA 60 
Rnf2/Ring1b CTGGGGCAGGAGCCGAAATGTC TCCGCGCAAAACCGATGTAAACAC 60 
Each set of primer was tested using samples of various known concentration of 
cDNA. Standard curves were built in order to assess the amplification efficiency. 
Different annealing temperatures were tested until the slope of the standard curve 
was equal to -3.3 (± 0.3) and a good correlation coefficient was obtained.   
!
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2.3.4 Microarrays 
Microarray technology is a high-throughput technique used to assess the expression 
activity of a large number of genes under different conditions. We choose to work 
with the NIA 15K mouse cDNA array. One slide contains 15,247 cDNA clones 
derived from early embryonic cDNA libraries with a average insert size of 1.5 kb 
(Kargul et al., 2001). 
The slides were printed by Antony Jones (College of Life and Environmental 
Sciences, University of Birmingham).  
 
2.3.4.1 slide labelling 
cDNA samples that had to be compared were labelled with two different 
fluorochromes, Cy3 and Cy5 (Amersham) using Bioprime Labelling kit (Invitrogen). 
Following purification of the probes (PCR purification Kit; Qiagen), quantification was 
performed on a spectrophotometer. Cy3 emits green fluorescence when excited at 
550nm while Cy5 appears red at 650nm.  
The quantity of labelled probes was obtained using the following formulas:  
pmol of Cy3 probes = (Absorbance at 550nm % volume)/0.15 
pmol of Cy5 probes = (Absorbance at 650nm % volume)/0.25 
80 pmol of probes labelled with Cy3 and Cy5 respectively were mixed together and 
precipitated with 1/17th volume of 5M NaCl, 2 volumes of cold absolute ethanol and 
1&l of Linear acrylamide (Ambion). Following incubation at -80ºC for 15 minutes and 
at 25ºC for 1 minute, the mix was spun at 11000g/4ºC for 20 minutes. The pellet was 
then mixed with 2 volumes of 70% ethanol and spun down again at 11000g/4ºC for 6 
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minutes. DNA was dried for 15-30 minutes and resuspended in 17&l of double 
distilled water (ddH2O).  
In the meantime, microarray slides were treated using the Pronto Backgrownd 
Reduction Kit (Corning) and then incubated for 2 hours at 42ºC in prewarmed 
prehybridisation Buffer (5XSSC, 25%(v/v)formamide, 0.1%SDS, 1%BSA). The slides 
were washed in 0.2XSSC (1min) and in 0.05XSSC (30sec, 2 times) and then dipped 
10 times in ddH2O and 10 times in absolute ethanol. Finally, slides were dried by 
centrifugation at 290g for 5 minutes.  
Labelled cDNA (17µl) was mixed with 16&l of formamide, 0.64&l of 10%(w/v)SDS, 
16&l of 20XSSC buffer (3M NaCl, 300mM C6H5Na3O7, pH7), 8&g of mouse Cot-1 
DNA (Invitrogen) to prevent non-specific DNA binding and 6.4&g of Oligo PolydA 
(Invitrogen) to block free primers. The mixture was denatured at 95ºC for 2 minutes 
and left to cool at room temperature. It was then applied to the slide in a incubation 
chamber. The chamber was wrapped in wet towels, covered with foil and incubated 
for 20 hours at 42ºC. Slides were finally washed using incubation and shaking in 2X 
SSC/0.1%SDS (42ºC, 2min), then in 0.2XSSC (2 min) and lastly in 0.05XSSC (2 min, 
4 times). Slides were dried by centrifugation for 5 minutes at 290g.  
 
2.3.4.2 Normalization of the data 
Slides were scanned using GenePix 4000A scanner: A laser excited each spot and 
the fluorescent emission gathered through a photo-multiplicator (PMT) coupled to a 
confocal microscope. PMT settings were set in order to balance the overall signal in 
the Cy3 and Cy5 channels. An image was obtained composed of spots going from 
green to red passing through the yellow colour (DNA in equal amount from both 
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condition). Spot alignment was made automatically and then manually using GenePix 
software (Figure 2.6). Data were exported from GenePix, giving the mean and the 
median values for each wavelength (635 and 532nm) per spot. Data were then 
normalized using the DNMAD web-software, providing M and A values: 
M-value = Log2(R/G) and A-value = Log2(R+G)/2 
M-values correspond to the ratio between the two signals red and green and are 
therefore representative of differential expression between the two samples. An M-
value of 1 means that the gene has been up-regulated by a 2-fold change while an 
M-value of -1 means that the gene has been down-regulated by a 2-fold change. A-
values represent the intensity of the signals, which tells us if the gene is more or less 
expressed.  
A box plot of M-values allows the visualization of the signal variation within an array. 
Each box plots show the data for an array divided in 4 groups around the median 
value. Because the software assumes that the expression of most of the genes is 
unchanged between the two conditions, median M-values are all normalized around 
0 within a slide. Slides that were compared had then to be normalized at the same 
time in order to adjust all together (Figure 2.7.a). 
The red (Cy5) and the green (Cy3) dyes differ in their physical properties such as 
heat and light sensitivity. Therefore, there is a difference in the dye incorporation 
efficiency during the hybridization. As a result, an intensity-dependant normalization 
was needed. In a perfect situation, MA-plots should be evenly distributed around 0 
across all intensity A-values. But most of the time, and as could be observed before 
normalization, the plot was curvy due to this difference in dye incorporation 
efficiency. The LOWESS (locally weighted linear regression analysis) statistical 
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regression method was used to rectify this. In addition, it reduced the standard 
deviation of the data set (Figure 2.7.b).  
Finally, to verify the quality of the slides, distributions of red and green signal data 
(RG densities) were provided as well as images of the slides background and 
foreground. RG densities had to matched between slides and within a slide. Slide 
backgrounds could vary between slides but had to be low enough to be corrected. 
Slide foregrounds gave then a good idea of the background correction efficiency 
(Figure 2.7.c).  
 
2.3.4.3 Analysis of the data 
After normalization, t-tests were performed on total M-Values using biological 
triplicates for each condition. T-tests were performed using the web-software TMEV, 
a microarray data analysis tool incorporating algorithms for clustering, visualization, 
classification and statistical analysis. Standard p-values were then corrected by the 
Benjamini-Hochberg false discovery rate (FDR) correction method. The FDR 
correction was performed using the statistical environment “R” and data for genes 
with associated FDR less than 10% were considered statistically significant and 
selected for further analysis. For example, clustering analysis was performed, using 
the Web-software “DAVID bioinformatic database” or the Ingenuity and Genego 
softwares. Those tools, using high throughtput studies, allowed the construction of a 
list of genes based for example on functional similarity.   
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Hybridization on 
slide + scanning Spot alignment 
Each pixel within a 
white circle is 
analysed. 
(each white circle is 
associated to one gene) 
Cy3 and Cy5 cDNA-dyes were used to label the two samples to be compared. 
Labelled cDNA were then mixed and hybridized on a NIA 15K microarray slide. 
Slide was scanned and an image obtained showing spots going from green to red. 
Each spot is associated with one gene and a yellow spot means cDNA in equal 
amount are present in both samples. An image composed by white circles was 
overlaid on the microarrays image. Each circle matches with one gene and was 
manually aligned with the corresponding spot. Fluorescence signals of each pixel 
in the circles were then analysed. 
Figure 2.6 Microarray experiment protocol   
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Figure 2.7 Normalization of microarray data  
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a, Adjustment of M-value. Each box plot presents the data for an array divided in 
4 groups around the median value. Here M-values are all normalized around 0 
within a slide. 
b, MA-plots correction. Because the two dyes differ in their physical properties, 
their incorporation efficiencies vary as well. This phenomenon induces the MA-plot 
to be curved. A statistical regression method was used to rectify this.  
c, RG densities distribution and background correction. In order to verify the 
quality of the slides, distributions of red and green signal data were provided as 
well as images of the slides background and foreground. RG densities have to 
match and backgrounds have to be low enough to be corrected.  
After Normalization 
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2.4 Protein extraction 
2.4.1 Histone acid extraction 
Cells were harvested by trypsinisation, centrifuged (250g; 10mins) and the pellet was 
washed 3 times in ice-cold-PBS/5mM NA-Butyrate to prevent histone deacetylation. 
Cells were suspended in Triton extraction buffer (TEB; in PBS, 4mM Na-Butyrate, 
0.5% (v/v) Triton X-100, 0.02% (v/v) Na-azide, 0.2mM PMSF) at a concentration of 
107 cells per ml and left to lyse on ice for 10 minutes. Cells were pelleted at 805g for 
10mins and resuspended in half of the previous volume of TEB before being pelleted 
again. Finally, histones were extracted by addition of 0.4M HCl at the concentration 
of 50&l/2%106 cells. After incubation on ice for three hours, the suspension was spun 
down and the supernatant – the histone containing fraction – was collected and kept 
at -20°C for further experiments (Figure 2.8.a). 
 
2.4.2 Total protein extraction 
Cells were harvested by trypsinisation, washed 2 times in ice-cold PBS and 
suspended in lysis buffer (20mM Tris-HCl pH7.4, 10mM EDTA, 100mM NaCl, 1% 
Triton X-100, 1mM NaF, 1mM #-glycerophosphate, 1mM EGTA, 5mM sodium 
pyrophosphate and 0.1mM PMSF) at 100µl per 106 cells. Cells were left to lyse on 
ice for 30 minutes and then centrifuged at 11000g/4°C for 10 minutes. The 
supernatant – the protein containing fraction - was collected and kept at -20°C for 
further experiments (Figure 2.8.b). 
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Figure 2.8 Protein extraction  
a b 
a, Histones were extracted from ES cells and then separated according to size 
using SDS-PAGE electrophoresis. The gel was finally stained with Coomassie  
blue for the proteins to be revealed. Five main histone proteins were clearly 
visible. 
b, Total proteins were extracted from ES cells and separated according to size 
using SDS-PAGE electrophoresis. Proteins were transferred to a nitrocellulose 
membrane and stained with Ponceau S. The SpectraTM Multicolor Broad Range 
Protein Ladder (Fermentas) was used for the approximate sizing of proteins. 
260kDa 
135kDa 
95kDa 
72kDa 
52kDa 
42kDa 
34kDa 
26kDa 
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2.4.3 Assessing protein concentration 
In order to obtain protein concentrations we used the Coomassie Plus protein assay 
(Thermo Scientific). This assay is based on an absorbance shift from 465nm to 
595nm that occurs when the reagent binds to proteins in an acidic solution, resulting 
in a color change from brown to blue. 20µl of protein samples were mixed with 1ml of 
the ready-to-use solution, incubated at room temperature for 10 minutes for a full 
colour change to occur and finally, the OD595nm was read. Firstly, a 2 fold-dilution 
BSA standard curve going from 2mg/ml to 0.125mg/ml was prepared from which the 
sample concentrations were read. A blank sample (20&l of 0.4M HCl) was used to 
calibrate the spectrophotometer (Ultrospec 2100 pro UV/visible spectrophotometer) 
before protein samples were analysed.  
 
2.5 Western Blot Assay 
2.5.1 SDS-PolyAcrylamide Gel Electrophoresis (SDS-PAGE) 
Using this technique, proteins were separated according to size. The resolving gel 
consisted of 15% acrylamide (for histones, but this percentage varies according to 
the size of the studied protein), 0.4% N’N’bisacrylamide, 375mM Tris-HCl pH8.8, 
0.1% sodium dodecyl sulphate (SDS) and was polymerised with 100&l of 10% (w/v) 
ammonium persulphate and 30&l of TEMED per 30ml of gel solution. The gel was 
overlaid with saturated iso-butanol to prevent evaporation and ensure a even 
polymerisation on the top. Iso-butanol was washed off before the addition of the 
stacking gel. 
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The stacking gel consisted of 3% acrylamide, 0.16% N’N’bisacrylamide, 125mM Tris-
HCl pH 6.8, 0.1% SDS and was polymerised with 100&l of 10% ammonium 
persulphate and 10&l of TEMED per 10ml of gel solution.  
5-20&g of protein were mixed with 12.5% (v/v) glycerol, 10&l of 10X Standard 
dissociation buffer (1M Tris-HCl pH7.5, 10mM Na2EDTA, 10%SDS, 1.4M 2-
mercaptoethanol, bromophenol blue, in distilled water) and made up to 100µl final 
volume in distilled water. Samples were boiled for 10 min incubated on ice for 5 min 
prior to loading. Gels were electrophoresed in 1X SDS Reservoir Buffer (in distilled 
water, 0.1%SDS, 50mM Tris base, 380mM glycine) at 30mA per gel and 400V. 
 
2.5.2 Transfer of proteins 
Proteins separated by SDS-PAGE were transferred onto a nitrocellulose membrane 
(Hybond C+, Amersham) using a method adapted from (Towbin et al., 1979). 
Transfer was performed in a cassette (Bio Rad) containing the following “sandwich”: 
1 sponge pad, 3 pieces of Whatman® chromatography 3MM Chr paper (Sigma), gel, 
nitrocellulose membrane, and again 3 pieces of Whatman® papers and 1 sponge 
pad. The cassette was tightly closed and placed into a tank (Bio Rad) so that the 
nitrocellulose membrane was between the gel and the anode. The tank was filled 
with transfer buffer (in distilled water, 25mM Tris base, 192mM glycine, 
20%methanol) and transfer performed at 300mA for 3 hours.  
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2.5.3 Western blot 
2.5.3.1 Antibodies 
Rabbit polyclonal antisera to H4K8ac, H4K5ac, H4K16ac, H3K9ac, H3K4me3 and 
H2BK12,15ac were raised by immunization with synthetic peptides conjugated to 
ovalbumin as previously described (Turner and Fellows, 1989). Specificity was 
assayed by inhibition ELISA for all in-house and commercial antisera and checked by 
western blotting. For all antisera, cross-reaction with epitopes other than that against 
which the antiserum was raised was insignificant. Antibodies and working dilutions 
are listed in Table 2.3. 
 
2.5.3.2 Western blot 
Presence of proteins on the membrane was checked by red staining with Ponceau S 
solution (Sigma). Membrane was then rinsed in TBST (TBS (20mM Tris base, 
150mM NaCl, pH 7.5), 0.1% (v/v) Tween-20) and blocked for an hour using 5% 
powdered milk/TBST at room temperature. The membrane was incubated with the 
primary antibody diluted in 5% milk/TBST for 1 hour at room temperature. Following 
three 10 minutes-washes in a large volume of TBST, the membrane was incubated 
with IRDyeTM800CW conjugated with an anti rabbit or anti mouse IgG secondary 
antibody (Rockland). The IRDyeTM800CW is a near infrared dye that absorbs at 
774nm and emits at 789nm. After an hour incubation with the secondary antibody, 
membranes were once again washed 3 times in TBST. Proteins were detected and 
quantified using the Odyssey® Infrared Imaging System (Li-COR). 
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2.6 Native Chromatin Immuno-Precipitation (N-ChIP) 
(Figure 2.9) 
2.6.1 Chromatin preparation 
Cells were harvested by trypsinisation and washed 3 times in ice-cold PBS/5mM Na-
butyrate (453g, 10mins, 4°C). Pellets were suspended in TBS (in distilled water, 
15mM NaCl, 10mM Tris-HCl, 3mM CaCl2, 2mM MgCl2, 5mM Na-butyrate) to a 
density of 2x107 cells per ml. Equal volume of 1% (v/v) Tween-40/TBS was added as 
well as 1/200th volume of 0.1M PMSF and the cell suspension was stirred on ice for a 
hour. Nuclei were released by homogenisation, on ice, using a hand operated 
Dounce all-glass homogeniser with a “tight” pestle (1 stoke per ml of cell lysate, but 
varied according to cell type). The nuclei yield was verified by examining a small 
aliquot under the microscope in a standard counting chamber. Following 
homogenisation, nuclei were centrifuged  (805g, 20mins, 4°C) and washed in 20ml 
25%sucrose/0.1mMPMSF/TBS. After centrifugation (805g, 10mins, 4°C), nuclei were 
suspended in 5mls of Digestion buffer (0.32M sucrose, 50mM Tris-HCl (pH7.5), 4mM 
MgCl2, 1mM CaCl2, 0.1mM PMSF, 5mM Na-butyrate). The amount of chromatin was 
checked using spectrophotometry. The sample was centrifuged (805g, 10mins, 4°C) 
and the pellet resuspended in Digestion buffer to a density of 0.5mg chromatin per 
ml. Chromatin was digested using 50U micrococcal nuclease for 0.5mg of chromatin 
at 37°C for 5mins. The reaction was stopped by addition of 5mM EDTA and samples 
placed on ice for 5mins. Samples were centrifuged (11000g, 5mins) and 
supernatants (S1 fraction) kept at 4°C. Pellets were resuspended in 1ml Lysis buffer 
(in distilled water, 1mM Tris-HCl (pH7.5), 0.2mM Na2EDTA, 0.2mM PMSF, 5mM Na-
butyrate) and dialysed overnight at 4°C against 2 litres of the same buffer.  
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Dialysed chromatin was pelleted (805g, 10mins, 4°C). The supernatant was kept on 
ice (S2 fraction) and the pellet was resuspended in 200µl of lysis buffer (P fraction). 
As previously, the amount of chromatin in each fraction was checked using 
spectrophotometry. Samples (in water, 2µg chromatin, 0.1%SDS, 2µl loading buffer, 
25µl final volume) were analysed by 1.2% agarose gel electrophoresis. It was 
important not to place ethidium bromide in the gel due to the presence of SDS in the 
samples. The gel was stained afterwards in electrophoresis buffer containing 
ethidium bromide (Figure 2.10.a). S1 and S2 fractions were combined and chromatin 
concentration was measured (Figure 2.10.b). 
 
2.6.2 Immuno-precipitation 
For immunoprecipitation of chromatin, SAS cut or affinity purified antibodies were 
used. According to the antibody, 50-100µl was added to 100 µg of unfixed chromatin 
(S1+S2) (Table 2.3). The final volume was made up to 1ml with Incubation buffer (in 
distilled water, 75mM NaCl, 20mM Tris-HCl, 20mM Na-butyrate, 5mM EDTA, 0.1mM 
PMSF). After overnight incubation at 4°C on a slow turntable, 200µl of 50% (w/v) 
Protein A SepharoseTM Cl-4B (Amersham Biosciences) were added and incubation 
continued for a further 3 hours at room temperature on a fast turntable. The sample 
was centrifuged (11000g, 10mins) and supernatant was kept as the UNBOUND 
fraction (UB). The pellet was resuspended in 1ml of Wash buffer A (50mM Tris-HCl 
(pH7.5), 10mM EDTA, 5mM Na-Butyrate, 50mM NaCl) and layered onto 9mls of the 
same buffer using a siliconised pasteur pipette in a 15ml siliconised polypropylene 
centrifuge tube. After centrigugation (805g, 10mins), the pellet was sequentially 
washed with 10mls of Wash buffer B (50mM Tris-HCl (pH7.5), 10mM EDTA, 5mM 
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Na-butyrate, 100mM NaCl) and 10mls of Wash buffer C (50mM Tris-HCl (pH7.5), 
10mM EDTA, 5mM Na-butyrate, 150mM NaCl) and finally resuspended in 1ml of 
Wash buffer C. Following transfer in siliconised eppendorfs, the sample was 
centrifuged (11000g, 10mins) and the pellet resuspended in 250µl of 
1%SDS/incubation buffer for 15mins at room temperature on a fast turntable. This 
step eluted the bound material from the Protein A Sepharose, so after centrifugation 
(11000g, 10mins) the supernatant was kept as the Bound 1 fraction. The pellet was 
washed again in 250µl of 1%SDS/incubation buffer and centrifuged (11000g, 10mins) 
and the supernatant mixed with the bound 1 fraction to obtain 500µl of BOUND 
fraction (B). In order to reduce the SDS concentration to 0.5%, 500µl of incubation 
buffer was added to the bound fraction. 
  
2.6.3 DNA isolation 
Each fraction was added to 333µl of phenol/chloroform, then vortexed and 
centrifuged (805g, 10mins). The Upper phase was added to 1ml of 
phenol/chloroform, then vortexed and centrifuged (805g, 10mins), and then re-
extracted with two 1ml volumes of chloroform. Finally, the upper-phase was mixed 
with 100µl of 4M LiCl, 2.5µl of glycogen (20mg/ml) and 4mls of ice-cold ethanol. 
Following overnight incubation at -20°C in order to precipitate the DNA, the sample 
was centrifuged (1811g, 20mins, 4°C), The pellet dried, and resuspended in 250µl of 
distilled water.  
DNA samples were initially analysed on 1% agarose gels (Figure 2.10.c). DNA in 
bound and unbound fractions was then quantified using Quant-it PicoGreen (PG) 
Reagent (Invitrogen). 2µl of DNA was added to 48µl of TE buffer (10mM Tris, 1mM 
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EDTA, pH8) and 50µl of PG (1/200 in TE buffer). The assay was performed in a 96-
well plate using the Wallac Victor3 1420 fluorometer. The percentage pull down was 
finally calculated (=(B/UB+B)*100) and the UB was diluted to the B in distilled water 
to ensure that equal amounts of DNA were analysed.  
In order to detect area of mark enrichment, specific regions of specific genes were 
analysed by qPCR (Table 2.4; 2.5). The ratio (B/UB) was calculated and considered 
as enrichment if equal or above 1.     
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Figure 2.9 Native chromatin immunoprecipitation   
Nuclei were isolated and chromatin was extracted from ES cells. Chromatin was 
then digested with the micrococcal nuclease, generating a ladder of !200bp 
fragments. Chromatin was immunoprecipitated using antibodies raised against 
specific post-translational histone modifications. Protein A sepharose was used to 
separate bound (B) and unbound (UB) fractions. DNA was then purified by 
phenol-chloroform extraction. Analysis of the mark enrichment was done at 
specific sites using PCR or qPCR. High-throughput technologies such as 
hybridization on high density arrays or sequencing could be used for global 
studies. 
Isolation of chromatin. 1 
2 Digestion and Immunoprecipitation 
3 
Bound and Unbound fractions 
are separated and the DNA and/
or Proteins are purified 
BOUND UNBOUND 
DNA is analyzed by PCR or qPCR. It could also be 
hybridized on high density arrays (ChIP-chip)  or 
sequenced (ChIP-Seq).  
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Figure 2.10 ChIP analysis using gel electrophoresis   
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a, Chromatin was extracted from ES cells untreated or treated with VPA (1mM, 
8hrs). Chromatin was then digested with the micrococcal nuclease. S1 and S2 
fractions correspond to the soluble digested chromatin, respectively after 
digestion and after overnight dialysis of the pellet. P fraction corresponds to the 
pellet resuspended in lysis buffer after overnight dialysis.  
b, Good quality S1 and S2 fractions were pooled for immunoprecipitation. The 
imput chromatin was visualised using 1.2% agarose gel electrophoresis. 
c, After immunoprecipitation, DNA from unbound and bound fractions was isolated 
using phenol-chloroform extraction. DNA was then analysed on a 1.2% agarose 
gel. As expected, more genomic material was present in the unbound fractions. 
Also, no DNA was detected in bound fractions of samples which were 
immunoprecipitated with no  antibody (imput) or preimmune serum.  
(-mono) 
(-di) 
(-tri) 
S1 S2 P 
S1 
+ 
S2 
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Table 2.3 Antibodies and dilutions   
Antibody 
Raised     
against 
Dilution for 
Western blot 
Dilution for 
ChIP          
(for 100µg of 
chromatin) 
Dilution for 
immuno-
fluorescence 
R403 H4K8ac 1/1000 100µl  
R41 H4K5ac 1/500   
R252 H4K16ac 1/1000   
R607 H3K9ac 1/500 50µl  
R612 H3K4me3 1/400 50µl  
Millipore 07-449 H3K27me3 1/2500 5µl 1/400 
Ab-4729 H3K27ac 1/500  1/200 
R209 H2BK12,15ac 1/400   
Ab-1791 H3 C-term 1/10000   
Ab-19857 Oct4 1/500   
Ab-26648 Klf4 2.5µg/ml   
Ab-8227 Actin 1/2500   
Rockland        
611-131-122 
Rabbit IgG 1/1000 
  
Rockland        
611-131-121 
Mouse IgG 1/1000 
  
Sigma        
F1262-1ML 
Rabbit IgG 
  
1/50 
Rx = Rabbit house antibodies; Ab-x = Abcam antibodies; H = histone; K = Lysine; 
ac = acetylated; me3 = tri-methylated     
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Table 2.4 Primers used for ChIP-DNA analysis by qPCR   
  
Forward primer Reverse primer Annealing 
temp (°C) 
Egr1/1 GGCAAGCTGGGAACTCCA ACCCGGAGTGACGTGAAG 60 
Egr1/2 GGCTTCCTGCTTCCCATA TGGGATCTCTCGCGACTC 60 
Egr1/3 CTGCACCCCGCATGTAAC GCGAGCTGGAGAACTGATGT 60 
Egr1/4 TGTTGTTTCTCCTGGGCTTG AGTTCCCAGAACCACCACAC 60 
H1f0/1 GCCCTTCCAACTCTTTCAGG CGGCCCCAACTAACACAC 60 
H1f0/2 GAGTGGGGCTCCTGGTAGTC GGCACATTTCCCCTTTGC 60 
H1f0/3 GGTGCGTTTTTCTTTAACTGG TCTCCCGAAGACCCACCTAC 60 
Ndrg4/1 AGCTTCTCCTCGGGTCTAGC GCACCATCCATTAGGTACAGC 60 
Ndrg4/2 CTTGAGCGGCAGAAGCTG CCTCCCTGCAAGGTTTCTG 60 
Ndrg4/3 GAGCTCTACCCCACCACAGA GACCCTCACTCACCCCATC 60 
Ndrg4/4 CCTATCACAGGGAAGGCTCA CAGCCTGGGCTACAGAAAGA 60 
Anapc7/1 TTAGCGCAGCAAAACTACGA ACGGACGTGCCTGAGTAAAA 60 
Anapc7/2 GAGCCTCTGCTCTCGGTTC CGGGTTGTTGTTACTCATGG 60 
Anapc7/3 GCCTGGCTCTTCACTGAGAT CAACCTCTCACATTCCTAGCAC 60 
Slc6a8/1 CAACCTTGGTGAAGGATGGT CATTCGTTCCAGGATCACCT 60 
Slc6a8/2 GAGAGGGACAGTTGGAGTGC CAAGTGGCTGTCCTGTTCG 60 
Slc6a8/3 TGGCTCCTGTTTCTGCTTCT GAGGCTTCCTTTCCTGCTCT 60 
Nanog/1 GCAGCCGTGGTTAAAAGATG AGGGAGGGAAAGCTTAGGG 60 
Nanog/2 ATCCACTGAGCCATCTCACC CTGGTCTGCAGAGCTAGTTCAA 60 
Each set of primer was tested using samples of various known concentration of 
cDNA. Standard curves were built in order to assess the amplification efficiency. 
Different annealing temperatures were tested until the slope of the standard curve 
was equal to -3.3 (± 0.3) and a good correlation coefficient was obtained.   
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Table 2.5 Primers used for ChIP-DNA analysis by qPCR (2)   
  
Forward primer Reverse primer 
Annealing 
temp (°C) 
Hoxb1/1 AGCCCTACAGCCTTGGGGTGG TTCAACCCAGCTGCCCCTCAC 58 
Hoxb1/2 TCCTAGGGGATCGCTGGCGG GCCGTTTGGGGGAGACACCC 58 
Hoxb1/3 CCGCAGCCCCCATACGGAAC CGGGGAGTGAGAGTGCTGGGT 60 
Hoxb2/1 TCCCCCAAGGTATGGAAGCCTCT CCTACCACCACCTCAGCCCCC 60 
Hoxb2/3 CAAGCCGGAGATGGGCCTGC GAGGCGGCTGGAGAAGGGGA 60 
Hoxb4/1 GCTACACCCGCAGCCCCAAC GAGACCCCCTCCTCGCCTGG 60 
Hoxb4/2 GGTGGCCATTGGCTCGGAGG CGCACGGAGGGAACTTGGGG 60 
Hoxb4/3 TGTCCCCTCGGGCTCCAGTG GGGCTCTTTGCACGCGGAGT 60 
Hoxb5/1 AGAGGGGATAGCCGCACCCT CTGGCTCTGTGCAACCGCCA 58 
Hoxb5/2 TGGCCGCATACATAGCAAAACGA GGAGGGCTTGATTTGTGGATCGTGG 58 
Hoxb5/3 GCCCTGCACTAACGGCGACA TCCTCGGGCTCAGAGGACGC 60 
Hoxb7/1 CACCAAGTTGCGAACATTCA CAGCTTGCAGGCGAGATT 60 
Hoxb7/2 ACCGACACTAAAACGTCCCCGA AGCGAAAACCGAACTTGCGGC 58 
Hoxb7/3 GCGCCAAGGAGCAGAGGGAC CGGAGCCCTTCTGGGGACCG 58 
Each set of primer was tested using samples of various known concentration of 
cDNA. Standard curves were built in order to assess the amplification efficiency. 
Different annealing temperatures were tested until the slope of the standard curve 
was equal to -3.3 (± 0.3) and a good correlation coefficient was obtained.   
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2.7 Immunofluorescent Labelling:  
2.7.1 Immunofluorescent labelling of cells grown on coverslips 
Cells were grown on a coverslip in a 24 well plate. Tissue culture medium was 
removed and cells gently washed three times with 1XPBS. Cells were fixed in 
4%(v/v) formaldehyde/PBS for 30 minutes at room temperature before blocking with 
1%BSA/0.5%Triton-X100/PBS for 30 minutes at room temperature. The primary 
antibody was diluted in the blocker solution (Table 2.3) and a minimum of 150µl was 
applied on cells. Following incubation at 4°C for an hour, cells were washed three 
times with 1XPBS. The last four steps were repeated with the secondary antibody, a 
goat anti rabbit-IgG labelled with fluorescein isothiocyanate (FITC, Sigma) . The 
coverslip was finally carefully lifted from the well using fine tweezers and placed on 
clean tissue, upper side facing up. 8µl of DAPI (Sigma) diluted to 1µl/ml in 
Vectashield mounting medium (H-1000; Vector Labs) was applied on cells and a 
glass slide (VWR 1.0-1.2mm, ethanol washed) gently lowered down on coverslip. 
Bubbles were carefully eased away and the slide and coverslip sealed together with 
nail varnish. Slides were kept at room temperature in the dark until images were 
taken using fluorescent microscopy.  
 
2.7.2 Immunofluorescent labelling of metaphase chromosomes 
In order to block cells in metaphase, 10µl/ml of Colcemid (Gibco, 10µg/ml) was 
added into the culture medium for 3 hours. Cells were harvested by trypsinisation 
and the suspension centrifuged at 250g for 5 minutes. The pellet was washed twice 
with ice cold PBS before being resuspended to 2x105 cells/ml in 75mM KCl for a 10 
minutes incubation at room temperature. Chromosome spreads were then prepared 
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on glass slides using a Shandon Cytospin 4. 4x104 cells per chamber were added 
and spun at 1800rpm for 10 minutes. Slides were then immersed in KCM buffer 
(120mM KCl, 20mM NaCl, 0.5mM EDTA, 0.1%(v/v) Triton-X-100, 10mM Tris-HCl 
pH8) for 10 minutes at room temperature. 50µl of primary antibody diluted in 
KCM/0.1%BSA (Table 2.3) were applied to slides and covered with Parafilm for one 
hour incubation at 4°C in a humid chamber. Slides were then washed twice by 
immersion in KCM buffer for 5 minutes. As previously, 50µl of secondary antibody, a 
goat anti rabbit-IgG labelled with fluorescein isothiocyanate (FITC), diluted in 
KCM/0.1%BSA was applied on slides and covered with Parafilm for one hour 
incubation at 4°C in a humid chamber. Following two 5 minute-washes with KCM 
buffer, slides were immersed in KCM/4%(v/v) formaldehyde for fixation. Slides were 
then rinsed with distilled water. Finally, 7.25µl of DAPI (Sigma) diluted to 1µl/ml in 
Vectashield mounting medium (H-1000; Vector Labs) was applied on cells and a 
glass coverslip gently lowered down on the slide and sealed with nail varnish. Slides 
were kept at room temperature in the dark until pictures were taken using fluorescent 
microscopy.  
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3. Results 
3.1. Epigenetic inheritance in ES cells: Role of histone acetylation 
3.1.1 Introduction 
Many processes have been described in the literature as epigenetic events. Genomic 
imprinting, X-chromosome inactivation, differentiation or phenomena like 
reprogramming and carcinogenesis require the establishment and long-term 
maintenance of specific gene expression patterns. We believe that cellular 
transcriptomes are partly specified by epigenetic mechanisms including the post-
translational modifications of histones. There is now evidence that these proteins 
play a major role in gene transcription, directly by changing the chromatin 
conformation (Shogren-Knaak et al., 2006) and indirectly by acting as binding sites 
for other proteins like chromatin modifiers or transcription factors (Taverna et al., 
2007). Thus, for a particular phenotype to be maintained through mitosis, epigenetic 
modifications have to survive replication and be transmitted to daughter cells. Little is 
known about how epigenetic marks are transmitted during the cell cycle but some 
mechanisms have been described, implicating pre-existing histone modifications as 
templates for newly formed nucleosomes (Nightingale et al., 2006). We decided to 
test this idea by asking whether or not an environmentally-induced epigenetic change 
could be heritable through mitosis. If histone modifications are read and duplicated 
during the cell cycle, we hypothesized that several generations of cells might keep 
the memory of an epigenetic change induced by drug treatment. In order to test our 
hypothesis we designed a model system using mouse embryonic stem (ES) cells and 
the histone deacetylase inhibitor (HDACi) valproic acid (VPA). Cells were treated for 
different periods of time with VPA so that global histone acetylation levels were 
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increased. Following the treatment, the effect of hyperacetylation on different 
parameters in our cell line was measured. In the meantime, VPA was removed from 
treated cells and these cells were kept in culture free from VPA for a further 5 days. 
After this wash out period, the same series of experiments were carried out in order 
to detect any persistent effect (Figure 3.1).        
Mechanisms that allow epigenetic inheritance remain unclear. However, it has been 
suggested that duplication of the marks associated with chromatin structure and DNA 
replication are connected (Zhang et al., 2000). Therefore, ES cells offered a good 
model for our study as they divide very rapidly - due to a lack of checkpoint controls, 
they show a significantly shortened G1 gap phase in comparison with most somatic 
cells. As a result, cells in an ES cell culture spend most of their time in the S phase 
(replication phase) of the cell cycle and display an unusually rapid doubling time of 
approximately 8-10 hours (Stead et al., 2002). This particular feature of ES cells 
constituted an advantage for our model. Valproic acid being a toxic drug, we wanted 
to treat the cells for relatively short periods of time, but long enough for most of the 
cells to go through a complete cell cycle.  
In an embryo the pluripotent state is transient while in an ES cell culture this unique 
characteristic has to be maintained. Constantly fighting differentiation and 
maintaining a chromatin structure with high plasticity (Meshorer et al., 2006), ES cells 
are thought to be highly sensitive to their environment and were therefore more likely 
to respond to VPA treatment.  
For those reasons, ES cells were considered a suitable model for our study.   
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Figure 3.1 Model system #1:  
Is it possible to induce a heritable epigenetic change in ES cells?    
The model system was designed to measure the effects of the HDACi Valproic 
acid (VPA) on ES cells (CCE/R line) and whether or not those effects could persist 
through the cell cycle.  
ES cells were treated for 8 hours with 1mM VPA. Because VPA is a HDACi we 
expected the treatment to induce hyperacetylation of histones. After 8 hours, cells 
were harvested and tested for several parameters including cell cycle profile, 
histone modifications levels or global gene transcription activity. In order to detect 
any heritable change, a pool of cells were kept in culture for 5 days in VPA-free 
medium following the treatment. After the wash out, cells were harvested and 
tested again.       
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3.1.2 Effect of valproic acid treatment on viability, self-renewal and 
pluripotency of ES cells  
The potential anti-cancer activity of Valproic Acid (VPA) has been linked to its ability 
to induce cell cycle arrest, apoptosis or differentiation (Bolden et al., 2006). We 
wanted to limit those effects in our study because we were specifically interested in 
the epigenetic long-term effect(s) of the drug. As ES cells are extremely sensitive to 
the environment, we had to choose a concentration of VPA we could use to induce 
hyperacetylation without dramatically disrupting the cell cycle, or the viability, or 
pluripotency of the cells.  
 
3.1.2.1 Cell cycle 
As mentioned earlier, due to a shortened G1 phase, ES cells divide very rapidly in 
comparison to differentiated cells. In a first experiment, ES cells were treated for 8 
hours with different concentrations of VPA (0.2mM, 1mM and 5mM) and the 
percentages of cells in each phase of the cell cycle were measured using flow 
cytometry. As expected in untreated cultures, more than 60% of the cells were in the 
S-phase of the cell cycle while a mean of 11.8% were in the G1-phase and 22% in 
the G2-M-phase. None of the treatments significantly changed this distribution. 
Indeed, the proportions of cells in S-phase stayed over 60% and proportions of cells 
in G1-phase and G2-M-phase remained very consistent (Figure 3.2.a). As 1mM VPA 
appeared to be well tolerated by the cells, and (as seen later) was enough to induce 
hyperacetylation, we decided to use VPA at this concentration for future experiments.  
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A time-course experiment was then performed, which would have allowed the 
detection of any major effect occurring at earlier time points within 8 hours treatment. 
1mM VPA treatment was carried out for 1, 2, 4 and 8 hours. Cells were harvested at 
each time point and the percentages of cells in each phase of the cell cycle were 
measured. Despite the treatment, a very high percentage of cells were still 
undergoing replication at each time point. In fact, the percentage of cells in S-phase 
never went below 60%. Although this percentage was slightly decreased during 
treatment (76% to 65%), we concluded that the treatment did not induce major 
changes in the cell cycle profile as this small drop in the number of replicating cells 
could simply reflect normal time-variations due to culture conditions.  
In addition to the time course, we decided to look at the cell cycle profile of cells that 
were treated for 8 hours with 1mM VPA and washed out for 5 days. A control flask 
(untreated cells) was harvested at the same time. Again, more than 60% of the cells 
were found in S-phase in both samples. The numbers of cells in each phase showed 
small differences between the two samples, but this variation was not greater than 
that observed during the 8 hours time course (Figure 3.2.b).  
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Figure 3.2 Effect of VPA treatment on ES cell self-renewal 
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a 
CCE/Rs were first treated for 8hrs with 0.2mM, 1mM or 5mM VPA (a). In a second 
experiment, CCE/R were treated with 1mM VPA for 1, 2, 4 or 8 hours. Following 
the 8 hours treatment, VPA was removed (Wash-out, wo) from some cells for 5 
days before analysis (b). For each sample, 50000 cells were stained with 
propidium iodide (PI). The intensity of the signal from each cell was then analysed 
using a Flow cytometer in order to obtain the mean percentage of cells in each 
phases of the cell cycle. For the time course, histograms from one of the two 
independent experiments used to calculate percentage of cells are shown.  
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3.1.2.2 Cell Viability 
Affecting several pathways, VPA is known to induce cell death but also to have an 
anti-apoptotic activity (Bielecka and Obuchowicz, 2008). Therefore, we decided to 
measure ES cell viability after VPA treatment. Cells were treated with 1mM VPA for 
1,2,4 and 8 hours and stained with Trypan Blue. Metabolically active cells were able 
to exclude the dye while dead cells appeared blue. For each time point, white and 
blue cells were counted using a Malassez hemocytometer. On average in untreated 
cultures, 84.1% of the cells appeared alive and 15.9% of the cells were dead. 
Although cell death slightly increased after 2 hours of treatment, the proportions of 
alive and dead cells didn’t significantly vary during the treatment (Figure 3.3.a).  
Because Trypan blue staining is not very accurate, cell viability was assessed a 
second time using a calorimetric assay that allows the quantification of metabolically 
active cells in proliferation. During the assay, a compound was bioreduced by living 
cells into a coloured product. The quantity of product measured in the medium by the 
absorbance at 492nm was directly proportional to the number of living cells. 
Untreated cells and cells treated with 1mM VPA for 8 hours were compared. Empty 
well, medium only and cells treated with 10% DMSO were used as negative controls. 
As expected, the difference between the dead cells sample (+DMSO) and untreated 
cells was statistically significant, while no effect was detected between untreated and 
VPA-treated cells (Figure 3.3.b).       
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Figure 3.3 Effect of VPA treatment on ES cell viability 
a 
b 
a, CCE/Rs were treated with 1mM VPA for 1,2,4 or 8 hours and stained with 
trypan blue. Alive and dead (remaining blue) cells were counted using a malassez 
hemocytometer. Means of alive and dead cell percentages were calculated at 
each time point (n=3).  
b, CCE/Rs were treated with 1mM VPA for 8 hours or with 10% DMSO in order to 
induce cell death. The calorimetric MTS assay was performed to assess viability 
of cells in each conditions. An empty well and a well containing media only were 
used as additional negative controls. The quantity of the colored formazan 
product, directly proportional to the number of living cells, was measured by the 
absorbance at 492nm (n=3).  
Two-tailed unpaired t-test were done using the GraphPad software.  
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3.1.2.3 Cell pluripotency 
Although 1mM VPA didn’t induce massive changes in cell cycle profile or affect the 
viability of our ES cells, it did induce an important change in cell morphology. ES 
cells commonly grow in colonies where one cell often can’t be distinguished from 
another. However, when cells were treated with 1mM VPA for 8 hours the colony 
morphology was affected. Single cells were becoming visible at the edges of the 
colonies by adopting a monolayer growth pattern. We speculate that the cytoskeleton 
of the cells was affected by the treatment, possibly as a consequence of an early 
differentiation process. Therefore, we decided to test untreated and treated cells for 
alkaline phosphatase activity, a marker of pluripotency (Berstine et al., 1973). As 
expected, colonies of untreated ES cells stained red which confirmed a strong 
enzymatic activity. After 1mM VPA treatment for 8 hours, the staining still appeared 
uniform but was noticeably weaker. At this stage, it was difficult to say if this was a 
consequence of an early differentiation process or if this was because cells within the 
colonies were less compacted and therefore the colour more diluted (Figure 3.4.a).   
Cells treated with 1mM VPA for 8 hours and washed out for 5 days were tested for 
alkaline phosphatase activity as well. The test revealed cells with a normal 
morphology and strong alkaline phosphatase staining (Figure 3.4.b).   
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Figure 3.4 Effect of VPA treatment on cell morphology and  
Alkaline phosphatase activity    
Untreated 2 hours VPA 8 hours VPA a 
b 5 days wash out 
One colony of  
ES cells 
CCE/Rs were treated with 1mM VPA for 2 and 8 hours (a) or treated with 1mM 
VPA for 8 hours and washed out for 5 days (b). Light microscopy was used to 
assess the cell morphology at each time point. In addition, untreated cells, 8 hour 
treated cells and washed out cells were stained for alkaline phosphatase activity 
(AP), a marker of pluripotency. Pluripotent, AP-positive colonies appeared red. 
Pictures were taken using 20X magnification.  
Phase contrast AP staining 
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To further investigate the impact of VPA treatment on cell pluripotency, we decided to 
measure the transcription activity of five genes implicated in pluripotency 
maintenance: Oct4, Nanog, Klf4, Sox2 and c-Myc (Figure 3.5). Expression levels 
were initially analysed after 1mM VPA treatment for 8 hours, and then after 1 day or 
5 days post wash out. For each time point, control untreated cells were harvested as 
well. Expression profiles revealed that after 8 hours of treatment the expression of 
Klf4 and Nanog was significantly decreased by VPA while Sox2 was significantly up-
regulated. Transcription of c-Myc and Oct4 was unaffected by the treatment, 
although there was a small decrease in Oct4 transcript.  
Very little effect was observed after 1 day wash-out. Moreover, the differences 
between controls and wash out samples were not greater than that observed 
between the various controls. Transcription levels in wash out samples could simply 
be the reflection of natural variations between asynchronous ES cell populations and 
we concluded that VPA treatment has no long-term effects on the expression of 
pluripotency-associated genes.  
Lastly, the transcriptional activity of c-Myc in washed out cells was consistently 
maintained at the control level. However, the expression of this gene decreased 
substantially in wash out and control cultures compared to day 0. The transcription 
factor c-Myc is cell cycle-regulated which could explain this observation. c-Myc is 
expressed when the cell is actively dividing, promoting G1/S transition (Amati et al., 
1998). As, in contrast to day 0 samples, when cells were harvested at 1 and 5 days 
after wash out they were confluent enough to be split. Similarly to what was observed 
during cell cycle analysis, a change in cell division activity due to normal culture 
condition variations could explain this change in c-Myc expression (Figure 3.5).   
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Figure 3.5 Effect of VPA treatment on transcription levels of pluripotency-
associated genes   
CCE/Rs were treated for 8 hours with 1mM VPA and then washed out and 
cultured for 1 or 5 days. RNA was extracted and quantified by RT-qPCR. The 
expression of five pluripotency associated genes was normalized against the 
housekeeper !-actin. A parametric two-tailed unpaired t-test showed significant 
differences for Nanog, Klf4 and Sox2 on the day of treatment (day0).    
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A drop in gene transcription doesn’t always lead to a decrease in protein abundance. 
Therefore, we decided to use western blotting to quantify OCT4, NANOG and KLF4 
in untreated cells and cells treated for 8 hours with 1mM VPA. Although Klf4 
transcription was decreased after the treatment, the amount of KLF4 protein 
remained unchanged following exposure to VPA. A very small decrease in Oct4 
transcript abundance was detected after the treatment and interestingly a slight effect 
was observed at a protein level, but this drop was non-significant. Sox2 transcript 
abundance was increased following VPA treatment. Interestingly, the SOX2 protein 
has been found to be a cofactor of OCT4 (Avilion et al., 2003). Quantification of 
SOX2 protein level would be therefore relevant. Finally, NANOG protein abundance 
couldn’t be assessed due to lack of availability of a specific antibody (Figure 3.6).   
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KLF4 
actin 
OCT4 
Figure 3.6 Effect of VPA treatment on OCT4 and KLF4  
protein abundance   
(42kDa) 
(50kDa) 
(43kDa) 
(U    T    U    T    U   T)  
CCE/Rs were treated for 8 hours with 1mM VPA. Total protein was extracted and 
levels of OCT4 and KLF4 assessed using western blotting. !-actin was used for 
normalisation.     
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3.1.3 Effect of valproic acid treatment on global histone modifications in ES 
cells  
Once a non-toxic concentration of VPA has been established, we assessed the effect 
of the drug on global histone modifications. Initially we looked at global changes in 
acetylation level on specific histone isoforms. Histones extracted from untreated cells 
or cells treated for 8 hours with 1mM VPA were separated on a triton-acid-urea 
(TAU) gel and silver stained, allowing the visualisation of acetyl histone H4-isoforms. 
Histone H4 from untreated cells were predominantly mono-acetylated correlating with 
observations that chromatin in ES cells is hyperacetylated compared with chromatin 
in differentiated cells (Spivakov and Fisher, 2007). As expected, histone H4 from 
treated cells was found to be mostly di-, tri-acetylated (Figure 3.7.a).  
Using western blotting, specific histone modifications were then examined on 
histones extracted from cells that had been treated with 1mM VPA for 1, 2, 4 and 8 
hours. As expected, the enrichment of each acetyl mark increased progressively 
during the time course, though to different extends, depending on the isoforms. 
Interestingly, methylation on H3K4 was increased as well in response to VPA 
treatment. This result confirmed a previously characterised cross talk between 
histone acetylation and H3K4me3, both marks being associated with active 
transcription (Nightingale et al., 2007) (Figure 3.7.b).  
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Figure 3.7 Effect of VPA treatment on global histone modifications 
a, Histones from untreated or treated (1mM; 8hrs) CCE/Rs were separated on a 
Triton-Acid-Urea (TAU) gel and then silver-stained. This type of gel allows the 
resolution of proteins according to mass and charge and thus, can resolve histone 
H4-acetyl isoforms (i.e. H4-1ac vs H4-2ac).  
b, Histones were extracted from CCE/Rs that were treated with 1mM VPA for 1, 2, 
4 and 8 hours. Changes in global levels of several histone modifications were 
assessed using western blotting. Coomassie blue staining was used as a loading 
control.  
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After we showed that 1mM VPA treatment induced general hyperacetylation of 
histones in our ES cell line, we investigated if those global changes could be 
heritable through mitosis. Because the turnover of histone modifications is very high, 
it was expected that if the cells couldn’t retain hyperacetylation, abundance would 
drop very fast. Therefore, it was decided that cells would be washed out for short 
period of time at first. Cells were treated with 1mM VPA for 2, 4, and 8 hours. 
Following 8 hours of treatment some cells were washed out and cultured for a further 
15 minutes, 30 minutes, 1, 2 or 4 hours. Histones were extracted at each time point 
and specific marks immunodetected by western blotting (Figure 3.8.a). The 
secondary antibody was conjugated with a fluorescent dye allowing quantification of 
the signal. Each value was normalized using an antibody raised against the H3 C-
terminal region (Figure 3.8.b).  
As expected, the abundance of each mark was increased by VPA treatment, 
reaching a plateau after 4 hours. The magnitude of the increase varied between the 
marks, for example the increase of H3K9ac ('16 fold) was more significant than the 
increase of H2BK12,15ac ('3 fold). The increase in acetylation on histones has 
previously been shown to be site specific in Hela cells, particularly on histone H3. 
With regard to histone H4, acetylation started at residue 16 and progresses in a N-
terminal direction (i.e. mono-acetylation of H4 occurs on lysine 16 and further 
addition of acetyl groups occurs on lysine 12, 8 and 5) (Thorne et al., 1990; Turner et 
al., 1989). As a result, because of the shift to higher levels of acetylation following 
VPA treatment, the fold change of H4K16ac should be less substantial than the fold 
change of H4K5ac. Consistent with this, VPA treatment induced a (')15-fold increase 
in H4K5ac, a (')5-fold increase in H4K8ac and a (')3-fold increase in H4K16ac. 
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Finally, in contrast with H3K4me3, H3K27me3 abundance did not change in 
response to the treatment.  
Removal of the drug after 8 hours of treatment induced a massive drop in histone 
acetylation and concomitantly of H3K4 methylation within only 15 minutes. This 
observation, consistent with a high histone acetylation turnover, very clearly showed 
that the cells were not able to retain the hyperacetylation, at least at a global level 
and for the modifications we looked at.  
One possible explanation was that the cells hadn’t been treated for long enough to 
keep the memory of hyperacetylation. Thus, we decided to repeat the experiment 
with a longer initial treatment. Cells were treated with 1mM VPA for 2, 4, 8, 12 and 16 
hours before being washed out for 15 minutes, 30 minutes, 1, 2 or 4 hours. The 
same observations were made, with a loss of mark abundance within 15 minutes of 
wash out (Figure 3.9).   
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Figure 3.8 Global histone modification abundance after VPA treatment 
followed by wash out   
a, Histones were extracted from CCE/Rs that were treated with 1mM VPA for 0, 2, 
4 and 8 hours followed by wash out (15mins, 30mins, 1,2 and 4 hours). Changes 
in global levels of several histone modifications were assessed using western 
blotting. Blotting with an H3 C-terminal antibody was used as a loading control.  
b, Image analysis of a. H3 C-terminal staining was used to normalize values.  
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Figure 3.9 Global histone modification abundance after VPA treatment 
followed by wash out 
H3c-term 
a, Histones were extracted from CCE/Rs that were treated with 1mM VPA for 0, 2, 
4, 8, 12 and 16 hours followed by wash out (15mins, 30mins, 1,2 and 4 hours). 
Changes in global levels of several histone modifications were assessed using 
western blotting. Blotting with an H3 C-terminal antibody was used as a loading 
control.  
b, Image analysis of a. H3 C-terminal staining was used to normalize values.  
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3.1.4 Effect of valproic acid treatment on global gene expression in ES cells  
VPA is an HDACi and as expected induced global hyperacetylation of histone in ES 
cells as well as an increase in H3K4me3. Those two modifications have been widely 
associated with active transcription so gene expression was likely to be affected after 
treatment. Microarray technology was used to compare global transcription activity 
before and after VPA treatment. In order to detect any persistent effect, gene 
expression in washed out cells was assessed as well.  
Cells were treated for 8 hours with 1mM VPA and then harvested or washed out for 5 
days. Two colour arrays were used to compare global gene expression in treated and 
control cells. cDNAs of treated and control cells were respectively labelled with the 
red Cy5 dye and the green Cy3 dye. M-values were obtained, representing the ratio 
between red and green fluorescent signals and therefore the differential expression 
in treated and control samples. The same experimental procedure was used to 
compare gene expression in wash out and control cells. For each condition, M-values 
from three independent experiments were tested for statistical significance using the 
web-software T-MeV and p values were corrected with the statistical environment “R” 
(Benjamini False Discovery Rate correction). After exposure to 1mM VPA for 8 
hours, 1144 genes showed a significant change in transcription activity (p(0.1 after 
FDR correction), including 674 up-regulated and 470 down-regulated genes (Figure 
3.10.a). However, after 5 days of wash out, transcriptional activity had reverted back 
to basal levels, as no change in expression between washed-out cells and control 
cells was statistically significant.  
Twelve genes (6 up-regulated, 2 unchanged and 4 down-regulated) were quantified 
using qPCR in order to validate the microarray data. We decided to look at a 
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representative set of genes, more or less affected by the treatment. The heat map 
representing the triplicate data for each gene was generated, showing up-regulated 
genes in red and down-regulated genes in green. Fold changes were correlated with 
the brightness of the colour on the map (Figure 3.10.b). These microarray data were 
confirmed by qPCR, showing different levels of up- and down-regulation after 
treatment, and no persistent effect after wash out (Figure 3.11 and 3.12). We 
therefore concluded that VPA could not induce heritable changes of gene expression 
at least for the genes we examined in ES cells.   
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Change in 
expression 
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No 
change 
Down 
regulated 
Total 674 9399 470 
! 2 fold 95  28 
1.5-2 fold  241  118 
1-1.5 fold 338  324 
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Figure 3.10 Effect of a 1mM VPA treatment on global gene expression 
a 
b 
(n=3) 
a, CCE/Rs were treated for 8 hours with 1mM VPA. RNA was extracted from 
control and treated cells and retrotranscribed. cDNA was then labelled using 2 
different dyes for microarray hybridization. Values reflecting the ratio of 
fluorescence between the two dyes were obtained for each gene and normalized 
with the DNMAD web-software. Statistical tests were carried out with the web-
software Tmev using three biological replicates and genes were classified as up-
regulated, down-regulated or unchanged following VPA treatment. Genes were 
considered up- or down-regulated when the p value after FDR correction was 
equal or less than 0.1.   
b, Heat map of the genes used for qPCR validation showing fold-changes 
between control and VPA treated cells. Red corresponds to a positive fold change 
in expression after treatment while green correspond to down-regulation of the 
gene. The larger the fold change the more bright the colour. In order to validate 
the microarray result we selected genes more or less affected in both groups as 
well as unchanged genes and tested them using qPCR.  
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Figure 3.11 qPCR validation for up-regulated genes after VPA treatment  
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A group of genes significantly up-regulated after 8 hours of 1mM VPA treatment 
was selected from microarray data. Expression levels of each of those genes, 
after VPA treatment and after wash out, were obtained using qPCR for microarray 
validation. Values marked in red under each graph correspond to the average fold 
change obtained after microarray analysis.  
Statistical analysis were processed with GraphPad software. Up-regulation of the 
genes in treated samples was tested using the nonparametric one-tailed Mann-
Whitney test at 95% confidence interval. The same results were obtained when 
differences between untreated and treated samples was assessed with the 
parametric two-tailed unpaired t-test. 
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Figure 3.12 qPCR validation for down-regulated genes after VPA treatment  
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A group of genes significantly down-regulated (a) or un-affected (b) after 8 hours 
of 1mM VPA treatment were selected from microarray data. Expression levels of 
each of those genes, after VPA treatment and after wash out, were obtained using 
qPCR for microarray validation. Values marked in green under each graph 
correspond to the average fold change obtained after microarray analysis. 
Statistical analysis were processed with GraphPad software as before (see figure 
3.11).  
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3.1.4.1 Gene cluster analysis 
Because VPA is used for the treatment of diseases like cancer, it was interesting to 
explore the effect of the drug exposure on gene activity. This was even more relevant 
as ES cells were used for our study and the concept of cancer stem cells is now 
growing (Alison et al., 2011). The web software DAVID and the software IngenuityTM 
were used for microarray data analysis. Those tools were used for the identification 
of gene clusters that were significantly enriched in a list of genes and thus, allowed 
the extraction of biological meaning from large data sets.  
 
DAVID: 
The 1144 genes affected by the VPA treatment were mapped to associated- 
biological annotations. The proportion of genes in each annotation from our list and 
from a background list (the entire mus musculus genome) were then compared. This 
comparison led to the identification of over-represented annotations in our data set 
(Table 3.1.a). Interestingly, in the annotation with the highest enrichment score, 102 
genes were connected with non-membrane-bound organelles including 57 genes 
participating in cytoskeleton organisation. This result was consistent with the 
morphological change of the cells observed after VPA treatment. Lysine acetylation 
is known to occur on important proteins for the formation and the movement of 
microfilaments like actin, cofilin, thymosin b10, profilin, moesin and tropomyosin. In 
addition, the treatment of epithelial cells with the HDACi TSA led to the accumulation 
of stable actin stress fibres (Kim et al., 2006). Our data have shown that cytoskeleton 
dynamics was also affected by VPA at a transcriptional level with the up-regulation of 
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!-actin, Arpc2, Arpc5, tropomyosin, coronin, destrin, gelsolin, vinculin and laminA. All 
of these genes are associated with cytoskeleton or cell mobility. 
 
Although the treatment did not induce cell death, cell cycle arrest or differentiation, 
some associated genes show a change in expression after 8 hours in the presence 
of 1mM VPA. The cell cycle annotation was found to be over-represented in our data 
set with for example the down-regulation of Ccnd1 and Ccnd2 (Cyclin D1 and D2) 
and the up-regulation of Ccne1 (Cyclin E1). Intriguingly, phosphorylation of the Rb 
(Retinoblastoma) protein by cyclin D is required to activate the E2F family of 
transcription factors, which then promotes the expression of cyclin E and therefore 
the G1/S transition (Coqueret, 2002). However, Rb-E2F was found to form a 
repressor complex at promoters of target genes through the recruitment of HDACs 
(Frolov and Dyson, 2004). This could explain the up-regulation of cyclin E despite the 
down-regulation of cyclin D. Anapc1 was up-regulated by VPA treatment. The 
product of this gene is the subunit 1 of the anaphase promoting complex (APC) 
which targets cell cycle regulatory proteins to the proteasome through its ubiquitin 
ligase activity (Jorgensen et al., 2001). Interestingly, TSA treatment has been shown 
to enhance APC protein assembly rather than up-regulate the subunits (Kimata et al., 
2008). Our data showed that the VPA treatment also induces down-regulation of 
genes that promote cell cycle progression like Hcfc1 (Host cell factor C1) or Mybl2 
(Myeloblastosis oncogene-like 2). Hcfc1 is a chromatin bound protein that associates 
in complexes with HDAC or HMT to regulate cell proliferation (Tyagi et al., 2007; 
Wysocka et al., 2003). Similarly, the Mybl2 transcription factor, was shown to interact 
with a protein complex that promotes the G2/M transition (Knight et al., 2009).  
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Very few genes associated with pluripotency were affected by VPA treatment. For 
example, microarray data confirmed the down-regulation of Nanog in addition to the 
down-regulation of Dppa2 (developmental pluripotency associated 2) and the up 
regulation of Creg1 (Cellular repressor of E1A-stimulated genes 1). Dppa2 encodes a 
protein that inhibits the differentiation of ES cells and promotes proliferation (Du et 
al., 2010) while the product of Creg1 represses E1A-stimulated genes involved in 
differentiation processes (Sacher et al., 2005).  
The apoptosis annotation was not found to be over-represented in our data set. 
However, some associated genes were affected by the treatment. For instance, the 
expression of Dap (Death-associated protein), a protein involved in the autophagic 
cell death pathway (Bialik and Kimchi, 2009), was increased by VPA. The Clusterin 
gene, which encodes a protein with roles in apoptosis and survival during 
tumourigenesis (Rizzi and Bettuzzi, 2010), was up-regulated by VPA treatment. We 
also observed the up-regulation of several heat-shock proteins, pro-survival 
chaperones implicated in the cellular stress-response (Pratt et al., 2010). 
 
Hyperacetylation induced by VPA treatment may alter chromatin through the up- and 
down-regulation of several factors involved in nucleosome formation and histone 
modification. The expression of several histone isoforms was modulated by the 
treatment. Expression of H1f0 (H1 histone family member 0) and H3f3b (H3 histone, 
family 3B) was increased, while expression of H2afy2 (H2A histone family, member 
Y2) was decreased. In addition, four different lysine-specific demethylases (Kdm2a, 
Kdm3a, Kdm3b and Kdm6a) were down-regulated by VPA while Kdm1b was up-
regulated. Myst2 (Histone acetyl transferase 2) was down regulated by VPA as well 
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as the lysine acetyltransferase Kat2b. Finally, DNA methylation was also potentially 
affected by the treatment as dnmt3a (DNA methyl-transferase 3a) was up-regulated.  
 
The synthesis of a functional protein is a long process that requires multiple steps. 
Our study has shown that a VPA treatment induced changes in the transcriptional 
activity of genes involved in histone modifications, one of the major events that act on 
gene expression. In addition, we identified genes that participate in RNA processing 
and protein processing. Cftf2t, a germ cell expressed gene coding for a protein 
involved in polyadenylation of pre-mRNAs (Monarez et al., 2007), was found to be 
up-regulated. Transcription of Gle1l, a gene coding for a protein that participates in 
RNA transport to the cytoplasm (Stewart, 2007), was also increased after treatment. 
In addition, RNA processing was potentially altered by the down-regulation of 
Hnrph2, Pabpn1, Tcerg1 and a series of splicing factors. HNRPH2, a heterogeneous 
nuclear ribonucleoprotein isoform, plays a suggested role in pre-mRNA processing, 
transport and interaction with nuclear structure (Honore et al., 1995). PABPN1 
(Poly(A) binding protein nuclear 1) is part of a protein complex that ensures the 
elongation of poly(A) tails by poly(A) polymerase (Kuhn and Wahle, 2004). Finally, 
TCERG1 is a protein part of the spliceosome and interacts with RNA polymerase II to 
block its action (Banman et al., 2010).  
Translation is the mechanism by which proteins are synthesised from mRNA. A 
group of five translation initiation factors and two translation elongation factors, small 
subunits of the ribosome (Rodnina and Wintermeyer, 2009), were found down-
regulated after treatment. We also observed down regulation of Iars, a gene that 
encodes the isoleucyl-tRNA synthetase, an enzyme responsible for the attachment of 
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the amino acid isoleucyl to the corresponding tRNA (Shiba et al., 1994). On the other 
hand, Rars (Argininyl-tRNA synthetase) was up-regulated after treatment. 
Furthermore, VPA treatment induced a decrease in transcription of 5 ribosomal 
proteins. Translation in the mitochondria was also potentially affected by the 
treatment as Mrps18b (28S mitochondrial ribosomal protein S18B) was down 
regulated. Finally, expression of Pdia6 (protein disulfide isomerase family A, member 
6) coding for an enzyme that catalyses the formation of disulphide bonds in the 
endoplasmic reticulum (Jessop et al., 2009) was increased by VPA.  
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a 
b 
Table 3.1 Gene cluster analysis (DAVID; Ingenuity)   
a, The bioinformatic software DAVID allowed the analysis of a large data set by 
mapping genes with associated biological annotations. Representation of each 
annotation, in our list of genes compared to the mouse genome, was given by 
enrichment scores. Each annotation contains several groups and the enrichment 
score is the geometric mean of all the group p-values (in minus log 
transformation). An enrichment score of 1.3 is equivalent to 0.05 in non-log scale, 
therefore any annotation with a enrichment equal or above 1.3 is significantly 
overrepresented in our data set. The table contains some of those relevant 
annotations.  
b, The software Ingenuity was used for Network analysis. Genes were mapped 
together in a network when they were found to interact with each other in a 
biological context. For each network a score was generated, equivalent to the 
negative log of a p-value. A score of 2 indicated at 99% confidence that genes 
within a network did not associate due to random chance.  
Network Score 
Cellular movement, assembly and organisation 50 
RNA, Post-transcriptional modifications, cellular 
growth and proliferation 47 
Protein degradation, synthesis and post-
translational modifications 45 
Development 44 
Cell morphology 40 
Cluster E.S. Examples of affected genes 
Cytoskeleton/                   
cytoskeleton interracting 
proteins 
4.29 
Actin!, Arpc2, Coronin, Destrin, 
tropomyosin, coronin, destrin, gelsolin, 
vinculin, laminA. 
Transport 3.35 
Cldn6, Eea1, Dstn, Tcte1l, Ipo11, 
Kif3a, Kpnb1, Nsf, Sl4a2, Vdac1.   
Ubiquitine conjugation 3.31 
Nedd4, Psmb4, Rnf128, Mir, 
CathepsinL1, Smurf2. 
Cell cycle 3.17 
Ccnd1, Ccnd2, Ccne1, hcfc1, Mybl2, 
Anapc1. 
Vesicule formation 3.09 
Cltb, Ap2a1, Rab3d, Rad18, Scamp1, 
Itsn2.  
Lysosome metabolism 3.05 Ctsl, Gm2a, Bcl10, Slc11a2, Manba. 
Transcription cofactors 2.41 
Nlk, Tbl1rx1, Trim28, Hcfc1, Ncoa1, 
Creg1, Maged1.  
Steroid/lipid metabolism 2.25 Dpm1, Mvd, Pcyt1a, Lss, Agpat3.   
Chromatin organisation 2.19 
Dnmt3a, H1f0, H2afy2, H3f3b, Hira, 
Kdm1b-2a-3a-3b-6a, L3mbtl3, Myst2.  
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Figure 3.13 Example of a network built using Ingenuity   
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This network generated by Ingenuity was named “ Protein degradation, synthesis 
and post-translational modifications”. Red and green represent direction of change 
in our data set.  
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Ingenuity: 
The software Ingenuity was subsequently used to build networks of interacting genes 
from our gene list. For each network a score was generated, equivalent to the 
negative log of a p-value. A score of 2 indicated at 99% confidence that genes within 
a network were not together due to random chance. Although the annotations were 
not as precise as the DAVID ones, Ingenuity highlighted similar functions, reinforcing 
confidence in the meaning of our data set (Table 3.1.b). As an example, we chose to 
describe network 3, which showed interactions between proteins affected by VPA 
treatment and implicated in the ubiquitination pathway (Figure 3.13). Ubiquitination 
of proteins is fundamental as it leads to degradation by the proteasome or lysosome 
but is also implicated in various processes like signalling or cell death. Three types of 
enzymes are required for the establishment of ubiquitin chains on substrates: 
ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and 
ubiquitin protein ligases (E3s) (Dikic et al., 2009). Many biological events require 
protein degradation, for instance cell cycle progression or the elimination of damaged 
proteins. NEDD4 (neural precursor cell-expressed developmentally downregulated 
gene 4) is an ubiquitin ligase that belongs to the HERC familly of E3s. This enzyme is 
implicated among others in the down-regulation of growth factors (Yang and Kumar, 
2010) and the quantity of Nedd4 transcript was decreased in VPA treated cells. 
However, transcription of Ndfip2 (Nedd4 family interacting protein 2) was increased 
by the treatment. The corresponding protein enhances the activity of Nedd4 family-
E3s and brings them to endosomes (Mund and Pelham, 2010). RLIM (Ring finger 
protein LIM domain interacting) is an E3 ubiquitine ligase that was identified as an 
important activator of X-chromosome inactivation. In fact it was shown to enhance 
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the expression of Xist in a dose-dependant manner. Interestingly, it was suggested 
that NANOG inhibits the transcription of Rlim (Barakat et al., 2010). This correlates 
with our data set where Nanog was down-regulated and Rlim up-regulated. VPA was 
previously shown to trigger HDAC2 degradation by the proteasome through up 
regulation of the E2 conjugating enzyme UBC8. However, RLIM protein level was 
found unaffected by VPA treatment (Kramer et al., 2003). The three additional ring-
finger proteins Rnf4, Rnf11 and Pja2 were affected by VPA treatment. The gene 
Rnf4, down-regulated by VPA, encodes a Ring-finger protein that transfers ubiquitin 
on SUMOylated proteins. RNF4 acts on genome stability and enhances DNA 
demethylation (Hu et al., 2010). Rnf11 was on the other hand up-regulated by the 
treatment. This gene is up-regulated in some tumours and was demonstrated to be 
essential for the activity of A20, a negative regulator of NF-kB (Shembade et al., 
2009). E3s ubiquitin-ligase enzymes interact through the HECT domain with E2s 
ubiquitin-conjugating enzymes like UBE2D2 or UBE2E2 (Kamadurai et al., 2009) that 
were up-regulated by VPA treatment. As mentioned earlier, ubiquitination is 
implicated in a multitude of processes and therefore ubiquitin enzymes have a lot of 
substrates. Some of them were affected by the treatment as seen in the network. For 
instance, the RING finger ubiquitin ligase ARIH2 inhibits cell proliferation for myeloid 
differentiation (Marteijn et al., 2009) and was down-regulated in VPA-treated cells. 
Skil, up-regulated by VPA, encodes a negative regulator of TGF# signalling. For 
example, SKIL blocks TGF#-induced expression of ADAM12, a gene often found up-
regulated in cancer or cardiovascular diseases. Upon TGF# stimulation, SKIL is 
ubiquitinated by SMURF2 and degraded by the proteasome (Solomon et al., 2010). 
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We could therefore imagine here that the up-regulation of Skil was balanced by the 
up-regulation of Smurf2.  
 
We observed that VPA treatment affected about 10% of genes and those genes were 
associated with many biological functions like cytoskeleton dynamics, ubiquitin 
conjugation or cell cycle progression. However, fold changes were not very large and 
a change in transcriptional activity does not always affect protein abundance. For 
instance, our FACS experiments have previously shown that the cell cycle of VPA 
treated cells was not extensively disrupted. Therefore we concluded that an 8 hour 
exposure to 1mM VPA induced consistent but small effects on gene expression in ES 
cells. In addition, the changes observed after treatment were not persistent when the 
drug was removed from the media.     
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3.1.5 Effect of valproic acid treatment on local histone modifications in ES cells 
Although VPA induced fast and substantial hyperacetylation of histones in ES cells, 
only a small proportion of genes showed a change in their transcriptional activity. We 
therefore used chromatin immunoprecipitation to examine local histone modifications 
at specific loci before and after treatment with 1mM VPA for 8 hours. Chromatin was 
extracted from cells and precipitated with different antibodies raised against four 
specific histone marks: three marks associated with active transcription H3K9ac, 
H4K8ac, H3K4me3 and the silencing mark H3K27me3. DNA from bound and 
unbound fractions was analysed using qPCR. Sets of primers were designed in order 
to look at specific regions in the promoters of several genes. A ratio of B/UB greater 
than 1 indicates that the mark is enriched at that locus. We wanted to investigate 
whether the hyperacetylation of histones occurred uniformly throughout the genome 
or only at genes showing transcriptional change. We decided to look at the three up-
regulated genes Egr1, Ndrg4 and H1f0 (Figure 3.14-16), two unaffected genes 
Anapc7 and Slc6a8 (Figure 3.17-18) as well as the down-regulated gene Nanog 
(Figure 3.19). As expected in untreated cells, the enrichment of the different marks 
was for most cases found in the promoter (i.e. Egr1/2 and 3).    
The first important observation concerned acetylation on H3K9 that appeared to 
increase at the promoter of all the genes we looked at. Interestingly, levels of 
enrichment in untreated cells didn’t correlate with fold changes after treatment. 
Importantly, hyperacetylation of H3K9 at those loci were not related to the 
transcriptional change induced by VPA, and the fold changes on individual promoters 
were not as high as expected. In fact, when bulk histones were analysed by western 
blot we observed a 16-fold increase in H3K9ac. But, surprisingly, at specific regions 
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of the promoters we studied by ChIP, the increase in H3K9ac was never greater than 
2-fold.  
While H3K9ac generally increased after treatment, acetylation on H4K8 consistently 
decreased over the promoters of the genes we looked at. Surprisingly, but consistent 
with this result, a recent study showed that VPA treatment induces significant 
deacetylation of H3 and H4 (Rada-Iglesias et al., 2007).   
As expected, H3K4me3 was affected by VPA treatment but not uniformly. Decrease 
in enrichment after treatment was observed at the promoter of Nanog and Anapc7 
and very modestly at the promoter of Slc26a8. Interestingly, increase in H3K4me3 
was only observed at the up-regulated genes Egr1 and Ndrg4. However, no change 
was observed for the H1f0 gene. H3K4me3 could play a major role in the VPA 
response but more genes should be analysed for final conclusions.      
Finally, consistently with the data obtained by western blotting, most of the genes we 
looked at were not enriched for H3K27me3 and this feature was unaffected by the 
treatment. The mark was present on the promoters of Egr1 and H1f0 only and slightly 
increased after VPA treatment on Egr1, although H3K27me3 is a silencing mark and 
Egr1 was up-regulated by the treatment.  
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Figure 3.14 Distribution of histone modifications on the Egr1 gene before 
and after VPA  treatment  
CCE/Rs were treated with 1mM VPA for 8 hours. Chromatin was extracted from 
control and treated cells and immunoprecipitated with antibodies raised against 
three histone modifications associated with active transcription (H3K9ac, H4K8ac, 
H3K4me3) and one associated with repressed transcription (H3K27me3). DNA in 
bound (B) and unbound (UB) fractions were analysed by qPCR using region-
specific primers. The relative enrichment was calculated as the ratio B/UB and the 
mark was considered as present if this ratio was equal to or greater than 1. Error 
bars represent the standard error of the mean (n=2).  
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Figure 3.15 Distribution of histone modifications on the H1f0 gene before 
and after VPA  treatment  
H1f0 3’ 5’ 
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CCE/Rs were treated with 1mM VPA for 8 hours. Chromatin was extracted from 
control and treated cells and immunoprecipitated with antibodies raised against 
three histone modifications associated with active transcription (H3K9ac, H4K8ac, 
H3K4me3) and one associated with repressed transcription (H3K27me3). DNA in 
bound (B) and unbound (UB) fractions were analysed by qPCR using region-
specific primers. The relative enrichment was calculated as the ratio B/UB and the 
mark was considered as present if this ratio was equal to or greater than 1. Error 
bars represent the standard error of the mean (n=2).  
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Figure 3.16 Distribution of histone modifications on the Ndrg4 gene before 
and after VPA  treatment  
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Ndrg4 
CCE/Rs were treated with 1mM VPA for 8 hours. Chromatin was extracted from 
control and treated cells and immunoprecipitated with antibodies raised against 
three histone modifications associated with active transcription (H3K9ac, H4K8ac, 
H3K4me3) and one associated with repressed transcription (H3K27me3). DNA in 
bound (B) and unbound (UB) fractions were analysed by qPCR using region-
specific primers. The relative enrichment was calculated as the ratio B/UB and the 
mark was considered as present if this ratio was equal to or greater than 1. Error 
bars represent the standard error of the mean (n=2).  
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Figure 3.17 Distribution of histone modifications on the Anapc7 gene before 
and after VPA  treatment  
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CCE/Rs were treated with 1mM VPA for 8 hours. Chromatin was extracted from 
control and treated cells and immunoprecipitated with antibodies raised against 
three histone modifications associated with active transcription (H3K9ac, H4K8ac, 
H3K4me3) and one associated with repressed transcription (H3K27me3). DNA in 
bound (B) and unbound (UB) fractions were analysed by qPCR using region-
specific primers. The relative enrichment was calculated as the ratio B/UB and the 
mark was considered as present if this ratio was equal to or greater than 1. Error 
bars represent the standard error of the mean (n=2).  
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Figure 3.18 Distribution of histone modifications on the Slc6a8 gene before 
and after VPA  treatment  
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CCE/Rs were treated with 1mM VPA for 8 hours. Chromatin was extracted from 
control and treated cells and immunoprecipitated with antibodies raised against 
three histone modifications associated with active transcription (H3K9ac, H4K8ac, 
H3K4me3) and one associated with repressed transcription (H3K27me3). DNA in 
bound (B) and unbound (UB) fractions were analysed by qPCR using region-
specific primers. The relative enrichment was calculated as the ratio B/UB and the 
mark was considered as present if this ratio was equal to or greater than 1. Error 
bars represent the standard error of the mean (n=2).  
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Figure 3.19 Distribution of histone modifications on the Nanog gene before 
and after VPA  treatment  
5’ 3’ Nanog 
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CCE/Rs were treated with 1mM VPA for 8 hours. Chromatin was extracted from 
control and treated cells and immunoprecipitated with antibodies raised against 
three histone modifications associated with active transcription (H3K9ac, H4K8ac, 
H3K4me3) and one associated with repressed transcription (H3K27me3). DNA in 
bound (B) and unbound (UB) fractions were analysed by qPCR using region-
specific primers. The relative enrichment was calculated as the ratio B/UB and the 
mark was considered as present if this ratio was equal to or greater than 1. Error 
bars represent the standard error of the mean (n=2).  
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3.1.6 Summary  
A model system was designed to study short and long-term effects of a VPA 
treatment in ES cells. Firstly we looked at the effect of a VPA treatment on the cell 
cycle profile, viability and pluripotency of ES cells. We decided to use VPA at a 
concentration of 1mM and showed that it didn’t significantly affect the cell cycle or the 
viability of the cells. On the other hand, VPA appeared to have an effect on 
pluripotency, inducing a change in cell morphology and a decrease of Oct4, Nanog 
and Klf4 transcripts. However, we could not observe any significant effect at a protein 
level for Oct4 and Klf4. Importantly, after 5 days of wash out, cells displayed a normal 
cell cycle profile, regained typical morphology and expressed pluripotency-associated 
genes.  
Western blot analysis confirmed that 1mM VPA treatment for 8 hours induced global 
hyperacetylation of histones in ES cells. Hyperacetylation was shown to occur on all 
histone isoforms and in a site-specific manner. Immunoblotting of different histone 
marks reasserted the existence of cross-talk between two active marks, H3 
acetylation and tri-methylation of H3K4. In fact, the increase in H3K4me3 was 
concomitant with the hyperacetylation induced by VPA treatment.  
Short time wash out experiments revealed that within only 15 minutes after removal 
of VPA, cells recovered normal levels of acetylation. Increasing the time of treatment 
up to 16 hours did not alter this result, as rapid loss of acetyl-marks was still 
observed. At a global level, and at least for the marks we examined, we could 
conclude that cells were not able to retain hyperacetylation in the absence of VPA. 
However, as the western blot technique can not resolve modifications at individual 
genes or at a local level (e.g. on the promoter of a specific gene), it was not possible 
!
"&$!
to assess the distribution and/or inheritance of hyperacetylation after VPA removal. 
Microarray analysis revealed that the VPA treatment did not extensively affect 
transcription activity. Indeed, only 10% of the genes were affected with almost equal 
number showing up- and down-regulation. Fold changes were not substantial, 
however we could detect specific groups of genes affected by the treatment. VPA-
induced changes were not retained post wash-out. We therefore used ChIP 
experiments to assess histone modification abundance at specific regions of defined 
genes before and after VPA treatment. Because we looked at a small number of 
genes and qPCR only allowed the analysis of small regions of the genome, it was 
difficult to draw general conclusions from those experiments. However, we couldn’t 
detect any pattern of histone modifications induced by VPA treatment that was 
specific to up- or down-regulation. In fact, an increase in H3K9ac was always 
observed at promoters after VPA treatment. Furthermore, although western blot 
experiments revealed that H4K8ac abundance increased following exposure to VPA, 
down-regulation of the mark was observed on promoters of individual genes. Finally, 
fold changes observed by ChIP did not reflect what was observed using western 
blotting. This phenomenon may suggests the existence of mechanisms that protect 
genes against hyperacetylation. 
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3.2 Effect of histone hyperacetylation on hoxb gene expression 
patterns during differentiation of ES cells 
3.2.1 Introduction 
Our first model system was intended to investigate the short and long term effect of 
histone hyperacetylation induced by the exposure to an HDACi, VPA. Measurement 
of gene transcription activity and histone modification levels showed that a time-
restricted VPA treatment wasn’t enough to induce heritable effects in ES cells. 
Although this result indicated that histone modifications on their own are not likely to 
be causative of long-term changes in genome function, it didn’t prove that they 
couldn’t be predictive of transcription. In fact, histone modifications are probably only 
one layer of all the many signals participating in the establishment of specific gene 
expression patterns. In order to test this hypothesis, we designed a second model 
system involving differentiation of ES cells and VPA treatment (Figure 3.20). ES cells 
were replated in non-adherent dishes for the formation of embryonic bodies (Figure 
3.21). Differentiation was induced by the withdrawal of the pluripotency signalling 
factor LIF (Leukaemia Inhibitory Factor) and Retinoic Acid (RA) treatment, which was 
essential for the induction of hoxb gene expression. RA is a derivative of vitamin A, 
and plays an important role as a cell-signalling molecule during organogenesis, 
notably for the development of the hindbrain, spinal cord, heart, eye and other organs 
(Duester, 2008). RA acts as a ligand for the nuclear receptors RAR!,#,) and 
RXR!,#,) which then bind to response elements present in the promoter of target 
genes (Rochette-Egly and Germain, 2009). Two RA response elements (RAREs) 
have been identified 3’ of the Hoxb1 gene, participating in the induction of gene 
expression in the hoxb cluster in response to retinoid exposure (Langston et al., 
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1997). In normal conditions, RA induces hoxb gene expression in a very specific 
manner, in which the 10 hoxb genes (hoxb1-9;13) are successively expressed during 
differentiation following their physical order on the cluster. A protocol allowing ES cell 
differentiation in culture using RA has been optimized (Chambeyron and Bickmore, 
2004). Based on this protocol, 1µM RA was added to the medium 2 days after LIF 
withdrawal and the differentiation of CCE/R cells was conducted for 8 days. In a first 
experiment cells were only treated with RA and samples were harvested every day 
for RNA extraction and quantification. In a second experiment, cells were 
differentiated using the same protocol with the addition of 1mM VPA to the culture 
medium for 16 hours (8 hours before and after LIF withdrawal). We hypothesised that 
histone hyperacetylation combined with the signal to differentiate could impact on 
hoxb gene expression timing. Thus, RNA was extracted every day during eight days 
and hoxb gene transcripts were quantified using qPCR (Figure.3.20).   
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Figure 3.20 Model system #2:  
Can VPA impact on the expression timing of Hoxb genes during ES cell 
differentiation?    
LIF 
withdrawal 
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!! Does VPA alter hoxb gene 
expression timing? 
$The model system was made to investigate the effect of hyperacetylation on the 
hoxb gene expression timing during differentiation. The hoxb gene cluster contains 
10 genes that are successively induced in the developing embryo. Genes within 
the cluster are arranged in their temporal order of expression during differentiation 
as well as their expression domains along the antero-posterior axis. It was 
possible to reproduce the co-linear timing of hoxb gene expression in culture. For 
that, ES cells received 3 signals: on day 0 (1) detachment from the flask for the 
formation of embryonic bodies; (2) withdrawal of the pluripotency associated 
signal molecule LIF; and 2 days later (3) addition of 1µM retinoic acid in the 
medium.  
CCE/Rs were first differentiated using this protocol and several hoxb genes were 
quantified with qPCR. In a second experiment 1mM VPA was added into the 
medium for 16 hours overlapping with the first two signal of differentiation. 
Expression of hoxb genes was then quantified in order to measure the effect of 
the initial hyperacetylation.   
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Figure 3.21 Cell morphology during differentiation 
Undifferentiated CCER: 
Two colonies attached to the flask  
Differentiated CCER (Day1): 
Three floating embryonic bodies 
Differentiated CCER (Day7): 
Three floating embryonic bodies 
CCE/Rs were differentiated for 8 days using the standard protocol and observed 
through light microscopy. Images were taken at three different stages: 
undifferentiated cells, 24 hours and 7 days after LIF withdrawal. 
Undifferentiated CCE/R were growing in colonies when one cell could not be 
distinguished from another. As expected, the differentiation induced the formation 
of floating embryonic bodies which were noticeably more compact at day 7.  
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3.2.2 Expression of pluripotency-associated genes and hoxb genes during 
differentiation of ES cells 
RNA was extracted from differentiating CCE/R cultures every day from day 0 to day 
8. The expression of five pluripotency-associated genes (Oct4, Nanog, Klf4, Sox2 
and c-Myc) was measured using qPCR. As expected, the expression of those genes 
dropped as cells were differentiating, with the exception of c-myc. One day after LIF 
withdrawal, the expression of Klf4 was almost completely lost and remained absent 
until the end of the time course. In contrast, Oct4 and Sox2 didn’t show this dramatic 
decrease, with the first sign of down-regulation visible only after 2 days of 
differentiation. Expression of the two genes then continued to drop progressively. 
Interestingly, half of the Nanog transcript was lost after 1 day of differentiation and 
stayed stable at this level until day 7 to finally drop again on day 8. Lastly, c-myc 
revealed a cycling profile, alternating between up- and down-regulation. Surprisingly, 
one day after LIF withdrawal, the gene was substantially up-regulated (Figure 3.22).  
The expression of genes within the Hoxb cluster was then quantified, as RA 
treatment successfully induced the transcription of all hoxb genes we looked at. A 
typical profile of expression timing was observed, with for instance a peak of hoxb1 
expression early during differentiation (day 3) and a peak of hoxb6 expression much 
later (day 8). Timing of induction generally correlated with the position of the gene in 
the cluster. However, hoxb7 and hoxb8 showed a particular feature, being activated 
earlier than predicted (day 4). In addition, while expression of hoxb7 decreased 
between day 4 and 8, hoxb8 was successively down- and up-regulated again (Figure 
3.23).     
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Figure 3.22 Pluripotency associated-gene expression  
during ES cell differentiation 
CCE/R cells were induced to differentiate using a standard protocol over 8 days. 
RNA was extracted from differentiating cells every day and quantified by RT-qPCR 
using specific primers. Relative expression was calculated from standard curves. 
The expression of each gene was normalized against Gapdh. Error bars represent 
the standard error of the mean from three independent experiments.  
LIF RA 
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Figure 3.23 hoxb gene expression during ES cell differentiation 
LIF RA 
Cells were induced to differentiate using a standard protocol over 8 days. RNA 
was extracted from differentiating cells every days and quantified by RT-qPCR 
using specific primers. Relative expression was calculated from standard curves. 
The expression of each gene was normalized against Gapdh. Error bars represent 
the standard error of the mean from three independent experiments.  
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3.2.3 Valproic acid treatment during LIF withdrawal: Effect on Hoxb gene 
expression during differentiation 
Using the same method, CCE/R cells were induced to differentiate. In addition, 
overlapping with the LIF withdrawal signal, histones were hyperacetylated by 1mM 
VPA treatment for 16 hours. RNA was extracted during the VPA treatment (T0hr, 
T8hrs and T16hrs) as well as every 24 hours from LIF withdrawal (T8hrs, d1-d8) 
(Figure 3.20). Three independent experiments were carried out and results 
normalised using Gapdh and calculated as a percentage of the highest value in the 
untreated sample. As absolute values varied significantly between different 
experiments, this allowed the three sets of results to be merged and allowing 
visualisation of a general trend. The main observation was that the overall pattern of 
hoxb gene expression did not vary between untreated and treated samples. 
Sequential expression of genes in the cluster was observed throughout the 
differentiation time course, in the presence or the absence of VPA. Yet, a small effect 
was observed with over-expression of hoxb genes observed in the VPA-treated 
samples at certain time points. For instance in VPA-treated samples, the important 
peaks of hoxb4 and hoxb5 transcripts at day 6 or the more general over-expression 
of hoxb9 throughout the time course (Figure 3.24). 
When experiments were analysed separately, the existence of hidden effects in the 
merged data was revealed. In fact, in two of the three independent experiments, 
peaks of expression of hoxb genes in VPA-treated samples were consistently larger 
and earlier than expression in control samples. Replicates 1 and 3 are presented as 
examples (figure 3.25-26). Because those effects were observed on different days in 
the two experiments and because of the lack of effects in replicate 2, these effects 
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Figure 3.24 Effect of time-restricted VPA treatment on hoxb gene expression 
during differentiation (merged replicates) 
Control CCE/Rs were induced to differentiate using a standard protocol over 8 
days. In parallel, CCE/Rs were treated with 1mM VPA for 16 hours while subjected 
to the same protocol. VPA was added 8 hours prior to LIF withdrawal and was 
washed out 16 hours later. RNA was extracted from control and treated 
differentiating cells every day and quantified by RT-qPCR using specific primers. 
Relative expression was calculated from standard curves. The expression of each 
gene was normalized against Gapdh and calculated as a percentage of the 
highest value in the untreated sample. Error bars represent the standard error of 
the mean from three independent experiments.  
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Figure 3.25 Effect of time-restricted VPA treatment on hoxb gene expression 
during differentiation (replicate 3) 
Hoxb gene quantification in one of the three replicates from the experiment 
previously described in figure 3.25. Because merged data can sometimes hide the 
effects on individual experiments, we showed this replicate that could be 
representative of a real effect induced by VPA treatment.   
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Figure 3.26 Effect of time-restricted VPA treatment on hoxb gene expression 
during differentiation (replicate 1) 
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Hoxb gene quantification in one of the three replicates from the experiment 
previously described in figure 3.25. Because merged data can sometimes hide the 
effects on individual experiments, we showed this replicate that could be 
representative of a real effect induced by VPA treatment.   
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were not visible when data were merged. In order to validate one result or the other, 
it would be essential to do more experiments, possibly under more tightly controlled 
conditions. In fact, independent experiments were carried out at different times using 
different batches of unsynchronised cells.  
So far, the inconsistency between replicates and the general trend observed when 
data were merged led us to conclude that the VPA treatment had no general effect 
on the timing of hoxb gene expression during differentiation.            
 
3.2.4 summary 
CCE/R were differentiated using cell detachment, LIF withdrawal and RA treatment. 
In order to investigate if histone modifications can predict gene transcription, we 
designed an experiment where the LIF withdrawal signal was supplemented by VPA 
treatment. In control conditions, it was possible to reproduce the specific pattern of 
hoxb gene expression when ES cells were differentiated with RA treatment. Addition 
of VPA to the culture medium at the start of the differentiation time course didn’t 
globally affect hoxb gene expression timing. However, analysis of individual 
experiments suggested the hyperacetylation of histones at the beginning of the time 
course could result in the premature expression of hoxb genes during differentiation.  
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3.3 Role of polycomb silencing mechanism in the response to VPA 
treatment: the hoxb gene cluster case 
3.3.1 Introduction 
When ES cells were treated with VPA, we observed that the effect on global gene 
expression was not as extensive as expected. In fact, despite the massive global 
hyperacetylation of histones, only 10% of genes examined using microarrays showed 
a change in expression. In addition, although acetylation of histone has been 
associated with active transcription, almost equal proportions of genes were up- and 
down-regulated by VPA treatment. This small effect of VPA on transcription raised 
the possibility that some mechanisms protect genes against hyperacetylation. HDACi 
are naturally present in the environment, as products of the gut microflora, or as 
dietary components, and this could justify the need for processes that maintain 
normal gene expression levels within a cell in the presence of HDACi.  
One could imagine that a modification on its own does not drive transcription and 
hyperacetylation could be buffered by “cross-talk” with other epigenetic events. Here 
we decided to assess whether there is a role for polycomb-deposited marks in the 
response to hyperacetylation. The polycomb proteins assemble in two complexes 
(PRC1 and PRC2) that put in place two histone modifications, tri-methylation at 
H3K27 (H3K27me3) and ubiquitination at H2AK119 (H2AK119ub), associated with 
repressed transcription. Polycomb complexes regulate an important number of 
developmental genes, playing a crucial role in the maintenance of pluripotency and 
cell fate decision in ES cells (Boyer et al., 2006). The homeobox (hox) genes are 
known targets of polycomb group proteins. Hox genes are not expressed in 
pluripotent embryonic stem cells and are activated in a very specific manner during 
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differentiation in order to specify the antero-posterior axis of the embryo. Polycomb 
and Trithorax proteins, that respectively repress or activate gene expression by the 
deposition of specific marks, play a key role in the regulation of hox genes in ES cells 
and in differentiated cells (Bernstein et al., 2006).  
We decided to quantify hoxb gene expression under VPA treatment in an ES cell line 
deficient for both the PRC1 component Ring1b and the PRC2 component Eed (Leeb 
et al., 2010). If hoxb genes were up-regulated in Eed/Ring1b double knock-out (dko) 
cells but not in the corresponding wild type (wt) cells, the role of polycomb in the 
maintenance of gene silencing despite the hyperacetylation of histones would be 
highlighted. After we characterised the dko cell line grown under our conditions, wt 
and dko cells were treated with VPA to assess the impact on global histone 
modifications and hoxb gene activity (Figure 3.27).   
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1. Knockout 
2. Knockout 
3. Effect of the knockout 
4. Effect of the knockout combined with VPA treatment. 
Figure 3.27 Model system #3:  
Role of polycomb group proteins and their associated histone marks  
in the response to the HDACi VPA 
Previous studies have shown that polycomb proteins maintain the silencing of 
hoxb genes in ES cells. Expression of those genes was measure in Wild type (wt) 
ES cells and in Eed-Ring1b double knockout (dko) ES cells. Eed and Ring1b 
code for two major proteins, members of Polycomb complexes PCR2 and PCR1 
that respectively put in place the silencing marks H3K27me3 and H2AK119ub. Wt 
and dko cells were treated with VPA and hoxb gene expression was compared in 
untreated and VPA-treated cells.  
Figure adapted from (Spivakov and Fisher, 2007).    
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3.3.2 Characterisation of the double knockout cell line 
3.3.2.1 Cell morphology and cell cycle 
Cell morphology is an important indicator of ES cell pluripotency. Using light 
microscopy, we looked at wt and dko cells grown on a layer of MEF feeder cells. 
Both cell lines showed typical growth morphology with cells forming colonies. In 
addition, both cell lines strongly stained for alkaline phosphatase activity, a marker of 
pluripotent (undifferentiated) cells. As expected, ES cells appeared red while MEFs 
remained unstained, which validated the use of the alkaline phosphatase marker for 
ES cells (Figure 3.28.a).   
We then assessed cell cycle profiles of wt and dko cells using flow cytometric 
analysis of cells stained with propidium iodide (PI). 50000 cells on average were 
analysed and the intensity of the PI signal for each cell was measured. In a wt cell 
culture, 38% of cells were in the G1-phase and 23% were in the S-phase. In the dko 
cell culture those percentages changed to 45% and 17% respectively. This could be 
the result of technical variation, as demarcation of each population on the histogram 
is inaccurate for FACS analysis. But this result was consistent with observations that 
dko cells grew slower than wt cells in culture. These variations possibly highlighted 
the fragile nature of dko cells and their tendency to easily differentiate. However, 
those changes were considered very small and the dko cell cycle profile was still 
viewed as a typical ES cell cycle profile (Figure 3.28.b).  
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Figure 3.28 Effect of a Eed/Ring1b double knockout on ES cell morphology, 
alkaline phosphatase activity and cell cycle 
One 
colony of     
ES cells 
MEFs 
a 
b 
a, Wt and Eed/Ring1b dko cell morphologies were observed using light 
microscopy. Both cell lines were grown on a layer of mouse embryonic fibroblasts 
(MEF) feeder cells. Dko cells required double the amount of MEFs in order to 
maintain pluripotency. Cells were stained for alkaline phosphatase activity (AP), a 
marker of pluripotency. Pluripotent, AP-positive colonies appeared red.  
b, Wt and dko cells were stained with propidium iodide (PI), a DNA intercalating 
dye. The intensity of the signal from each cell was then analysed using flow 
cytometry in order to obtain the percentage of cells in each phase of the cell 
cycle.  
wt cells  dko cells  
Phase 
contrast 
AP 
staining 
(n=1) 
!
"("!
3.3.2.2 Global histone modifications  
RNA was extracted from wt and dko cells and the expression of Eed and Ring1b was 
quantified by RT-qPCR. As expected, the expression of those genes was lost in dko 
cells (Figure 3.29.a). Following the verification of gene knockouts, we investigated 
the effect on global histone modification levels. Histones were extracted from wt and 
dko cells and levels of four histone marks were quantified using western blotting 
(Figure 3.29.b). The secondary antibody was conjugated with a fluorescent dye and 
the signal was quantified with the LICOR Odyssey scanner. Each value was 
normalized using an antibody raised against H3 C-terminal domain (Figure 3.29.c). 
Despite the loss of Eed and Ring1b transcription, the H3K27me3 mark was not fully 
abolished in dko cells. The H3K27me3 enrichment was undoubtedly reduced in dko 
cells (' 2 fold) but still present. This intriguing observation could simply reflect a 
persisting proportion of MEFs after ES cell purification, as a small quantity of MEFs 
could generate the H3K27me3 signal. On the other hand, the ES cell culture we 
examined could be heterogeneous with wt and dko cells growing together, though 
this seems unlikely given the absence of Eed and Ring1b transcripts in dko cells. 
Finally, it is possible that another enzyme compensated for the loss of Eed and 
deposited the H3K27me3 mark.  
We decided to measure H3K27ac as well because this trithorax-dependant mark is 
understood to antagonize the polycomb-mediated silencing (Tie et al., 2009). Indeed, 
the decrease of H3K27me3 in dko cells was concomitant with a major increase of 
H3K27ac (' 7 fold) when compared with wt cells. The trithorax-dependant mark 
H3K4me3 was also increased in dko cells (' 2 fold), as well as H3K9ac (' 2 fold). 
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b c 
Figure 3.29 Measure of Eed/ring1b expression and  
global histone modification in wt and dko cells 
a, RNA was extracted from wt and Eed/Ring1b dko cells and quantified by RT-
qPCR using specific primers. The relative expression of Eed and Ring1b genes 
was calculated from standard curve and normalized against !-actin. Parametric 
two-tailed unpaired t-test were processed with the GraphPad software. Error bars 
represent the standard error of the mean from three independent experiments.   
b, Histones were extracted from wt and Eed/Ring1b dko cells. Changes in global 
levels of H3K27me3, H3K27ac, H3K9ac and H3K4me3 were assessed by 
western blotting. H3 C-term staining was used as a loading control.  
c, Quantitative presentation of modification abundance. H3 C-terminal staining 
was used to normalize values. Error bars represent the standard error of the 
mean from two independent experiments. 
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Once again, the analysis of global histone modification levels suggested cross-talk 
and the interdependence of different marks.  
In order to investigate more the residual H3K27me3 modification in dko cells, 
immuno-fluorescent staining was used to examine the location of this histone mark. 
Firstly, colonies of wt and dko cells grown on coverslips were directly fixed and 
stained with antibodies raised against H3K27me3 and H3K27ac. In addition, DAPI 
staining allowed the visualisation of nuclei. As expected, H3K27ac was present in wt 
and dko cells. In contrast, while wt cells were enriched in the H3K27me3 mark, dko 
cells appeared depleted (Figure 3.30). However, the resolution of the technique was 
not very high and quantification was not possible. We therefore decided to extend 
this study by staining metaphase chromosomes. Wt and dko cells were treated with 
colcemid, which induces an arrest in metaphase, and trypsinised to obtain a single 
cell suspension. Cells were then fixed to slides, and stained for H3K27me3. In wt 
cells, all cells and each of the chromosome spreads showed strong green staining 
meaning that the histone mark H3K27me3 was present. Surprisingly in dko cells the 
staining was heterogeneous, with 68.4% of cells appearing completely red (DAPI 
staining only, average count from 6 images, n=2) while 31.6% of cells stained for 
H3K27me3. Chromosome spreads showed the same pattern with some spreads 
entirely red whereas others were identical to wt (Figure 3.31). This observation 
almost eliminated the possibility of a redundant mechanism for H3K27me3 
deposition, as in this case, staining would be weaker but homogeneous. Positive 
cells for H3K27me3 could therefore be MEFs or wt cells. Prior to incubation with ES 
cells, MEFs were irradiated to stop their division. This leads to DNA damage that was 
not visible on the dko stained spreads. In addition, the proportion of cells 
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Figure 3.30 Immunofluorencent labelling of wt and Eed/Ring1b dko ES cell 
colonies for H3K27ac and H3K27me3 
Wt and dko cells were grown on coverslips in a 24-well plate. Cells were then 
directly fixed and immunostained with antibodies raised against the two histone 
modifications H3K27me3 and H3K27ac. Images were taken using a fluorescent 
microscope. The red staining corresponds to the DAPI signal, a molecule that 
strongly fluoresces when bound to DNA (a). The green staining (FITC) reveals the 
presence of the marks (b). Finally, both signals were merged in order to detect 
the enriched nuclei (c).  
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Figure 3.31 Immunofluorencent labelling of wt and dko mataphase 
chromosomes for the H3K27me3 mark 
WT dko 
(x100) 
(x40) 
(x10) 
In order to block wt and dko cells in metaphase, Colcemid was added into the 
culture medium for 3 hours prior harvesting. Cells were then fixed and 
immunostained with an antibody raised against the histone modification 
H3K27me3. The red staining corresponds to the DAPI signal, a molecule that 
strongly fluoresces when bound to DNA. The green staining corresponds to the 
secondary antibody that reveals the presence of the mark. Both signals where 
merged and images were taken using a fluorescent microscope at different 
magnifications.  
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and spreads positive for H3K27me3 appeared too large to reflect MEF 
contamination. In fact, metaphase chromosomes come from dividing cells and yet 
MEFs were not cycling due to the irradiation treatment. For these reasons, even if the 
other possibilities were not fully excluded, we concluded that our dko cell population 
wasn’t pure and contained a small proportion of wt cells.  
 
3.3.2.3 Gene expression 
Finally, we decided to quantify pluripotency-associated genes and hoxb genes in wt 
and dko cells. RNA was extracted from wt and dko cells and the expression of 
specific genes was quantified using RT-qPCR. Nanog, Klf4 and c-Myc were 
expressed at the same level in dko and wt cells. On the other hand, Oct4 was down 
regulated in the dko cells while Sox2 was slightly up-regulated. However, those 
differences were not statistically significant (Figure 3.32.a).  
The expression of hoxb genes in wt and dko cells was then quantified. With the loss 
of polycomb silencing marks, most of the genes in the cluster were up-regulated in 
dko cells. However, the fold changes were not uniform across the cluster. Hoxb7 
showed the most important increase (' 6 fold) followed by hoxb4, hoxb6 and hoxb9 
(' 3.5 to 4.5 fold). The effect of the knockout appeared less strong on hoxb2, hoxb3 
and hoxb8, whereas hoxb1 and hoxb5 were not affected by the knockout (Figure 
3.32.b). 
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Figure 3.32 Effect of the double knockout on the expression of  
pluripotency associated genes and hoxb genes 
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RNA was extracted from wt and dko cells and retrotranscribed into cDNA before 
quantification. Expression of specific genes was measured using qPCR and 
normalized to !-actin. Parametric two-tailed unpaired t-tests were processed with 
the GraphPad software. Error bars represent the standard error of the mean from 
three independent experiments.   
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3.3.3 Effect of valproic acid treatment on global histone modification levels in 
wt and dko cells 
Histones were extracted from wt and dko cells before and after an 8 hours exposure 
to 1mM VPA. Global levels of H3K9ac, H3K27ac, H3K4me3 and H3K27me3 were 
obtained by western blot analyses and normalised to the H3 C-term signal. As 
expected the enrichment of H3K9ac and H3K27ac increased following VPA 
treatment, in both wt and dko cells. For those modifications, fold changes were 
similar in the two cell lines. As already seen with the CCE/R cell line, VPA also 
induced a small increased in H3K4me3, but this was a larger effect in wt cells than in 
the double knockout. Finally, H3K27me3 abundance remained unaffected by VPA 
treatment (Figure 3.33). 
 
3.3.4 Effect of valproic acid treatment on gene expression in wt and dko cells 
RNA was extracted from wt and dko cells that had been treated with 1mM VPA for 8 
hours. VPA is known to affect pluripotency in ES cells. We showed with the CCE/R 
cell line that a 1mM VPA treatment for 8 hours induced a reduction of Nanog, Klf4 
and in some cases Oct4 expression. c-Myc was not affected by the treatment and 
Sox2 was up-regulated. Although the results were not statistically significant, the wt 
cell line was similarly affected by VPA - transcription of Oct4, Nanog and Klf4 was 
reduced after treatment and up-regulation of Sox2 was observed. In the dko cell line, 
all pluripotency-associated genes were down-regulated, especially Nanog and klf4. 
This result was consistent with the fragile nature of the dko cells and their tendency 
to easily differentiate (Figure 3.34).  
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Figure 3.33 Effect of VPA treatment on global histone modifications in wt 
and Eed/Ring1b dko ES cells 
wt cells dko cells 
Histones were extracted from wt and Eed/Ring1b dko cells before and after VPA 
treatment for 8 hours. The effect on levels of global histone modifications was 
assessed using western blotting and normalised using H3 C-terminal staining. 
Error bars represent the standard error of the mean from two independent 
experiments. 
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Figure 3.34 Effect of VPA treatment on the expression of  
pluripotent-associated genes in wt and Eed/Ring1b dko ES cells 
(n=3) 
(n=2) 
Wt and dko cells were treated with 1mM VPA for 8 hours. RNA was extracted and 
retrotranscribed into cDNA before quantification by qPCR. The relative expression 
of pluripotency-associated genes was measured using a standard curve and 
normalized to !-actin. Error bars represent the standard error of the mean.  
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The expression of genes within the hoxb cluster was quantified in wt and dko cells 
before and after VPA treatment. Very interestingly, not all the genes responded to the 
treatment in a similar manner. Futhermore, the changes in pattern of gene 
expression induced by the treatment were different in wt cells compared to dko cells. 
In wt cells, transcription of hoxb1, hoxb4, hoxb7 and hoxb9 was increased by more 
than 2-fold. On the other hand, the expression of hoxb2, hoxb3, hoxb5, hoxb6 and 
hoxb8 was unaffected or showed a very small increase after VPA exposure. In dko 
cells, the only gene significantly up-regulated by VPA treatment was hoxb1. Very 
small increases were visible on the other genes in the cluster but all were non 
significant. We therefore conclude that, with the exception of hoxb1, VPA had no 
effect on the transcription of hoxb genes in dko cells (Figure 3.35).  
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Figure 3.35 Effect of VPA treatment on the expression of  
hoxb genes in wt and Eed/Ring1b dko ES cells 
WT and dko cells were treated with 1mM VPA for 8 hours. RNA was extracted 
and retrotranscribed into cDNA before quantification by qPCR. The relative 
expression of hoxb genes was measured using a standard curve and normalized 
to !-actin. Parametric two-tailed unpaired t-tests were processed with the 
GraphPad software. Error bars represent the standard error of the mean of three 
independent experiments.  
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3.3.5 Effect of valproic acid treatment on hoxb gene expression in CCE/R cells 
In order to confirm these observations made with wt cells, we decided to quantify the 
expression of hoxb genes in the CCE/R ES cell line before and after an identical VPA 
treatment. Apart from hoxb2, that showed high expression compared to the other 
genes, these results were similar to those obtained with the wt cell line, with VPA 
inducing increased hoxb1, hoxb4 and hoxb7 transcripts. Meanwhile, the expression 
of other hoxb genes in the cluster remained stable (Figure 3.36).     
 
3.3.6 Effect of valproic acid treatment on histone modifications at hoxb genes 
in CCE/R cells    
Hoxb1, 4 and 7 were consistently up-regulated after VPA treatment in two different 
wild-type ES cell lines. This result suggested that regulation by histone modifications 
was not uniform across the hoxb cluster. For this reason, the abundance of histone 
modifications was assessed at the three affected genes (hoxb1, 4 and 7), and at two 
unaffected genes (hoxb2 and 5). The enrichment of marks was measured before and 
after eight hours VPA treatment at the promoter, the TSS, and in the first exon of 
each gene (Figure 3.37). Levels of three activating marks (H3K9ac, H4K8ac and 
H3K4me3) and one silencing mark (H3K27me3) were examined.  
As expected in untreated cells, levels of H3K27me3 were very high at all hoxb genes. 
Although down-regulation was observed at certain sites after VPA treatment, these 
effects were very small and it was concluded that H3K27me3 was mainly unaffected 
by the drug. Surprisingly however, and with the exception of hoxb4 and 7, hoxb 
genes appeared depleted in the second bivalent mark H3K4me3, as well as in acetyl 
marks in untreated cells. H3K4me3 and H4K8ac remained unaffected by VPA 
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treatment, whereas levels of H3K9ac increased at all hoxb genes, regardless of 
transcriptional activities (Figure 3.38).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!
")&!
Figure 3.36 Effect of VPA treatment on the expression of  
hoxb genes in CCE/R ES cells 
CCE/R cells were treated with 1mM VPA for 8 hours. RNA was extracted and 
retrotranscribed into cDNA before quantification by qPCR. The relative expression 
of hoxb genes was measured using standard curve and normalized to the !-actin. 
Parametric two-tailed unpaired t-tests were processed with the GraphPad 
software. Error bars represent the standard error of the mean of three 
independent experiments.  
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Figure 3.37 Distribution of primer sets used for qPCR analysis  
over hoxb genes 
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For each hoxb gene, the arrow corresponds to the transcription start site and 
boxes indicate exons. Numbers below each primer set indicate the base pairs 
surrounding the amplified region.  
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Figure 3.38 Distribution of histone modifications on hoxb genes before and 
after VPA treatment 
CCE/Rs were treated with 1mM VPA for 8 hours. Chromatin was extracted from 
control and treated cells and immunoprecipitated with antibodies raised against 
three histone modifications associated with active transcription (H3K9ac, H4K8ac, 
H3K4me3) and one associated with repressed transcription (H3K27me3). DNA in 
bound (B) and unbound (UB) fractions were analysed by qPCR using region-
specific primers (1.1 = hoxb1 promoter; 1.2 = hoxb1 transcription start site; 1.3 = 
hoxb1 first exon; Similarly for hoxb2, 4, 5 and 7). The relative enrichment was 
calculated as the ratio B/UB and the mark was considered as present if this ratio 
was equal or above 1. Error bars represent the standard error of the mean (n=2).  
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3.3.7 Summary 
These experiments were designed to examine the role of polycomb silencing in the 
transcriptional response to VPA treatment. Expression of genes in the hoxb cluster 
was assessed before and after VPA treatment in a wild-type ES cell line as well as in 
an ES cell line knocked out for the two polycomb proteins Eed and Ring1b. As 
expected, global levels of the silencing mark H3K27me3 decreased where 
expression of hoxb genes was up-regulated. Interestingly, loss of H3K27me3 was 
concomitent to a dramatic increase in H3K27ac. With the exception of hoxb1 in dko 
cells, VPA treatment failed to further up-regulate hoxb genes, suggesting the limited 
effect of histone hyperacetylation on transcription. The transcriptional activation of 
hoxb1 could reflect early differentiation in dko cells rather than a direct effect of 
HDAC inhibition. In wt cells, VPA treatment induced the up-regulation of hoxb1, 4 
and 7. However, ChIP analysis of hoxb genes did not provide a clear link between 
transcriptional activities and histone modifications. H3K4me3, H3K27me3 and 
H4K8ac remained mostly unaffected by VPA treatment whereas H3K9ac was 
consistently up-regulated at all hoxb genes. Interestingly, hoxb4 and 7 (up-regulated 
by VPA) were the only genes enriched for activating marks in untreated cells.     
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4. Discussion 
4.1 Do histone modifications code for epigenetic information? 
Epigenetic research has rapidly expanded in the last 50 years, and the high 
complexity of mechanisms described so far perhaps requires revisiting its 
fundamentals. The current consensus is that epigenetic mechanisms allow the 
establishment and the long-term maintenance of specific gene expression patterns. It 
was proposed that, without changing the DNA sequence, these mechanisms 
establish the expression of different programmes of genes in cells that carry the 
same genetic material. Thereby, one genome can produce various cell types in the 
development of a complex organism (Holliday, 2006).  
At first, the observation of different levels of DNA compaction in the nucleus 
emphasised the idea of DNA sequence-independent mechanism(s) for gene 
regulation. In fact, the more the DNA is compacted, the less it is accessible to 
regulatory proteins like transcription factors. Electron microscopy and crystallography 
studies allowed the discovery of the chromatin fibre, a result of the interaction 
between the DNA molecule and histone proteins (Olins and Olins, 1974; Widom, 
1986). Chromatin was revealed to be an organised structure when the nucleosome 
was characterised, eight histone proteins around which 146bp of DNA are wrapped 
(Luger et al., 1997). It was therefore suggested that the arrangement of nucleosomes 
would dictate degrees of chromatin compaction in different regions of the genome 
(Lee et al., 2007c). Importantly, many years of research showed the existence of 
cytosine methylation, post-translational modification of histones tails, incorporation of 
histone variants or RNAi-mediated regulation. All those events were classified as 
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epigenetic processes because of their potential short and long-term impact on gene 
transcription.  
Unquestionably, specific histone modifications and DNA methylation have been 
correlated with transcriptional activity. In fact, maps of key histone modifications on 
active and inactive genes have been defined using high throughput technologies. For 
instance, actively transcribed genes usually show high levels of histone acetylation or 
H3K4 tri-methylation around their transcription start site (TSS) while H3K27me3 and 
H3K9me3 were mainly found in silent genes (Barski et al., 2007). Histone 
modifications were proposed to regulate transcription via direct or indirect 
mechanisms, either by altering histone/DNA interactions (Tse et al., 1998) or by 
providing binding sites for regulatory proteins (Taverna et al., 2007). Furthermore, 
histone marks were suspected to regulate transcription through coordinated action, 
thus constituting a “histone code” where a specific group of modifications alter 
transcription in a distinct way (Jenuwein and Allis, 2001). Importantly, the term 
“epigenetic” involves inheritance through the cell cycle. Persistent patterns of DNA 
methylation in imprinting or X-inactivation, maintenance of chromatin states after 
mitosis in lineage-committed cells and the existence of bivalent domains in stem cells 
provid good arguments for the inheritance of epigenetic marks and their role in the 
long-term maintenance of gene expression patterns (Kaufman and Rando, 2010).  
In parallel to the development of the “nucleosome signalling” hypothesis, another 
literature has rapidly grown, pointing to the lack of evidence for a direct role for 
histone modifications in gene regulation. In fact, although specific marks have clearly 
been correlated with transcriptional activity, a causative role has not been proven. In 
addition, how histone modifications survive replication and mitosis remains largly 
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unclear. Therefore, it is only fair to wonder if histone modifications strictly constitute 
“epigenetic” information (Ptashne, 2007).  
If histone modifications are a cause rather than a consequence of gene activity, and 
if they are responsible for the memory of transcription states, they should (1) be able 
to target regulatory proteins where there are needed, (2) be sufficient for activation or 
silencing and (3) be retained through mitosis, before regulatory proteins re-associate 
at loci (Ringrose and Paro, 2007).  
In order to address some of those issues, we choose in this study to alter histone 
acetylation using an HDAC inhibitor and measure the short and long-term impact on 
global gene expression and levels of various histone modifications. Mouse ES cells 
were treated with valproic acid (VPA), an inhibitor of class I and IIa HDACs. Because 
VPA affects many HDACs, the treatment was expected to induce global 
hyperacetylation. Acetylation of histones has been widely associated with active 
transcription, therefore we hypothesised there would be important changes in gene 
expression following VPA treatment. In addition, if histone modifications were 
faithfully retained during the cell cycle, hyperacetylation and changes in gene 
expression should persist through to subsequent generations of cells, although VPA 
had been removed from the culture media. We thus decided to test this idea via 
washout experiments. Finally, we also turned our interest on the hox genes, VPA 
being a powerful teratogen (Nau et al., 1991). It was therefore interesting to assess 
the link between deregulation of hoxb genes and potential hyperacetylation. In fact, 
hox genes can be induced during ES cell differentiation and therefore offer a good 
model to study the potential predictive role of histone modifications.  
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4.2 Hyperacetylation in ES cells: Consequences on transcription 
and histone modifications   
4.2.1 The lack of evidence for a causative role      
High throughput experiments have highlighted a strong correlation between active 
transcription and acetylation of H3 and H4 (Roh et al., 2006). In addition, many 
studies using differentiation systems in vitro have shown that acetylation at 
transcriptional start sites correlates with cell- and stage-specific transcription as well 
as transcriptional poising (Cruickshank et al., 2010). However, as strong as the 
correlations can appear, they do not give evidence for a causative effect of 
acetylation. 
One putative direct effect of acetylation is the neutralisation of histone tail lysine 
positive charge and thereby the alteration of DNA/histone interactions leading to the 
opening of the chromatin fibre. It was proposed that chromatin opening would 
increase DNA accessibility to proteins including transcription factors, co-factors or 
even RNA polymerase II (Lee et al., 1993; Vettese-Dadey et al., 1996). Recombinant 
acetylated nucleosomal arrays in fact show reduced condensation (Tse et al., 1998) 
and transcription was affected by charge neutralisation of specific lysine residues 
(Dion et al., 2005). However, very few studies have explored the relationship 
between histone acetylation and DNA accessibility. A classic method exists in the 
mapping of DNase I hypersensitive (DHP) sites using high throughput sequencing. 
Interestingly DHP sites were found in promoters, enhancers, insulators or locus 
control regions. Importantly, the presence of DHP sites correlated with RNA pol II 
binding and active gene expression (Boyle et al., 2008). More recently, the measure 
of DNA accessibility using a methylation foot printing assay in Drosophila was 
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performed. Once again, accessibility was higher at the TSS of active genes and 
coincided with peaks of RNA pol II, H3K4me3 and H4K16ac. A particular role of 
H4K16ac was highlighted as the mark strongly correlated with early replication and 
high accessibility. On the other hand, the lowest accessibility was found in regions 
flanked by H3K27me3 (Bell et al., 2010). It is worth noted that DHP sites were also 
found in silent genes, along with active histone marks and RNA pol II, possibly as 
marks of poised genes (Boyle et al., 2008). Those studies seem to confirm the role of 
acetylation in chromatin opening and DNA accessibility. Although it is very tempting 
to conclude that acetylation can increase DNA accessibility, those studies still did not 
prove the causative role of this mark.  
The discovery of bromodomains, conserved domains capable of binding to 
acetylated residues, gave credit to the additional idea that histone modifications 
provide docking sites for regulatory proteins (Taverna et al., 2007). The human 
genome encodes for 42 bromodomain-containing proteins including co-factors, 
chromatin modifiers or DNA helicases (Sanchez and Zhou, 2009). For example, 
bromodomains were found in regulatory proteins such as TAFII250 (Jacobson et al., 
2000) or the chromatin remodeler Swi2/Snf2 (Chandy et al., 2006). Once again, a 
simple model in which regulatory proteins bind to a specific mark in order to modulate 
transcription is easily conceivable. However, modifying enzymes rarely contain a 
DNA-binding domain and often need to be recruited by other proteins, which 
suggests a secondary role of acetylation rather than a decisive role. For instance, the 
histone acetyl-transferases CBP and p300 interact with at least 400 proteins, many of 
them being transcription factors (Bedford et al., 2010). Nevertheless, knockout of 
HATs in mice are generally lethal (Yamauchi et al., 2000; Yao et al., 1998). 
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Thus, although acetylation seems to be indispensable, it appears to act downstream 
of original signals for a change in transcription. To test this hypothesis, the first 
question we have addressed in this study is whether or not hyperacetylation on its 
own can affect gene activity.    
 
4.2.2 The consequences of hyperacetylation on global gene expression 
Western blotting confirmed that 1mM VPA treatment was enough to induce a 
massive and fast increase of global acetylation levels on histone H3, H4 and H2B. 
The potential cross-talk between acetylation and methylation in response to VPA, 
which was found in Human promyelocytic leukemia cells (Nightingale et al., 2007), 
was also observed in ES cells, as VPA treatment was able to raise global levels of 
H3K4me3. However, H3K27me3 was not affected, at least at a global level.  
 
ES cells were treated for eight hours, maximising histone hyperacetylation. 
Microarray technology was then used to measure global gene expression. Stringent 
statistical analysis (p<0.1 after FDR correction) revealed that transcription of 1144 
genes was affected by the treatment. This represents only 10% of the total number of 
genes on the array, which is significant but not as large an effect as expected 
considering the dramatic increase in acetylation induced by VPA. Furthermore, no 
more than 123 genes showed a change greater than 2-fold (95 up and 28 down), 
suggesting a very limited effect of hyperacetylation on transcription. Small changes 
following HDACi treatment have already been observed in the past (Dannenberg and 
Edenberg, 2006; Joseph et al., 2004). 
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Chromatin in ES cells is generally highly acetylated compared to lineage-committed 
cells (Meshorer et al., 2006), therefore it is possible that another level of 
hyperacetylation would not be effective for further transcriptional changes. However, 
studies in our lab showed similar effects in Lymphoblastoid cells following VPA 
treatment, suggesting that limited transcriptional change following VPA treatment is 
not a characteristic of undifferentiated cells. Another potential explanation for the 
limited effects resides in the fact that 95% of the genome in complex organism is not 
protein-coding. However, those non-coding sequences are not functionless as they 
contain important elements for gene regulation including non-coding RNA or 
retrotransposons (Taft et al., 2007). Hyperacetylation at these loci could therefore 
generate indirect effects. Also, in favour of the histone code hypothesis, where a 
mark may act in unison with others and thus have a limited effect on its own, 
hyperacetylation could be simply not enough to impact on gene activity.  
 
Finally, in spite of the fact that acetylation has been associated with active 
transcription, the VPA treatment induced both up and down regulation of genes. This 
could first be because VPA interferes with several signalling pathways (Kostrouchova 
et al., 2007). More importantly, a wide range of proteins, including transcription 
factors, are substrates to the action of HDACs (Kim et al., 2006). In fact, butyrate 
treatment was shown to affect the binding of some transcription factors (Rada-
Iglesias et al., 2007). Furthermore, it is difficult to distinguish the primary effects of 
histone hyperacetylation and secondary effects resulting from the modulation of 
acetylated proteins. These phenomena are likely to explain the large proportion of 
genes down-regulated by VPA.  
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4.2.3 Global changes versus local changes  
Even though western blots revealed important increases in VPA-induced acetyl mark 
abundance, local patterns could vary from one gene to the other. In fact, it is rather 
unlikely that all genes are regulated by HDAC enzymes, so one could expect the 
hyperacetylation not to be uniform across the genome. Binding maps of five HATs 
(p300, CBP, MOF, PCAF, Tip60) and four HDACs (1, 2, 3, 6) in CD4+ T cells were 
generated using ChIP-sequencing (Wang et al., 2009). Surprisingly, occupancy of all 
of these enzymes positively correlated with gene expression, RNA pol II binding and 
H3/H4 acetylation. Importantly, treatment with the HDACi trichostatin A (TSA) 
induced H3K9 and H4K16 hyperacetylation mostly at active genes or silent genes 
enriched in H3K4me3 and suspected to be poised for transcription. However, TSA 
increased Pol II binding at silent genes enriched for H3K4me3 but did not induce 
transcription (Wang et al., 2009). The limited effect of a VPA treatment on 
transcription in ES cells could therefore be due to (1) the fact that HDACs are only 
active on a subset of genes and (2) the fact that hyperacetylation alone is not 
sufficient for the activation of silent genes.      
In addition, one could imagine several mechanisms of gene protection against 
hyperacetylation. For instance, important regulatory regions could be protected by 
insulators. Hyperacetylation could also be buffered by other modifications, or 
redundancy between HDACs could allow the maintenance of normal acetylation 
levels where it is important. In fact, VPA targets many HDACs but not all. Therefore, 
assessing the degree of mark enrichment at specific genes would be essential to 
understand their role in HDACi-mode of action. For this purpose, ChIP technology 
was used and allowed quantification of specific histone marks at specific regions of 
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the genome. Levels of the three “activating” marks, (H3K9ac, H4K8ac and 
H3K4me3), and the “silencing” mark (H3K27me3), were analysed across several 
genes that showed various responses to the VPA treatment: Egr1, Ndgr4 and H1f0 
were up-regulated whereas Anapc7 and Slc6a8 were unaffected and Nanog was 
down-regulated. 
 
Because we looked at a small number of genes, and qPCR only allows the analysis 
of small regions of the genome, it is very difficult to draw general conclusions from 
those experiments. However, we were able to detect trends within this specific pool 
of genes: First of all, levels of H3K9 acetylation were raised by VPA on all genes 
regardless of the transcriptional response to the treatment. Although levels of 
enrichment in untreated cells did not correlate with the fold changes after treatment, 
increases on non-affected genes and Nanog were modest compared with increases 
at up-regulated genes. More importantly however, while we showed by western 
blotting that H3K9ac was increased by 16-fold following VPA treatment, ChIP data 
never showed enrichment by more that 2.5-fold. These results suggest that the 
genes we analysed were protected against massive hyperacetylation. It is also 
possible that this set of genes was not targeted by HDACs to start with, so it would 
be interesting to measure the local abundance of these enzymes by ChIP.   
 
Even though levels of H4K8ac were low in untreated cells, loss of enrichment was 
consistently observed and seemed to be proportional to the H3K9ac increase. This 
result is consistent with a previous study in which hepatocarcinoma cells were 
treated with the HDACi butyrate. The authors reported frequent H4 deacetylation 
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after the treatment (Rada-Iglesias et al., 2007). However, H3 also appeared 
deacetylated and the authors concluded that hyperacetylation was only an early and 
transient event (occurring between 2 and 4 hours of treatment). In this study, 
deacetylation of both H3 and H4, along with loss of RNA pol II binding, correlated 
with down-regulation of the genes. Interestingly, the authors showed loss of binding 
of several factors including CBP at specific genes. That could well explain the loss of 
acetylation following VPA treatment (Rada-Iglesias et al., 2007). In our study 
however, we did not detect H3 deacetylation, and deacetylation of H4 occurred even 
on up-regulated genes. As we looked at only a small number of genes, this may not 
reflect a general trend.  
 
Histone acetylation and methylation have shown some degree of interdependence 
(Daniel et al., 2004; Dou et al., 2005) so it was interesting to measure the impact of a 
VPA treatment on some methyl marks. Working with ES cells, the enrichments of the 
“activating” mark H3K4me3 and the “silencing” mark H3K27me3 were measured. 
Although fold changes were not massive, it was interesting to see that H3K4me3 only 
increased at the promoter of the two up-regulated genes Egr1 and Ndrg4. On the 
other hand, significant losses of enrichment were observed at the promoter of Nanog 
(down-regulated by the treatment) and Anapc7 that was unaffected by VPA. It could 
therefore be speculated that the effect of VPA on transcription is translated by the 
histone mark H3K4me3 rather than hyperacetylation. A high throughput study would 
be essential to test this hypothesis.  
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Finally, consistently with western blot analysis, levels of H3K27me3 were low and 
were not affected by VPA treatment. Interestingly, the mark was more abundant at 
the promoters of up-regulated genes, particularly Egr1 and H1f0. This might suggest 
a certain level of bivalency at these genes and that they were poised for transcription. 
In this case, VPA would potentially have an enhancer role. The analysis of bivalent 
genes like the Hox genes was thus a possible next step.    
 
4.2.4 Hyperacetylation and pluripotency 
Because this study partly aimed to measure the long term effect of transient VPA-
induced hyperacetylation in ES cells, it was essential to limit “side” effects included 
differentiation. In fact, if the cells had differentiated after the treatment, potential long-
term effects could be the result of the loss of pluripotency rather than the memory of 
hyperacetylation. In addition, HDAC inhibitors are believed to combat malignancy by 
inducing apoptosis, cell cycle arrest, differentiation (Kuendgen and Gattermann, 
2007) or the reactivation of tumour suppressor genes (Takai and Narahara, 2008). 
With the concept of cancer-stem cells currently growing (Clevers, 2011), it was 
therefore interesting to analyse the global effect of VPA treatment on the ES cell 
transcriptome.  
  
Gene clustering analysis showed that eight hours VPA treatment significantly affects 
the expression of genes involved in cell cycle regulation or apoptosis. However, cell 
cycle profiles of treated ES cells obtained by FACS analysis showed that VPA has a 
very limited effect. Futhermore, measure of cell death by trypan blue staining did not 
show any significant changes. These results suggest that the changes in 
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transcription were compensated later. It is also important to remember that 
microarray analysis only allows one to measure effects at a transcriptional level. In 
fact, variations in transcript abundance do not mean variations in protein abundance.  
Interestingly, the expression of some histone modifying enzymes, including lysine 
demethylases and lysine acetyl-transferases, was down-regulated. This could explain 
the limited changes observed by ChIP at gene promoters. However, this 
phenomenon could not be global as western blotting experiments confirmed the 
massive hyperacetylation induced by VPA. We were however unsuccessful in 
detecting hyperacetylated loci. Interestingly, immunofluorescent staining showed that 
hyperacetylation of H3/H4 following butyrate treatment mostly occurs at the nuclear 
periphery, which suggests that hyperacetylation could take place on constitutive 
heterochromatin or cytoplasmic histones (Rada-Iglesias et al., 2007).  
Finally, at a transcriptional level, very few genes involved in the regulation of 
pluripotency and differentiation were affected by VPA. However, transcription of 
Nanog, Klf4 and Sox2, master regulators of pluripotency, was modulated in response 
to the treatment. Nevertheless, VPA treatment did not affect OCT4 and KLF4 protein 
levels and the transcriptional effects were only transient.  
      
Although the idea that HDACi affect transcription to inhibit the proliferation of cancer 
cells is attractive, it seems that cells were able to maintain their phenotype even 
when exposed to the drug. The analysis of complete transcriptome and proteome 
would be useful to draw final conclusions. However, our data confirmed that gene 
expression involves more than one level of regulation and systems must exist to 
ensure proper cell function in different conditions. For instance here, it seems that 
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hyperacetylation does not occur at important regulatory sequences (i.e. promoters). 
In addition, microarray data revealed that affected genes were both enhancers and 
inhibitors of functions like cell cycle progression or apoptosis, which could result in 
limited changes of the phenotype. In addition, changes may be needed to preserve 
the normal cell cycle under a different environment such as metabolic changes 
caused by VPA treatment. It is important to remember that these observations are 
only valid for eight hours treatment with 1mM VPA. Effects including cell cycle arrest 
or apoptosis could still be caused by longer treatment.  
It is also possible that HDAC inhibition acts via the modulation of non-histone protein 
acetylation. Several studies have shown that acetylation is an abundant post-
translational modification (Choudhary et al., 2009). For instance, a highly conserved 
lysine residue was found in the nuclear export signal of Sox2. Acetylation at this site 
is required for the nuclear export of Sox2 and its degradation via ubiquitination and 
proteasome degradation (Baltus et al., 2009b). The up-regulation of Sox2 we 
observed after VPA treatment could then be the result of an increase in Sox2 
degradation. Interestingly, expression of Nanog was shown to be regulated by Sox2 
that brings the mSin3A-HDAC complex to the Nanog promoter. Consistent with our 
data, loss of activity of the complex led to a decrease of Nanog expression (Baltus et 
al., 2009a). 
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4.3 Response of homeobox genes to a VPA treatment  
4.3.1 Histone modifications and transcription 
The Hox gene family, coding for homeobox transcription factors, plays a crucial role 
in the differentiation process (Krumlauf, 1994). Importantly in ES cells, these genes 
are maintained silent but hypothetically poised for activation via the establishment of 
bivalent domains at their promoters. The presence of H3K4me3 might predict rapid 
activation upon specific signals, whereas H3K27me3 is believed to ensure silencing 
(Bernstein et al., 2006). As VPA is a powerful teratogen (Nau et al., 1991), it was 
interesting to test if hyperacetylation could disrupt this bivalency and the expression 
state of Hox genes.  
 
Although levels of Hoxb gene expression were very low in ES cells, we observed the 
up-regulation of Hoxb1, 4 and 7 following VPA treatment in two different ES cell lines. 
We therefore decided to analyse histone modifications at the promoter of hoxb1, 4 
and 7 as well as hoxb2 and 5 that were not affected by the treatment. Levels of 
H3K9ac, H4K8ac, H3K4me3 and H3K27me3 were assessed by ChIP before and 
after eight hours treatment with VPA. Strikingly, hoxb4 and hoxb7 were the only 
genes showing bivalency around the transcription start site. Although levels of 
H3K27me3 were high at all studied hoxb genes before treatment, only hoxb4 and 
hoxb7 showed enrichment for H3K4me3. Those observations contradict the current 
consensus that describes hoxb genes as well-known bivalent genes. Bivalent genes 
have been described as genes enriched for both the activating mark H3K4me3 and 
the silencing mark H3K27me3. Co-localisation of these marks is believed to provide 
a mechanism for rapid activation or rapid silencing of a gene. However, because the 
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regulation of hox genes appear to depend on their clustering, it is possible that 
bivalency is not needed at each promoter. Interestingly, it appears that hoxb4 and 7 
were also the only genes enriched for H3K9ac and to less extent H4K8ac.  
After treatment, H3K9ac was increased at all promoters with significant fold changes. 
On the other hand, H4K8ac and H3K4me3 levels were not affected by the treatment 
suggesting no role for these marks in the response to VPA at the hoxb cluster. 
H3K27me3 levels remained very high after treatment, although modest deceases 
were sporadically observed. With the exception of H3K9ac that significantly 
increased after treatment, regardless of the transcriptional state of genes, the histone 
marks we analysed remained essentially unchanged following VPA treatment. These 
results again strongly suggest that hyperacetylation does not drive transcription on its 
own. Interestingly, the only genes that appeared bivalent (i.e. hoxb4 and 7) were up-
regulated by the treatment. We speculate that levels of histone modifications after 
treatment do not drive transcription, but levels at the start predispose genes for 
transcriptional change. However, hoxb1 was also up-regulated by VPA and showed 
very low levels of H3K9ac, H4K8ac, and H3K4me3. Analysis of additional regions 
could be informative as it is possible that cis-regulatory elements related to hoxb1 
drove its transcriptional response to the treatment via the modulation of histone 
modifications. In fact, the comparison of hox clusters from 19 vertebrate species 
identified 208 conserved non-coding regions including 43 in the hoxb cluster 
(Matsunami et al., 2010). Phylogenetic footprinting was then used to identify binding 
sites in non-coding sequences. Many of these regions had previously been known to 
generate micro-RNA or to be cis-regulatory elements, however 160 new elements 
were detected including a new RARE motif potentially associated to hox4 
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(Matsunami et al., 2010) (Figure 4.1). Acetylation at RARE has been shown to occur 
prior the induction of hox genes (Chambeyron and Bickmore, 2004; Gillespie and 
Gudas, 2007), therefore how VPA modulates histone modification at non-coding 
sequences in the hoxb cluster could be crucial for the understanding of 
transcriptional changes.       
 
Another element that could have been responsible for the behaviour of hoxb genes 
before and after treatment is the spatial organisation of the cluster. Very little has 
been published on the three-dimensional (3D) architecture of hox clusters. A recent 
study attempted to characterise the 3D organisation of human hox clusters in 
embryonal carcinoma cells (Ferraiuolo et al., 2010). Using chromosome conformation 
capture (3C), the authors identified regions of elevated interaction frequency and 
thereby predicted looping of the clusters (Figure 4.2). In the hoxA cluster, looping 
was more important in the 5’ region and was lost by the addition of retinoic acid and 
to a lesser extend by EZH2 depletion. Finally in this study, the insulator CTCF was 
identified as a potential mediator of DNA loops (Ferraiuolo et al., 2010). 
Unfortunately, the equivalent study has not been done in mouse. However, recent 
ENCODE data are starting to be available and provide some information on the hox 
clusters. Regarding histone modifications, only H3K4me3 data are currently 
displayed. In agreement with our results, enrichments at the TSS of hoxb4 and 7 are 
the highest. Hoxb2 appears depleted at the TSS but enriched in the gene body, 
which we could not have detected with our primers. The insulator CTCF appears to 
bind more often at the end of the cluster, which correlates with what was observed in 
the Ferraiuolo et al. study. Interestingly, hoxb1, 4 and 7 are found in a region widely 
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depleted in CTCF, which could partly explain their special behaviour. Finally, Pol II 
binding appears very low which correlates with silencing in ES cells (Figure 4.3).  
High-resolution analysis of the cluster 3D-organisation before and after treatment 
would be highly informative for a potential role of looping and CTCF binding in the 
transcriptional response to VPA.  
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Figure 4.1 Conserved non-coding sequences within the four 
human hox cluters 
Conserved non-coding sequences (CNSs) were identified using sequence 
alignment of 19 vertebrate species. Here is represented the schematic diagram of 
CNSs over the four human hox cluters. 208 CNSs were detected including 160 
new. Many of these sites constitute cis-regulatory elements or generate micro-
RNA. Interestingly, two of the three tetra-paralogous CNS contain RARE motifs.  
Exons of protein coding genes (Green boxes); Orthologous CNSs (Orange ovals); 
Tetra-paralogous (TP) and di-paralogous (DP) CNSs (Red and blue ovals); Newly 
detected CNSs (Light blue rectangles and circles). 
Taken from Matsunami et al., 2010  
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Figure 4.2 Three dimensional representation of the human 
hoxb cluster  
a, 3C interaction profile indicating looping contacts in the silent hoxb cluster. The 
solid orange vertical line represents the position of “fixed” 3C region.   
b, Predicted two-dimensional representation of the hoxb cluster. 
Taken from Ferraiuolo et al., 2010   
Genomic position relative to the start of the cluster 
a 
b 
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Figure 4.3 Mouse hoxb cluster ENCODE data 
The ENCODE (Encyclopaedia of DNA elements) project maps functional 
elements all over the human and recently mouse genome. Here are represented 
ChIP-seq data obtained for the Hoxb cluster including CTCF occupancy along 
with enrichment profiles of the active mark H3K4me3, the acetyl-transferase p300 
and the RNA pol II in mouse embryonic stem cells.  
H3K4me3 
CTCF 
p300 
RNA pol II 
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4.3.2 Role of the Polycomb proteins 
Results from our ChIP experiment confirmed that a “blanket” of H3K27me3 covers 
the hoxb cluster and is potentially responsible for the silencing of hoxb genes in ES 
cells. For many of the genes we studied, when hyperacetylation occurred at the 
promoter following VPA treatment, it was not sufficient to induce transcription. 
Therefore, we hypothesised that one protective mechanism involves the polycomb 
mark, which provided a silencing mechanism that hyperacetylation could not reverse. 
For this reason, the transcriptional states of hoxb genes in ES cells knocked out for 
the two polycomb proteins eed and ring1b were analysed before and after VPA 
treatment.     
 
Depletion of polycomb proteins induced a decrease of H3K27me3 global level and a 
striking increase in global H3K27ac abundance. These results are in agreement with 
previous studies that identified H3K27 methylation and acetylation as exclusive 
marks. In Drosophila knockout of e(z), a switch between the two marks was observed 
globally and at the promoter of hox genes including Abd-A (Tie et al., 2009). Similar 
observations were made at the promoter of polycomb-target genes in mouse ES cells 
knocked out for Suz12 (Pasini et al., 2010). In both studies, CBP and trithorax 
proteins appeared necessary for the increase in H3K27ac. These results suggested 
that one role of the polycomb complex is to prevent H3K27 acetylation (Pasini et al., 
2010). It would therefore be interesting to analyse levels of H3K27ac across the hoxb 
cluster, for instance at promoters or enhancers like RARE regions. Although VPA did 
not affect H3K27me3, western blot analysis of wild type and double knock-out cells 
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showed that global levels of H3K27ac were increased following treatment. Therefore, 
this mark could play an important role in the hox genes response to VPA.  
In knockout cells, hoxb transcripts were generally increased. However, this induction 
was small compared with that observed during retinoic acid differentiation. Here 
again, the modulation of histone modifications was not sufficient to induce maximum 
transcription. Even though the silencing mark H3K27me3 was decreased and 
acetylation was enhanced, expression levels remained very low. We then tested if 
further hyperacetylation induced by VPA could derepress hoxb gene transcription. 
With the exception of hoxb1, that was significantly up-regulated, none of the hoxb 
genes were affected by the treatment. Unfortunately, we have not performed ChIP 
analysis of the cluster in these cell lines so we can not claim that acetylation was 
raised specifically at the hox genes following treatment in dko cells. If so, it would 
indicate again that acetylation is not a causative signal for transcription. However, it 
is possible that mechanism prevented further hyperacetylation at these sites. Finally, 
the increase in hoxb1 transcript could be due to early differentiation. It would be 
interesting to analyse histone marks at its promoter or at the associated RARE-
enhancer. In fact, H3K27ac was shown to specifically occupy active enhancers 
(Creyghton et al., 2010).   
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4.4 Long term effect of transient hyperacetylation 
4.4.1 Role of histone modifications in epigenetic inheritance 
Histone modifications are believed to be heritable through the cell cycle for the 
maintenance of chromatin states and gene expression patterns. However, 
mechanisms of inheritance are not well understood. It has been hypothesised that 
histone modifications are put in place during replication, through interactions between 
modifying enzymes and the replication machinery (Probst et al., 2009). The role of 
histone chaperones in preventing the dilution of enzymes or histone proteins has 
been highlighted as well (Avvakumov et al., 2011; Quivy et al., 2008). In addition, 
past studies have shown that several binding proteins or histone modifications 
colocalise with metaphase chromosomes and therefore are potentially transmitted to 
daughter cells (Aoto et al., 2008; Blobel et al., 2009; Hansen et al., 2008; Terrenoire 
et al., 2010).  
One way of testing the inheritance of histone modifications is to induce them with an 
environmental signal and assess if they can persist, even in the absence of the 
original signal. Very little evidence of the inheritance of induced marks is available to 
date, leading to some controversy concerning the epigenetic nature of histone marks. 
An early study in yeast showed that TSA treatment was able to induce derepression 
of centromeric genes along with chromosome segregation defects and 
hyperacetylation. Those effects persisted for several rounds of cell division after TSA 
removal, suggesting that hyperacetylation could be remembered (Ekwall et al., 
1997). However, both hyperacetylation and transcription were persistent, introducing 
uncertainty over which is responsible for the other.  
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Another study claimed that relocation at the nuclear periphery was responsible for 
the transcriptional memory of Gal genes. The authors suggested that the histone 
variant H2A.Z was required (Brickner et al., 2007). However, experiments using 
heterokaryon cells – with two nuclei in the same cytoplasmic environment – revealed 
that the memory of previous transcription was dependent on a cytoplasmic element, 
Gal1-galactokinase (Zacharioudakis et al., 2007).      
     
4.4.2 Memory in ES cells  
Because so few studies have asked whether histone modifications could be the 
carrier of an epigenetic memory, we decided to test this hypothesis in our ES cell 
line. Cells were treated for eight hours with VPA and washed out for five days. 
Acetylation levels and global transcription were analysed after treatment and after 
washout in order to see if cells could remember hyperacetylation and induced 
changes in gene expression. HDAC enzymes have been shown to interact with 
PCNA suggesting that acetyl marks are deposited on incorporated histones during 
replication (Probst et al., 2009). In addition, active genes were associated with early 
replication and acetylation. Importantly, when gene templates were injected into early 
replicating nuclei, they became acetylated and transcribed and this state was 
preserved through the cell cycle (Zhang et al., 2002). It therefore appears that 
histone acetylation participates to the inheritance of chromatin states and 
transcription levels.  
 
When gene expression in washed out and control cells were compared, we could not 
detect any significantly up- or down-regulated genes. After five days post wash out, 
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expression of all VPA-affected genes was back to normal. We concluded that the 
HDACi VPA could not induce long-term effects on transcription in ES cells, at least 
for the genes we analysed and over the time of treatment we applied. In fact, the time 
of treatment was perhaps too short to induce long-term effects. The turnover of acetyl 
mark is generally considered high and increases with acetylation levels which 
suggests that this modification is not very stable (Zee et al., 2010). Therefore, 
acetylation is possibly not an ideal mark for memory. This would partly explain the 
rapid disappearance of the mark and the complete recovery of normal transcription 
activity after wash out. Although histone demethylases have been characterised, 
methylation appears as a more stable mark with little turnover and could thus provide 
a mechanism for histone mark inheritance (Rice and Allis, 2001). However, although 
we did observe an increase of H3K4me3 following treatment at a global level, the 
mark rapidly disappeared during the wash out.  
Finally, ES cells divide very rapidly which was an advantage for our model system. 
However, eight hours of treatment might have created heterogeneity of populations. 
Because cells were not synchronised for the experiment, it is possible that they didn’t 
respond uniformly to the short VPA treatment. Even if some of the cells kept the 
memory of hyperacetylation, they were rapidly diluted after wash out.  
 
4.4.3 Memory in differentiating cells 
Using retinoic acid, it is possible to progressively induce the hox genes during ES cell 
differentiation. This group of genes therefore provide a good model for the study of 
predictive marks, as if histone modifications form an epigenetic code, they must be 
predictive of transcription states. In ES cells, it was shown that H3K9ac and 
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H3K4me3 enrichments were increased by retinoic acid treatment in the promoter of 
hoxb9 days before its transcriptional induction (Chambeyron and Bickmore, 2004). In 
addition, several histone modifications have been shown to be predictive of 
transcription in differentiating B-cells. In fact, a region in the $5-VpreB1 locus was 
already acetylated on H3 and di-methylated on H3K4 in ES cells. At a later stage 
transcription factors including TAF10, TBP, Brg1 or PU.1 and the RNA pol II would 
bind the region. Finally in pre-B cells, histone marks and transcription factor binding 
spread and $5 and VpreB1 genes became expressed (Szutorisz et al., 2005). Finally, 
a previous study in our laboratory has shown that hyperacetylation, induced by VPA 
in differentiating mouse embryos, persisted after wash out of the drug. Embryos were 
treated between the 8-cells stage and the morula stage. An increase in H4 
acetylation and H3K4me3 was observed at the promoters of hoxb1 and hoxb9 and 
remained until the blastocyst stage (VerMilyea et al., 2009).  
 
Our experiments in ES cells showed that VPA treatment was not able to induce long-
term hyperacetylation or changes in gene expression. We concluded that acetylation 
on its own was not a sufficient signal for substantial transcriptional changes or 
epigenetic memory. However, because histone modifications seamed to be 
predictive of future transcriptional activation in ES cells, it was decided to test the 
effect of hyperacetylation added to the differentiation signal. Experiments in mouse 
embryos can detect persistent changes at the promoter of developmental genes. We 
therefore decided to use retinoic acid-differentiation of ES cells as a model and 
analyse the long-term effect of transient exposure to VPA on hoxb gene expression. 
Cells were treated for 16 hours with VPA (8 hours before and after LIF removal) and 
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retinoic acid was added two days later. Hoxb gene expression was quantified every 
day until day 8 of differentiation. The experiment was repeated three times and when 
results were merged we could not observe any differences in the timing of hoxb gene 
expression in control and treated cells. The current model is that retinoic acid (RA) 
binds to retinoic acid response elements (RARE) and leads to the loss of polycomb 
proteins binding and a consequential loss of H3K27me3. RA is also able to recruit 
acetyl-transferases including p300 and RNA pol II (Gillespie and Gudas, 2007; Lee et 
al., 2007a). An increase in H3/H4 acetylation is therefore an important step in the 
transcriptional activation of RA target genes during differentiation. Thus, it is possible 
that an overlap between the RA and VPA treatments might have been more efficient 
to induce long-term effects. In fact, removal of LIF along with the addition of TSA was 
shown to induce the hoxa1 gene but only at half the level of RA-induction (Lee et al., 
2007a). In our model system, the end of the VPA treatment and the beginning of the 
RA treatment were separated by 40 hours, which considering our previous results, is 
likely to be sufficient to reset histone marks and gene expression. In this case, 
normal timing of hoxb gene expression is not surprising.  
However, when separate replicates were analysed, two out of three did show early or 
greater induction of some hoxb genes. We could thus speculate that the timing of 
hoxb gene induction was disturbed by early hyperacetylation of promoters or 
associated RARE. In order to confirm this scenario, the experiment should be 
repeated and ChIP experiment performed to analyse the evolution of histone 
modifications at regulatory sequence during the differentiation time course. In fact, 
variations between time courses could also be due to very low expression of hox 
genes in ES cells, which could cause leaking expression. Finally, variations could be 
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the result of asynchronous population of cells differentiating or cells going down 
different differentiation pathways.    
  
4.5 Conclusions 
Although our study requires additional experiments in order to finalise some 
important results, it seems likely that histone acetylation is not a straightforward 
mechanism. In fact, hyperacetylation does not always correlate with transcriptional 
activation and is certainly not enough on its own to relieve polycomb silencing. The 
set of experiments we performed could lead to the conclusion that histone acetylation 
is not a causative event. However, it is important to remember that we have chosen 
to work with the HDACi VPA, which is not a specific inhibitor and induces the 
hyperacetylation of many non-histone proteins. It is therefore possible that its 
mechanism of action remains too complicated to be properly dissected. It is also 
important to note that VPA targets HDAC enzymes so the hyperacetylation could be 
classified as an indirect effect. Acetylation by acetyl-transferases could partly cause 
transcriptional activation whereas HDAC enzymes would for instance be involved in 
balancing acetylation levels and preventing over-production of transcripts. In this 
case, the removal of the drug is very likely to reset basal transcription activities. 
Another explanation for the absence of long-term effects resides in the fact that, 
although HDACs associate with the replication machinery, it is conceivable that they 
act in coordination with other factors or marks. Chromatin and transcriptional states 
have to survive replication to ensure cell identity. However, the replication phase 
provides a time window for changes. One could imagine that the presence or the 
absence of specific factors would dictate if an acetyl mark were to be transmitted to 
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the next cell generation. In this case, the removal of VPA would not be a sufficient 
signal for memory.  
In conclusion, histone acetylation could provide an important but not sufficient    
signal for active transcription. Although it would not be the first signal or the decisive 
signal for activation, it could still be important for the maintenance of open chromatin 
and active transcription. The fact that a biological event needs several layers of 
control makes sense, as cells have to buffer their environment in order to function 
properly.  
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